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Abstract  
The neural crest (NC) is a multipotent, migratory cell population that is unique to 
vertebrate embryos and gives rise to many derivatives, such as the craniofacial 
skeleton, sensory neurons and pigment cells. A complex gene regulatory network 
underlies the process of NC formation, which involves the early induction of the 
neural plate border (NPB), specification of the NC, migration of the NC away from 
the neural tube along distinct pathways and differentiation into diverse cell types. 
microRNAs (miRNAs) are a class of non-coding regulatory genes, which act post-
transcriptionally to regulate gene expression. They are of widespread 
significance and have been implicated in many biological processes. Many 
miRNAs have now been identified, however, as of yet, they have not been shown 
to have any direct roles in early NC development. Using various molecular 
techniques this study has placed specific miRNAs within the complex NC gene 
network. These miRNAs are miR-196a and miR-219. SRNA sequencing of 
induced Xenopus NC tissue generated a miRNA expression profile which in 
combination with whole mount in situ hybridisation (WISH) revealed multiple 
candidate miRNAs expressed in NC. Using knockdown (KD) experiments, the 
depletion of miR-196a and miR-219 resulted in aberrant NC development 
including abnormal craniofacial cartilage development. Using luciferase assays, 
this study shows for the first time that miR-219 directly targets the transcription 
factor Eya1 in vitro. This gene lies directly upstream of the NPB marker Pax3. 
When miR-219 is knocked down, Pax3 expression is expanded across the 
surface ectoderm of the embryo suggesting the miR-219 serves to inhibit the 
Pax3 domain. To begin to understand the molecular mechanisms behind both 
this phenotype and why the NC is lost, RNA sequencing on dissected NC tissue 
was employed. Results from this sequencing data demonstrated that following 
miR-219 KD the NPB and the placodes form whilst the NC is lost. This indicates 
that miR-219 is playing a role in ensuring the correct specification of NC. In 
comparison, following miR-196a KD the NPB development is impaired and 
derivatives are lost (placode and NC). This implies miR-196a has an earlier role 
in ensuring the correct induction of the NPB possibly through fine-tuning early 
inducing signals such as BMP and Notch.  Using the data presented in this study, 
the first models of how specific miRNAs could function in NC development have 
been formulated.   
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Chapter 1:  Introduction  
The neural crest (NC), often referred to as the “fourth germ layer”, is a transient, 
multipotent stem cell–like population of highly migratory embryonic cells found 
exclusively in vertebrates (Hall, 2000). Their derivatives contribute to a wide 
variety of tissues and organs in the developing embryo. These include, but are 
not limited to melanophores, enteric ganglia, neuroendocrine cells, neurons, 
craniofacial cartilage and bone (Le DouarinN, 1999). As a defining feature of 
vertebrates, NC cells have attracted the attention of embryologists for over a 
century as a model for studying embryonic induction, specification, tissue 
commitment, migratory potential and cell-fate determination. In addition to their 
multipotent characteristics, NC cells can regenerate after ablation, with residual 
neural tube cells and adjacent NC compensating for the missing tissue (Scherson 
et al., 1993, Hunt et al., 1995). As a result of these defining characteristics, NC 
cells have spawned wide interest from the scientific community in gaining an 
understanding of the mechanisms behind NC development as well as using these 
cells in stem-cell-based therapies (Crane and Trainor, 2006). 
During development, NC cells form over a time period that spans from pre-
gastrulation to late organogenesis, this is in response to both intrinsic and 
extrinsic influences (Simoes-Costa and Bronner, 2015, Hoppler and Wheeler, 
2015). To initiate NC development a combination of inductive signals emanating 
from surrounding tissues is required. Fate map studies have demonstrated that 
presumptive NC cells are in proximity to three different regions: the underlying 
mesoderm, the neuroectoderm (neural plate) and the non-neural ectoderm 
(presumptive epidermis) (Liem et al., 1995). It is as a response of signalling from 
these tissues that the presumptive NC region, namely the neural plate border 
(NPB) is set up. Once induced, this territory becomes competent to respond to 
signals specifying bona fide NC progenitors (Stuhlmiller and Garcia-Castro, 
2012). As neurulation progresses, these precursors come to lie within the 
elevating neural folds, then, following neural tube closure they come to reside in 
a domain of the dorsal neural tube from which they will subsequently migrate 
(Figure 1). During this period, NC cells lose cell–cell adhesion and undergo 
cytoskeletal rearrangements and morphological changes that allow them to 
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delaminate and emigrate from the neuroepithelium. They acquire a migratory 
ability, with the acquisition of cell-surface receptors, metalloproteases and 
adhesion molecules that allow them to respond properly to cell–cell interactions 
and environmental cues that guide them along their well-defined pathways of 
migration. After settling in diverse and sometimes distant sites in the periphery, 
NC cells finish their journey by differentiating into a vast array of derivatives 
including elements of the craniofacial skeleton and pigment of the skin (Simoes-
Costa and Bronner, 2015, Sauka-Spengler and Bronner-Fraser, 2008a). Cell 
lineage-tracing experiments have identified the various derivatives to be 
associated with specific NC populations. For example, cranial NC form the facial 
skeleton, including the upper and lower jaw bones of the neck and various 
aspects of the cranial ganglia (Couly et al., 1998) whilst the vagal NC form the 
outflow tract of the heart of enteric ganglia of the gut (Le Douarin and Teillet, 
1973, Creazzo et al., 1998). The trunk NC contribute to the ganglia of the 
sympathetic nervous system (Le Douarin and Smith, 1988). 
This complex array of events is guided by a well-orchestrated gene regulatory 
control network that has been extensively studied and reviewed (Sauka-Spengler 
and Bronner-Fraser, 2008a, Betancur et al., 2010, Simoes-Costa and Bronner, 
2015). This network is comprised of multiple regulatory modules that guide 
acquisition of specific properties such as multipotency and migratory capacity in 
NC cells. It involves signalling pathways and transcription factors that are 
responsible for the induction, specification and differentiation of the NC.  
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Figure 1: Key stages in NC development.  
Induction of NC initiates at the NPB and is mediated by signals including FGF, Wnt and BMP.  These signals 
collaboratively induce the expression of a number of NPB specifiers including Pax3 and Zic1. Pax3 and Zic1 
in turn act synergistically, in a Wnt-dependent manner, to up-regulate NC specifiers such as Snail and FoxD3 
in the neural folds.  c-Myc and Id work by mediating cell-fate decisions by controlling the cell cycle, but also 
may maintain the NC progenitor pool in a multipotent state. Sox9 confers survival properties to trunk NC 
precursors through up-regulation of Snail, an anti-apoptotic factor. Expression of these early NC specifiers 
in the NC progenitor population segregates them from the dorsal neuroepithelium, as these genes control 
the events of cell proliferation, delamination and the onset of the epithelial to mesenchymal transition (EMT). 
Other NC specifiers, such as FoxD3 and Sox10, persist in delaminating and migrating NC cells, where they 
control expression of downstream effector genes such as type II cadherin, cadherin-7 (Cad7) (Sauka-
Spengler and Bronner-Fraser, 2008a) 
 
MicroRNAs (miRNAs) are small non-coding regulatory RNAs that range between 
19-25 nucleotides (nt) in length, they are thought to regulate the expression of 
more than 30 percent of protein-coding genes in mammalian genomes (Filipowicz 
et al., 2008). By inhibiting target mRNAs through translational degradation, 
repression or other mechanisms, miRNAs are involved in a number of biological 
processes including but not limited to cellular differentiation and development 
(Bartel, 2004). With the tremendous improvement in the ability to identify miRNAs 
over the last decade, along with the ability to manipulate miRNAs both in vitro 
and in vivo with synthetic precursor and inhibitor miRNA molecules, the 
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understanding of the roles miRNAs play in various cell types has been vastly 
expanded (Croce, 2009) (Melo and Esteller, 2011). Up to this point, the role of 
miRNAs in early NC development is yet to be elucidated. The present study 
sought to investigate the roles of varying miRNAs in early NC development using 
Xenopus laevis as a model organism.  
1.  Neural crest – a vital cell population for 
development  
1.1. Induction and formation of the NPB 
The classical view of NC induction suggested that it occurs during the process of 
neurulation, as the neural folds elevate. This was thought to be caused by 
interactions resulting from the juxtaposition of epidermis on the elevating neural 
plate (NP) (Mancilla and Mayor, 1996, Selleck and Bronner-Fraser, 1995). 
Following that, findings in frog (Monsoro-Burq et al., 2005) and chicken (Basch 
et al., 2006) shed light that NC induction is underway much earlier, during 
gastrulation. During this period, the NPB is established, this region of cells is a 
broad territory between the future neural and epidermis domains which contains 
a multi-progenitor cell population. These cells give rise to NC as well as 
ectodermal placodes and the hatching gland (a gland that releases proteolytic 
enzymes to enable the tadpole to degrade the vitelline membrane) (Groves and 
LaBonne, 2014, Hong and Saint-Jeannet, 2007). More recently, it has been 
suggested that the process of NC induction arises even earlier, prior to 
gastrulation, this is discussed further in section 1.1.1 (Hoppler and Wheeler, 
2015, Buitrago-Delgado et al., 2015). 
Induction of the NPB is initiated in response to signalling molecules emanating 
from adjacent tissues. The “response” that sets future NC cells apart from other 
border cells requires the activation of a battery of transcription factors that imbues 
them with multipotency, characteristics of proliferating cells, and the competence 
to respond to later NC–specifying signals (Groves and LaBonne, 2014). As 
mentioned previously, fate map studies demonstrate that presumptive NC cells 
are in proximity to three different regions: the underlying mesoderm, adjacent 
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neuroectoderm and non-neural ectoderm (Liem et al., 1995, Steventon et al., 
2009). These tissues are thought to secrete signalling ligands, including 
Wingless-type proteins (Wnt), bone morphogenetic protein (BMPs) and fibroblast 
growth factor (FGFs), that have all been demonstrated as essential for the early 
induction, maintenance and differentiation of NC (Knecht and Bronner-Fraser, 
2002, Groves and LaBonne, 2014). 
In Xenopus, high levels of BMP have been shown to be necessary for the 
acquisition of epidermal fate, whereas inhibition of BMP is required for neural 
induction (LaBonne and Bronner-Fraser, 1998). The current model for both 
Xenopus and zebrafish suggests that an intermediate level of BMP is responsible 
for the induction of NC. Indeed, loss of BMP signalling activity in the Zebrafish 
mutants swirl (swr)/bmp2b and snailhouse (snh)/bmp7 results in the disruption of 
NC induction (Nguyen et al., 1998, Schmid et al., 2000). It is proposed that this 
gradient is established through diffusion of secreted BMP originating from the 
non-neural ectoderm thus creating a dorso-ventral gradient of BMP. Alternatively, 
it has been suggested that this gradient is achieved through the action of BMP 
antagonists including Cerberus, Noggin, Chordin, and Follistatins, all of which are 
ligands secreted by underlying paraxial mesoderm (Sauka-Spengler and 
Bronner-Fraser, 2008a, Tribulo et al., 2003, Wilson et al., 1997, Marchant et al., 
1998). Regardless of the way a BMP gradient is established, intermediate levels 
of BMP alone are not sufficient to induce expression of NC markers in Xenopus 
or any other vertebrate model organisms (Garcia-Castro et al., 2002, LaBonne 
and Bronner-Fraser, 1998). BMP signalling is therefore an important initial step 
but additional signals are required for induction of the NC.  
Gain and loss of function experiments in Xenopus and Zebrafish have been used 
to show that the canonical Wnt pathway is required at two time points during NC 
development (Garcia-Castro et al., 2002, LaBonne and Bronner-Fraser, 1998). 
Initially, during induction, an early gastrula-dependent Wnt-signal acts in 
collaboration with BMP antagonists to induce NPB tissue (Groves and LaBonne, 
2014). At later neural-stages, Wnt signalling acts in concert with BMP signalling 
to maintain NC cell fates (Steventon et al., 2009). Throughout the literature, the 
importance of Wnt signalling in NPB formation has been demonstrated 
extensively. For instance, overexpression of Wnt ligands or dominant negative 
forms of LRP6 and TCF proteins perturbed NC induction (Lewis et al., 2004, 
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Saint-Jeannet et al., 1997, Tamai et al., 2000). Several Wnts have been identified 
as key players in Xenopus NPB induction including Wnt6, Wnt8, Wnt1, Wnt3a 
and Wnt7b (Saint-Jeannet et al., 1997, Chang and Hemmati-Brivanlou, 1998, 
LaBonne and Bronner-Fraser, 1998, Schmidt et al., 2007) all of which are 
secreted from the paraxial mesoderm (Christian et al., 1991, Knecht and Bronner-
Fraser, 2002). The downstream frizzled receptors that these Wnts are signalling 
through have also been characterized and include both Frizzled 3 and 7 (Abu-
Elmagd et al., 2006, Deardorff et al., 2001). Another signalling molecule secreted 
from the paraxial mesoderm that is suggested to participate in defining the NPB 
is FGF. However, as with Notch signalling, the importance of these molecules 
varies somewhat between species (Endo et al., 2002, Monsoro-Burq et al., 2003, 
Yardley and Garcia-Castro, 2012). It has been suggested that Fgf8 acts 
indirectly, by activating expression of Wnt8 in the mesoderm, which then induces 
NC in the overlaying ectoderm (Hong et al., 2008). However, recent evidence 
from Xenopus suggests that FGFs can act directly on NC formation through 
activation of the Stat pathway (Nichane et al., 2010). 
Following reception of these ‘‘inducing signals’’ into the NPB territory, a cohort of 
transcription factors, collectively termed NPB specifiers, are activated. These 
specifiers work by imbuing the NPB cells with multipotency and competence 
equipping them with the molecular toolkit to later respond to appropriate signals 
that bestow NC cell fate. Interestingly, it is the region of overlap of these genes 
along with the previously maintained transcription factors which are originally 
characteristic of either the NP or non-neural ectoderm that defines the broad 
territory of the NPB (Simoes-Costa and Bronner, 2015). Expression of the NPB 
specifiers is first noted during gastrulation and includes Msx1, Pax3/7, Zic1 
Tfap2a, Gbx2, Dlx5/6, Gata2/3, Hairy2 and Foxi1/2 (Meulemans and Bronner-
Fraser, 2004, Nichane et al., 2008b, Khudyakov and Bronner-Fraser, 2009). 
Studies have shown that once the expression of these genes commence, these 
transcription factors engage in a series of reciprocal interactions that lead to the 
stabilisation of this regulatory state and ensure their continued expression 
(Monsoro-Burq et al., 2005, Sato et al., 2005). For instance, Nikitina and 
colleagues showed that Tfap2a and Msx1 activate not only each other, but also 
Zic1 and Pax3/7 (Nikitina et al., 2008).  
In Xenopus, integration of inputs from the BMP, FGF, Wnt, and Notch signalling 
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pathways activates expression of Msx1 (Monsoro-Burq et al., 2005, Tribulo et al., 
2003). The up-regulation of Msx1 in the border is essential for formation of bona 
fide NC, as assayed by expression of the NC specifier Snail2. This induction of 
Snail2 by Msx1 is indirectly achieved via the induction of two other NPB 
specifiers, Pax3 and Zic1 (Monsoro-Burq et al., 2005). Both Pax3 and Zic1 
expression require intermediate levels of BMP activity and FGF and/or Wnt 
signalling to be induced (Figure 1). Even though BMP and FGF signals can 
regulate individual expression of Pax3 and Zic1, both transcription factors need 
to be activated simultaneously to achieve NC specification (Sato et al., 2005). In 
Xenopus, high levels of either transcription factor, in the absence of the other 
promotes alternative NPB fates (hatching gland or preplacodal progenitors, 
respectively) (Hong and Saint-Jeannet, 2007, Litsiou et al., 2005). Recently, Pax3 
and Zic1 have been implicated in modulating the transcriptional output of multiple 
signalling pathways involved in NC development (Wnt, Retinoic Acid) through the 
induction of key pathway regulators such as Axin2 and Cyp26c1 (Plouhinec et 
al., 2014). 
1.1.1. Challenging the working model of neural crest cell 
induction 
Until recently, this has been the established model of NC induction. However, in 
2015, Buitrago-Delgado and colleagues published a fundamental paper that has 
questioned this working model of NC (Buitrago-Delgado et al., 2015, Hoppler and 
Wheeler, 2015). They demonstrated that the previous model (described above) 
in which the NC could be described as an endogenous population of induced 
pluripotent stem cells (from ectodermal tissue) was incorrect. This work provided 
insight into how NC cells retain pluripotency rather than gain it and that this is 
selectively inherited from the embryonic stem cells from which they are derived 
(Buitrago-Delgado et al., 2015) (for a more detailed analysis of this paper see 
section 13.4.3). This study raises questions about the identity of what we 
conventionally call the ectoderm (Hoppler and Wheeler, 2015). Moreover, the 
question arises as to how these cells at the NPB region selectively retain 
pluripotency while cells all around them become restricted in their developmental 
potential. The work in this PhD research project addresses one potential way in 
which this process could occur, that being through miRNAs. 
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1.2. Specification of the neural crest  
Once the competence of the NPB territory is established by the synergistic activity 
of NPB specifiers, the prospective NC cells will integrate new signalling inputs 
and commence the process of specification into the bona fide NC. This occurs 
because of spatial-temporal expression of another set of transcription factors 
named ‘‘neural crest specifier genes’’. These include, but are not limited to, 
FoxD3, Snail2, Tfap2a, c-Myc, Id, and members of the SoxE family (Sox9/10) 
(Khudyakov and Bronner-Fraser, 2009). These genes are either directly or 
indirectly regulated by NPB genes as well as receiving various signalling pathway 
inputs and intricate cross-regulatory activity with other NC specifiers. These 
transcription factors work together to define a new regulatory state of these cells 
and guide a complex sequence of developmental events to specify their NC fates 
(Sauka-Spengler and Bronner-Fraser, 2008a). These events involve substantial 
changes in the adhesive properties, shape, motility and signalling capacity of NC 
cell precursors. This allows them to segregate and delaminate from the 
neuroepithelium, migrate away from the neural tube along precise tracks and 
settle at distant territories and differentiate. NC specifiers achieve this by directly 
regulating various downstream targets. Despite working collaboratively to define 
this regulatory state, the NC specifiers display alternative expression profiles. 
Some specifiers are present only at the onset of the specification, prior to their 
migration (such as Snail2). Others, such as Sox10, persist in migrating and 
differentiating NC cells. Furthermore, some NC specifiers have a biphasic 
expression pattern in which they are present, first in NC progenitors and later 
again in specific differentiating derivatives (e.g., Sox9). A subgroup of 
transcription factors such as Tfap2α, Snail1, Id, c-Myc, and Twist are expressed 
even before NC progenitors become apparent, though the timing of their onset 
and presence within the NPB varies among different vertebrates (Betancur et al., 
2010, Nikitina et al., 2008, Sauka-Spengler et al., 2007). 
NC specifiers can be separated into two groups: early NC specifiers and late NC 
specifiers. The expression of early NC specifiers is first identified at the NPB. 
These include c-Myc Id3 and Snail1 (Khudyakov and Bronner-Fraser, 2009, Liu 
and Harland, 2003). It has been suggested that early NC specifiers such as c-
Myc and Id3 may have a role within the NC gene regulatory network (GRN) to 
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maintain NC cells in a multipotent state, mediating critical cell cycle and/or cell 
fate decisions by controlling the expression of genes involved in cell division and 
downregulating factors involved in the onset of terminal differentiation (Bellmeyer 
et al., 2003, Kee and Bronner-Fraser, 2005, Light et al., 2005, Hatch et al., 2016). 
Id is a small transcriptional regulator that, in Xenopus, acts directly downstream 
of c-Myc (Figure 1). It functions as a repressor and possesses a helix-loop-helix 
(HLH) domain for dimerization, but lacks a basic domain for DNA binding. Id 
proteins interfere with gene expression by binding to transcriptional activators 
from bHLH families and preventing them from activating their direct targets 
(Ruzinova and Benezra, 2003). Depletion of Id3, like depletion of c-Myc, leads to 
the loss of NC progenitors and excess formation of central nervous system 
progenitors (Light et al., 2005). Conversely, overexpression of Id3 maintains the 
NC in a prolonged multipotent progenitor state (Kee and Bronner-Fraser, 2005). 
Thus, Id3 has a role in maintaining the multipotency of the NC progenitor pool 
and in mediating the decision between proliferation and apoptosis, acting as a 
cell-cycle-control switch (Nikitina et al., 2008). 
The expression of late NC specifiers is first seen in pre-migratory NC cells of 
which some continue expression throughout migration. These include Snail2, 
FoxD3 and members of the SoxE family (Sox9 and Sox10) (Khudyakov and 
Bronner-Fraser, 2009). Snail2, the zinc finger transcription factor, was one of the 
first genes shown to affect NC formation in a cell autonomous manner. Its 
knockdown or overexpression suppresses or expands, respectively, NC cell 
migration from the neural tube (LaBonne and Bronner-Fraser, 2000). The 
expression of Snail2 is directly regulated by intermediate levels of BMP, which is 
modulated by input from the Wnt pathway. Accordingly, the Snail2 regulatory 
region contains binding motifs for Smad1, a transcription factor that mediates 
BMP signalling (Sakai et al., 2005), and Tcf/Lef1, which mediates the β-catenin-
dependent Wnt signal (Vallin et al., 2001). Overexpression of Hairy2, a direct 
downstream effector gene of Notch signalling, causes an expansion of Snail2 
expression in frog (Glavic et al., 2004) and has been proposed as a direct input 
into the Snail2 regulatory region. In addition, it has been demonstrated that the 
NPB specifiers Zic1, Msx1, and Pax3/7 are independently necessary and 
sufficient for the expression of a group of NC specifiers including Snail1/2, Foxd3, 
Twist1, and Tfap2b (Meulemans and Bronner-Fraser, 2004, Sato et al., 2005, 
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Tribulo et al., 2003, Plouhinec et al., 2014). The winged-helix transcription factor 
FoxD3 appears to play a role in maintaining NC multipotency by preventing early 
differentiation (Lister et al., 2006). It has been shown that, the collective activity 
of Zic1, Msx1 and Pax3/7 complemented with Wnt input induces FoxD3 
expression (Sato et al., 2005).  
The SoxE family of transcription factors, most notably Sox9 and Sox10, have 
well-established roles in NC development. In Xenopus, Sox9 expression is 
dependent on the activity of Tfap2α (Lee et al., 2004, Luo et al., 2003). It has 
been shown that Gbx2 together with Zic1 can induce the expression of NC 
specifier genes including Sox9 and Snail2 while inhibiting preplacodal fate (Li et 
al., 2009a). Relatively recently, Ets1 and cMyb have been added to the NC GRN 
as NC specifier genes. It was shown using knockdown experiments that through 
binding to the promoter region and by inducing the expression of Ets1, cMyb both 
directly and indirectly regulates the onset of Sox10 expression (Betancur et al., 
2014). Sox10 is expressed in migrating NC cells and later becomes restricted to 
the glial lineage (Britsch et al., 2001). Inhibition of Sox10 in Xenopus with 
morpholino antisense oligonucleotides prevents the formation of NC as 
characterised by a loss of Snail2 and FoxD3 (Honore et al., 2003). Mutations of 
Sox10 in mice result in a loss of neurons and glia in the peripheral nervous 
system (Pingault et al., 2013). Similar effects are seen in the zebrafish Sox10 
mutant, colourless (Dutton et al., 2009).  Ets1 however is specific to cranial NC 
population, it is suggested that it has a unique function of establishing a regulatory 
state that activates cranial crest–specific effector genes responsible for the 
transition from the pre-migratory to migratory state (Gao et al., 2010).  
Recently, Tfap2a has been described as a pioneer transcription factor in the 
process of NC specification. Genome-wide profiling of enhancers in NC obtained 
from human embryonic stem cells showed that this transcription factor, along with 
NR2F1 and NR2F2 work by reorganising chromatin conformation to provide 
access to other NPB specifiers, such as Msx1 and Pax3 (Rada-Iglesias et al., 
2012). This is consistent with functional studies that show Tfap2a is required for 
NC specification in Zebrafish, Xenopus and Chick (Schorle et al., 1996, de Croze 
et al., 2011, Wang et al., 2011). 
NC specifiers, in general, represent a node point onto which inductive inputs 
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mediated by or acting in parallel with NPB specifiers converge. Those specifying 
transcription factors in turn control the expression of effector genes that will give 
NC cells their unique migratory and multipotent characteristics. Therefore, in the 
life cycle of a NC cell, it is critical to keep the specifier genes expressed as a unit 
in the network. For this purpose, in frog, high interdependence among NC 
specifiers seems to exist (Sauka-Spengler and Bronner-Fraser, 2008a). Gain and 
loss of function experiments suggest that Snail2 regulates FoxD3, Twist, and 
Sox10 expression, probably in an indirect fashion (Aoki et al., 2003, Aybar et al., 
2003). Ectopic expression of Tfap2α in the NP activates the ectopic expression 
of Snail2 (Spokony et al., 2002), whereas Sox10 feeds back to maintain Snail2, 
Sox9, and FoxD3 expression (Honore et al., 2003). 
At the same time as NC specification, both the preplacodal region and the 
hatching gland are also being established. The cranial placodes give rise to the 
paired sensory organs (olfactory system, lens, inner ear), and contribute to the 
cranial peripheral nervous system (Saint-Jeannet and Moody, 2014). The 
hatching gland is a transient structure that produces proteolytic enzymes 
implicated in the partial digestion of the egg vitelline membrane that protects the 
embryo early in life (Carroll and Hedrick, 1974, Drysdale and Elinson, 1991, Hong 
and Saint-Jeannet, 2007). While NC and cranial placode progenitors are derived 
from the deep layer of the ectoderm, hatching gland cells arise from the outer 
layer of the ectoderm. 
Specification of the preplacodal region is achieved through the expression of the 
key placodal regulators Six1, Eya1/2 and Irx1 which are activated by lateral NPB 
specifiers (Foxi1/3, Gata2/3 and Dlx5/6) (Grocott et al., 2012, Sato et al., 2010) 
(Figure 2). In order to molecularly separate the placodal region from the NC both 
NC and preplacodal genes engage in a number of inhibitory interactions. For 
instance, in Xenopus, Pax3/7 and Msx1 repress the expression of Six1 (Sato et 
al., 2010). Although these molecular markers suggest a clear division between 
the NC and preplacodal domain, studies indicate that these two progenitor types 
are largely intermingled. Labelling of individual cells have shown that, despite 
their expression of specifier genes, the individual progenitors can give rise to 
either NC or preplacodal cells (Selleck and Bronner-Fraser, 1995). Conversely, 
specification of the hatching gland is largely due to the action of the transcription 
factor Pax3. Using a screen designed to identify downstream targets of Pax3 at 
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the NPB, Hong and Saint-Jeannet (2014) recently described a molecular marker 
of the hatching gland, that being the protease Xenopus hatching enzyme 2 
(Xhe2). Xhe2 is exclusively expressed in hatching gland cells and using gain of 
function experiments, they showed that Xhe2 is downstream of Pax3 and is 
sufficient to promote digestion of the vitelline membrane (Hong and Saint-
Jeannet, 2014). 
 
 
Figure 2: The gene regulatory network underlying the formation of the various 
stages of neural crest and the preplacodal region  
 As the NP folds during neurulation, the NPB specifier genes Zic1, Msx1 and Pax3/7 induce the expression 
of NC specifier genes FoxD3, Sox10 and Ets1 (green box). Lateral to the NC cells, are the preplacodal cells. 
They express a distinct set of transcription factors including Six1 and Eya1/2. To stay molecularly separate, 
the two regions (NC and preplacodal genes) engage in a number of inhibitory interactions (A). It is the action 
of the medially located NPB specifiers that activate the expression of premigratory NC specifiers. The 
neighbouring preplacodal region (PPR) is defined by expression of Six1 and Eya1/2, the expression of which 
are activated from the more lateral NPB specifiers. Six1 and Eya1/2 identify the progenitor field that will give 
rise to cranial placodes. Multiple Sox genes are expressed in the NP (B) (Simoes-Costa and Bronner, 2015). 
1.3. Neural crest migration 
After their specification, premigratory NC precursors reside within the dorsal 
neural tube. They subsequently undergo EMT and delaminate from the neural 
tube to undertake their migration and become bona fide NC cells. To permit 
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successful migration, cells are required to become less compact and acquire 
motility, to achieve this, the EMT induces changes at the cellular level that include 
switches in cell junctions and adhesion properties as well as major cytoskeletal 
rearrangements (Simoes-Costa and Bronner, 2015). Initially, the NC cells must 
lose their apical-basal polarity and tight junctions to permit detachment from the 
neuroepithelium (Theveneau and Mayor, 2012). To achieve this, a change in 
cadherin expression is thought to be central to this process. It is reported that 
Snail1/2, Sox10 and FoxD3 all play crucial roles in this process which involves 
upregulation of type II cadherins. These cadherins characterise mesenchymal 
cells and result in a concomitant downregulation of type I cadherins which are 
usually associated with stable cell assemblies (Chalpe et al., 2010, Kashef et al., 
2009, Cheung et al., 2005). Negative regulation of E-cadherin, which characterise 
epithelial cells, along with a loss of cell polarity are essential initial steps in NC 
EMT. This process seems to be directly regulated by Snail1/2, which have been 
shown to bind to the E-cadherin promoter and repress its transcription (Cano et 
al., 2000, Villarejo et al., 2014). Similarly, Snail2 and FoxD3 act directly to 
negatively regulate the expression of Cad6B, a molecule that characterizes cell-
cell adhesion among dorsal neural tube cells, most of which are premigratory NC 
progenitors (Taneyhill et al., 2007). Conversely, as migration is initiated, type II 
cadherin-7 is upregulated, possibly by the concerted action of Sox10 and FoxD3 
(Cheung et al., 2005).  
Snail1/2 genes have also been implicated in regulating cell adhesiveness of NC 
cells through downregulating the expression of structural proteins that constitute 
tight junctions. Such proteins include occludins, which are transmembrane 
proteins with possible roles in the regulation of signalling events at the tight 
junction, and claudins, which mediate calcium- independent cell–cell adhesion 
and are crucial for the barrier function of tight junctions (Shin et al., 2006, Fishwick 
et al., 2012). This occurs as the neural tube is fusing and results in an overall 
decrease in the epithelial character of pre-migratory NC cells, as a part of the 
EMT initiation. In addition to the downregulation of tight junctions, the 
concomitant upregulation of gap junction proteins, namely connexin-43 (Cx43), 
is also reported to influence a migratory phenotype. Cx43 is expressed in mouse 
NC cells at all axial levels (Lo et al., 1997). 
Sox5, a member of the SoxD family, is another transcription factor proposed to 
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have a regulatory role during NC delamination. Sox5 misexpression causes an 
increase in the number of cranial NC generated. Sox5 upregulates Snail2, 
FoxD3, and Sox10 in migrating crest cells and cell autonomously upregulates 
RhoB, a member of the Rho family of small GTPases that controls a variety of 
signal transduction pathways (Groysman et al., 2008, Perez-Alcala et al., 2004). 
RhoB is a well-known regulator of events that change cell morphology such as 
actin cytoskeleton rearrangements as well as the formation of focal adhesions 
and stress fibres (Liu and Jessell, 1998). All these cellular changes are necessary 
for NC delamination (Mackay et al., 1995). 
For NC cells to migrate effectively they must remodel and invade the extracellular 
matrix (ECM). To permit efficient dissemination from the neural tube, NC cells are 
required to penetrate basement membranes and invade extracellular matrices. 
This involves migrating through a mesenchyme containing intricate connective 
tissue barriers that are comprised of collagens, fibronectin, laminins, vitronectin 
and proteoglycans (Theveneau and Mayor, 2012). To navigate on and through 
this ECM, NC cells require proteolytic activity of membrane-bound and/or 
secreted forms of matrix metalloproteases (MMPs), which have been implicated 
in the invasive behaviour of many forms of metastatic cells (Egeblad and Werb, 
2002). NC cells can tightly regulate MMP activity themselves by the release of 
tissue inhibitors of MMPS (TIMPS) (Cai and Brauer, 2002). MMPs reported to be 
involved in in NC migration include MMP2, MMP14, and the disintegrin and 
metalloprotinase 10 (ADAM10) (Duong and Erickson, 2004, Schiffmacher et al., 
2014, Tomlinson et al., 2009, Harrison et al., 2004, Tan et al., 2016). ADAM 
metalloproteinases are cell-surface bound glycoproteins that act both by 
mediating cell–cell adhesion and as ‘sheddases’, in the remodelling of the ECM. 
Acting as sheddases involves facilitating the cleavage of extracellular portions of 
transmembrane proteins thus producing soluble ectodomains from the cell 
surface (McCusker and Alfandari, 2009). Xenopus ADAM13, which is expressed 
in both premigratory and migrating cranial NC cells, has several roles in NC cell 
migration. First, it decreases their adhesion to the ECM and therefore assists in 
detachment from the neuroepithelium and subsequently, during migration, by 
cleaving ECM barriers and therefore facilitating the passage of cells (Kee et al., 
2007, Abbruzzese et al., 2016). As a result, both the polarity and directionality of 
the migrating NC are tightly regulated thus permitting colonisation in specific 
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areas whilst preventing them from invading zones predestined for other cell fates. 
In the cranial region, such regulatory molecules include Neuropilin-1/2, 
Roundabout homologs Robo-1/2, and Ephrin receptors (Sauka-Spengler and 
Bronner-Fraser, 2008a). In addition to interacting with their environment, NC cells 
have also been shown to communicate with each other. If one NC cell encounters 
another it will repolarize due to activation of the noncanonical Wnt pathway and 
migrate in a different direction. This is known as contact inhibition locomotion 
(CIL) and in Xenopus it has been recently shown to be mediated by Cadherin-11 
(Becker et al., 2013). Despite this, large numbers of NC cells manage to migrate 
alongside in a continuous direction. This is because repulsive forces of CIL are 
balanced with attractive forces between NC cells due to the expression of 
chemoattractant C3a and the C3a receptor on their cell surface (Carmona-
Fontaine et al., 2011).  
In summary, the combined regulatory function of NC specifier genes and their 
downstream effectors endows NC cells with the characteristics that render them 
mesenchymal, proliferative, and motile. However, out of the many NC 
downstream effector genes, the direct regulatory inputs and links to upstream NC 
specifiers are known for only a few, which makes it difficult to assign their precise 
positions within the NC GRN. 
1.4. Neural crest differentiation 
There are two main streams of NC cells; those migrating cranially and those 
migrating in the trunk, which together give rise to an elaborate list of derivatives 
(Dupin et al., 2006). Cephalic NC cells which arise from the diencephalon to the 
third somite, give rise to many cranial structures including the bone and cartilage 
of the face and neck as well as tendons, muscles and connective tissues of the 
ear, eye, teeth and blood vessels. They will also form cranial melanophores and 
give rise to most of the cephalic peripheral nervous system (PNS). A 
subpopulation of cephalic NC cells, called the cardiac NC, emerge from the otic 
level to the anterior limit of somite 4. It migrates to the heart and is essential for 
the septation of the outflow track (Couly et al., 1998). Trunk NC cells, form the 
dorsal root and sympathetic ganglia of the PNS, pigment cells and endocrine cells 
of the adrenal gland (Le Douarin and Smith, 1988). Finally, the enteric NC cells 
delaminate from the neural tube facing somites 1 to 7 and colonise the entire gut 
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to form the enteric PNS, which controls the digestive track (Mayor and 
Theveneau, 2013, Le Douarin and Teillet, 1973). 
Cis-regulatory analysis combined with functional and binding affinity assays have 
revealed several subcircuits of direct gene regulatory interactions specific for 
each of the NC lineages. Each subcircuit comprises of a network of unique 
transcription factors regulating specific effector genes, which in turn will give the 
cell its fully differentiated properties and characteristics. NC differentiation is 
thought to be both spatially and temporally regulated. After NC cells have 
migrated and reached their final destinations, typically expression of most early 
NC specifiers, including Snail1/2, FoxD3, Id, and Tfap2α are down regulated 
although the direct regulatory interactions triggering this down-regulation are 
unclear (Meulemans and Bronner-Fraser, 2004). However, this is not always the 
case. Down-regulation of FoxD3 in migrating cells prior to differentiation does not 
take place in all NC derived lineages. While absent from melanoblasts, FoxD3 
expression persists in neural/glial precursors, where it prevents Pax3 from 
binding to the promoter of Microphtalmia-associated transcription factor (MITF) 
and thus protects sensory precursors from adapting a pigment cell fate (Thomas 
and Erickson, 2009). In addition, SoxE transcription factor family members Sox9 
and Sox10 also persist in specific subpopulations of NC derivatives and appear 
to be master regulators of terminal differentiation in the majority of NC derivatives 
(Kelsh, 2006, Sauka-Spengler and Bronner-Fraser, 2008b). Sox10 persists in 
melanoblasts and elements of the PNS, whereas Sox9 is characteristic of NC 
derived chondrocytes. Experiments in Xenopus suggest that the HLH 
transcriptional repressor Id prevents premature NC differentiation during NC 
migration. Overexpression of Id3 in Sox10-expressing melanoblasts or Sox9-
expressing NC–derived cartilage cells inhibits SoxE expression, which affects 
melanocyte and chondrocyte differentiation (Light et al., 2005). Thus, 
downregulation of Id is necessary for the initial steps of NC differentiation to 
occur. 
NC cells are often referred to as the fourth germ layer and have been central to 
vertebrate evolution. In addition, defects in NC cell development are associated 
with several congenital defects, collectively known as neurocristopathies (Shahar 
and Shinawi, 2003). These include disorders of craniofacial and organ 
development as well as diseases such as neuroblastoma and melanoma. 
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Consequently, understanding the normal epigenetic mechanisms of NC cell 
development will provide important clues regarding errors in regulation that may 
finally lead to abnormal development or loss of the differentiated state. 
2. miRNAs and their role in development  
Due to advances in high-throughput transcriptome analyses, several projects 
have demonstrated that mammalian transcriptomes have a large complement of 
noncoding RNAs (ncRNAs). In fact, only 1–2% of the genome codes for proteins, 
while the great majority codes for ncRNAs (Amaral et al., 2008). A specific sub- 
group of ncRNAs are miRNAs, that are involved in myriad cellular events 
including but not limited to a number of vital processes during early 
embryogenesis (Ebert and Sharp, 2012, Goljanek-Whysall et al., 2014). miRNAs 
are evolutionarily conserved and represent small non-protein-coding RNA gene 
products that regulate gene expression at the posttranscriptional level (Bartel, 
2004, Ambros, 2004). This novel mode of regulating gene expression was first 
discovered in C. elegans. In 2000, two separate groups discovered that a small 
RNA, let-7, was essential for the development of a later larval stage to adult in C. 
elegans (Reinhart et al., 2000, Slack et al., 2000). Subsequently, homologues of 
this gene were discovered in many other organisms, including humans 
(Pasquinelli et al., 2000). Following this pioneering discovery, multiple 
laboratories worked quickly to clone numerous small RNAs from various model 
organisms in order to further define their functions. 
2.1. Biogenesis and mechanism of miRNAs 
This well-defined family of ~19–24 nucleotides (nt), non-coding RNA species is 
known to regulate translation of specific messenger RNA (mRNA) targets in a 
wide variety of organisms (Filipowicz et al., 2008). Acting through the recognition 
of binding sites usually located in the 3′ untranslated region (UTR) of mRNAs, 
miRNAs are suggested to regulate approximately 60% of the genes in humans 
(Bartel, 2009). Expressed from miRNA genes transcribed from the genome, 
miRNAs are generated from a primary transcript (termed pri-miRNA). This 
transcript may contain one or more hairpins as miRNAs can be clustered together 
to give rise to polycistronic transcriptional units (Davis and Hata, 2009). In the 
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nucleus, the hairpin is excised from the pri-miRNA by the microprocessor 
complex, minimally composed by the RNAseIII Drosha and the double-stranded 
RNA-binding protein DGCR8 (Figure 3). The resulting hairpin precursor (pre- 
miRNA) is usually 60–110 nt long, and is actively exported to the cytoplasm by 
the nuclear-membrane protein Exportin-5 (Lee et al., 2003, Bohnsack et al., 
2004). In the cytoplasm, another protein complex containing the RNAseIII 
enzyme Dicer further processes the pre-miRNA to the mature miRNA, which is 
loaded onto the RNA Induced Silencing Complex (RISC) (Gibney and Nolan, 
2010). Only one of the two strands of the original pre-miRNA stem remains bound 
to the RISC (the guide strand) as mature miRNA, whereas the other strand 
(passenger strand) is usually eliminated. Once incorporated into a silencing 
complex, the miRNA binds to its target sequences resulting in RNA interference, 
which results in degradation, translational stop or to other means of inhibition of 
the respective RNA molecule (Figure 3) (He and Hannon, 2004, Bartel, 2004, 
Meister et al., 2004, Ambros, 2004). The method in which a miRNA binds to its 
target gene is discussed further in section 13.11.1.. 
2.2. miRNAs in development  
Tight spatio-temporal control of miRNAs occur resulting in the distinct expression 
patterns of many miRNAs (Wienholds et al., 2005, Kloosterman et al., 2006, 
Ahmed et al., 2015), with levels changing quite dramatically in some contexts 
such as stem cell differentiation (Gangaraju and Lin, 2009). The ability of miRNAs 
to alter the expression program of many target mRNAs and their encoded 
proteins, combined with their tight control suggests that miRNAs may affect 
phenotypic transitions. The importance of miRNAs in development has been 
demonstrated using knockout Dicer mutants in various model organisms. 
Germline deficiency of Dicer in mice and Zebrafish causes lethality early in 
embryogenesis (by embryonic day 7.5 in mice) characterised by abnormal 
morphology in almost all organs and result in significant lack of stem cells 
(Bernstein et al., 2003, Andl et al., 2006, Harfe et al., 2005, Kloosterman and 
Plasterk, 2006, Giraldez et al., 2005) 
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Figure 3: miRNA biogenesis and mechanism of action 
MiRNAs are transcribed as primary transcripts (pri-miRNAs) by RNA polymerase II. Each pri-miRNA 
contains at least one hairpin structure that is recognized and processed by the endonuclease, Drosha. This 
complex generates a stem loop known as the precursor miRNA (pre-miRNA), which is exported to the 
cytoplasm by exportin 5. In the cytoplasm, the pre-miRNA is recognised by another endonuclease, Dicer. 
Dicer, along with the RNA-binding protein TRBP binds to the precursor and cleaves the pre-miRNA, 
generating a 20-nucleotide mature miRNA duplex. Generally, one strand is selected and incorporated into 
the RNA-induced silencing complex (RISC) which is composed of Argonaute (Ago) protein and the single 
stranded miRNA, whilst the other strand is degraded. Mature miRNA guides the RISC to its target mRNAs 
through base pairing between the seed sequence of the miRNA and the seed match sequences in the 
mRNA. The RISC can inhibit the translation of the target mRNA through multiple mechanisms including 
removal of the polyA tail (deadenylation) which results in mRNA degradation or through blockage of 
translation at the initiation step or at the elongation step; for example, by inhibiting eukaryotic initiation factor 
4E (EIF4E) (Inui et al., 2010). 
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Using miRNA specific deletions, the function of individual miRNAs within various 
aspects of development have been explored. For example, miR-273 is required 
for establishing left-right asymmetry during neuronal development (Hobert, 
2006), and in mice, deletion of miR-1-2 caused severe and irreparable defects in 
cardiac morphology suggesting critical roles for this miRNA in regulating 
cardiogenesis (Zhao et al., 2007). In a muscle context, double gene knockout of 
the muscle-enriched miRNA (myomiR), miR-133a, in mice resulted in increased 
proliferation and apoptosis of myocytes, ventricular septal defects, and 
embryonic lethality (Liu et al., 2008). Upregulation of another myomiR – miR-27, 
along with subsequent downregulation of its target protein, Pax3, were found to 
be important in reducing myocyte proliferation and facilitating myogenic 
differentiation (Crist et al., 2009). Together, these studies, along with the spatial 
and temporal expression patterns of miRNAs in specific organ systems, have 
unequivocally established the role and relevance of miRNAs as enforcers of the 
changes in cellular states that occur during development. 
2.3. miRNAs regulate pluripotency and cell migration in 
many systems 
Throughout the literature, miRNAs have been described as key players in the 
regulation of pluripotency in many systems including embryonic stem cells (ESC) 
and induced pluripotent stem cells (IPSC). Many miRNAs including miR-145, 
miR-134, miR-296, and miR-470 have been shown to represses the pluripotency 
of human ESCs by repressing the expression of key transcription factors 
including Oct4, Sox2, Nanog and Klf4 (Tay et al., 2008, Xu et al., 2009). Another 
family of miRNAs reported to have roles in the repression of pluripotency is the 
Let-7 family, more specifically, this family of miRNAs are highly expressed in 
somatic cells where they function to repress genes involved in self-renewal. 
Interestingly, the inhibitory effect of let-7c on self-renewal can be rescued by co-
transfection of let-7 and miR-294, a member of the ESC specific miR-290 cluster. 
Introduction of miR-294 indirectly enhances the expression of Lin28 and c-Myc 
(self-renewal genes). Lin 28 is known to directly block the maturation of let-7 
(Viswanathan et al., 2008, Rybak et al., 2008), thereby silencing the Let-7 family 
and maintaining self-renewal. 
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In addition to self-renewal, miRNAs have been vastly reported to regulate cell 
migration in many systems including cancer. Korpal et al. (2008) reported that 
ectopic expression of the miR-200 family miRNAs significantly increased E-
cadherin expression and altered cell morphology to an epithelial phenotype in 
mouse carcinoma cells. Furthermore, Zhuang et al. (2012b) reported that the 
tumour secreted miR-9, promotes endothelial cell migration and angiogenesis by 
activating the JAK-STAT pathway. 
 
2.4. The role of miRNAs in neural crest cell 
development 
miRNAs were first demonstrated to be critical for NC development through work 
published by a number of groups (Huang et al., 2010, Nie et al., 2011, Zehir et 
al., 2010). All three groups showed independently using Wnt1-cre-mediated 
conditional mice knockouts of zygotic dicer in NC cells that the differentiation of 
this cell type is severely impaired resulting in a phenotype consisting of many NC 
related abnormalities including impaired craniofacial organogenesis. Following 
on from this work, several groups have shown that miRNAs are central regulators 
of NC differentiation (Cordes and Srivastava, 2009). Although all three papers 
found that miRNAs were involved in NC differentiation, they also all claimed that 
removal of zygotic Dicer did not impair induction, specification or EMT of the NC 
(Nie et al., 2011, Huang et al., 2010, Zehir et al., 2010). This therefore 
inadvertently suggested these processes occur independent of miRNA gene 
regulation. However, there are concerns with the temporal expression of the wnt-
1 promoter as it may be too late for early NC development. In addition, in 
Zebrafish, it is reported that maternal dicer activity has hampered the analysis of 
the single dicer gene. Mutants for the zygotic function of dicer (Zdicer) retain pre-
miRNA processing activity up to 10 days postfertilization as a consequence of 
maternally contributed dicer (Wienholds et al., 2003). Therefore, it is possible that 
the presence of maternal Dicer may have allowed for early NC development to 
occur. Morpholino knockdowns of maternal Dicer1 result in an earlier 
developmental arrest than Zdicer mutants (Wienholds et al., 2003) and MZdicer 
mutants (loss of maternal and zygotic dicer) display abnormal morphogenesis 
during gastrulation, brain formation, somitogenesis, and heart development 
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(Giraldez et al., 2005). The effects of these knockdowns are even more prominent 
in mice whereby a knock down of maternal dicer results in the embryo failing to 
progress through the first cell division (Tang et al., 2007). This therefore 
demonstrates that although there are differences between species, maternal 
Dicer1 plays a pivotal role during early vertebrate embryonic development and 
therefore possibly during early NC development. To further support this, Gessert 
et al. (2010) showed that a more targeted Dicer knockdown in the anterior neural 
tissue of Xenopus leads to eye and cranial cartilage defects. 
3. Rationale  
Since miRNAs are aberrantly expressed in a vast number of embryonic cell types 
and have been demonstrated to be involved in a number of processes that are 
vital to NC development including EMT, there is strong reason to believe that 
miRNAs are key players in early NC development. Functional NC development 
is key to successful embryogenesis in vertebrates. It is therefore essential to 
elucidate the mechanisms by which they develop, including the roles miRNAs 
have in this process.   
The aims of this study were: 
1. To identify NC enriched miRNAs 
2. To explore the function of the candidate miRNAs during Xenopus NC 
development  
3. To explore the molecular mechanisms through which these candidate 
miRNAs are working during Xenopus NC development  
4.  To identify miRNAs that are possibly contributing to NC multipotency  
In summary, Chapter 3 shows results of both the XenmiR and the sRNA 
sequencing approaches to identify candidate miRNAs. This includes an analysis 
of the top miRNAs differentially expressed in NC tissue compared to neural 
tissue. From these results, several candidate miRNAs were identified. The 
functional role of these miRNAs in relation to NC development is explored in 
Chapter 4. From these candidates, two miRNAs (miR-219 and miR-196a) gave 
a NC related phenotype. In Chapter 5 an in-depth analysis using both online 
target algorithms and RNA sequencing was used to identify the targets of miR-
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219 and miR-196a and therefore try and decipher the mechanisms behind these 
miRNAs in NC development. 
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Chapter 2: Materials and methods 
4. Husbandry 
4.1. Obtaining embryos 
All experiments were performed in compliance with the relevant laws and 
institutional guidelines at the University of East Anglia. The research has been 
approved by the local ethical review committee according to UK Home Office 
regulations.  
Females are primed 5-10 days prior to the day embryos are required using 100 
units of PMSG (pregnant mare serum gonadotropin). To induce ovulation, primed 
female Xenopus laevis were injected with 500 units of human chorionic 
gonadotrophin (hCG) into their dorsal lymph sac and stored at 18°C. Eggs can 
then be collected 14-16 h following induction. Testes were isolated from an 
euthanized male frog and placed in testes buffer. To obtain eggs, the abdomen 
of the frogs were manually massaged over a clean petri dish. A piece of 
masticated testes is then crushed with 1ml of high salt solution, 1XMMR, and 
distributed over the collected eggs and then left for 5 mins at 18°C. 0.1MMR can 
then be added to the eggs and left for 20 mins at 18C. After fertilization the jelly 
coat which encases the eggs is removed. For this they are added to a 250ml 
beaker containing 2% (w/v) L-cysteine pH 8.0 dissolved in 1XMMR. Swirling the 
eggs in this solution gently removes the jelly. Eggs are then washed in 1X MMR 
then 0.1XMMR to remove the cysteine. Embryos can then be left to develop until 
they reach the required stage according to the Niewkoop and Faber 1967. 
Materials: 
• 0.1XMMR: 10mM NaCl, 0.2mM KCL, 0.1mM MgCl2, 0.2mM CaCl2, 0.5mM 
HEPES (PH7.5) 
• 1XMMR: 100mM NaCl, 2mM KCl, 1mM MgCl2, 2mM CaCl2, 5mM HEPES 
(PH7.5) 
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• Testis buffer: 80% (v/v) fetal calf serum, 20% (v/v) 1X MMR, gentamycin 
(Sigma 1:1000U) 
• PMSG (Intervet): 1000U/ml PMSG prepared in solvent and stored at 4°C 
• Chorulon (Intervet): 1000U/ml Chorulon prepared in solvent and stored at 
4°C. 
4.1.1. Fixing embryos 
Once Xenopus embryos or animal caps reach their desired stage (depicted by 
Nieuwkoop and Faber, 1967) they were fixed using MEMFA (3.7% (v/v) 
formaldehyde, 1X MEM salts made up with DEPC H20).  They were then left at 
RT for 1-2 h or overnight at 4°C. The embryos were then washed 2 times in 
phosphate buffered saline with 0.1% (v/v) Tween-20 (PBST) and then stored at -
20°C in 100% EtOh. 
5. Whole mount in situ hybridisation (WISH) 
5.1. mRNA probe synthesis 
5.1.1. Preparation of competent cells 
A 5 ml culture of DH5α E.coli was grown overnight in Luria Broth (LB) at 37°C 
and with shaking. 1ml of this culture was added to 200 ml of LB medium and 
grown at 37°C with shaking until optical density (OD600) reached 0.3 to 0.4. At 
this point the culture was divided into 4x 50ml Falcon tubes and put on ice for 15 
mins. The cells were centrifuged at 4°C for 15 mins at 6000 x g. The supernatant 
was discarded and the bacterial pellet was resuspended in 16 ml filter sterilized 
TB I buffer. Cells were put on ice for 15 mins, centrifuged at 4°C at 20,000 x g for 
30 mins. The supernatant was discarded and the pellet was resuspended in 4ml 
of sterilized TB II. Aliquots were stored at -80°C. 
Materials: 
• TB I pH 5.8: RbCl2 0.1M, MnCl2H2O 0.068M, CaCl2, 0.01M, KAc 1 M pH 
7.5, 37.5 ml Glycerol adjust to 250 ml and pH using 0.2 M HAc 
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• TB II: MOPS 0.5M pH 6.8, RbCL2 0.01M, CaCl2 H2O 1.04 M, 37.5 ml 
Glycerol adjust to 250 ml aliquoted and stored at -80°C 
5.1.2. Transformation 
1 µl of plasmid was added into 100µl of competent E.coli cells, left on ice for 30 
mins and heat shocked at 42°C for 90 secs. 300 µl of LB media was added and 
cells were left for one h at 37°C. 200 µl of transformation mix was plated out onto 
LB agar containing the required antibiotic O/N at 37°C. 
5.1.3. DNA mini prep 
Colonies from the transformation were incubated in 5 ml LB/carbicillin liquid 
media O/N at 37°C with rocking. The DNA plasmid was then isolated using 
Qiagen mini plasmid purification kit (Qiagen, UK) according to manufactures 
instructions. 1µl of the final product was run on an agarose gel by electrophoresis. 
5.1.4. DNA midi prep 
Colonies from the transformation were incubated in 50 ml LB/carbenicillin liquid 
media O/N at 37°C with rocking. Plasmid DNA was isolated using Qiagen mini 
plasmid purification kit (Qiagen, UK) according to manufactur’s instructions. 1 µl 
of the final product was analysed by gel electrophoresis. 
5.1.5. DNA and RNA quantification 
DNA was quantified using a standard spectrophotometer; 260/280 ratios of 1.8-2.0 
indicated good quality DNA. 
5.1.6. Probe synthesis 
Plasmids containing a gene of interest were linearized by by restriction digest 
downstream/upstream of the sense/ antisense probe, respectively. Linearized 
DNA was purified before probe synthesis. For probe synthesis, the following 
reaction mixture was used and in a total volume of 20 µl of nuclease free water 
(Table 1). 
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Table 1: Probe Synthesis 
Reagent 1 reaction 
5X transcription buffer (Invitrogen) 4 µl 
DDT (100mM; Invitrogen) 2 µl 
1 µl Fluorescin labeled UTPs (Roche) 1 µl 
RNAsin (40 U/µl; Promega) 1µl 
linearized DNA 1µg 
RNA polymerase (EcoR1 antisense polymerase T3) 2µl 
Total volume 20 µl 
 
The reaction mix was incubated at 37°C for 3 hrs. Any remaining DNA template 
was removed by adding 1 µl of DNase 1 (2 U/ul; Roche) and incubated for 30 
mins at 37°C. 1 µl of the probe was verified on a 2% (w/v) agarose gel and 
visualized in a UV transmitter (BIO-RAD). Plasmids and enzymes used to make 
probes are displayed in (Appendix 1). 
5.1.7. Purification of probes 
Probes were purified by using Illustra MicroSpin G-50 Columns (GE healthcare 
life sciences) according to manufacturer’s instructions. 5 µL of probe was 
analysed on a 2% (w/v) agarose to confirm probe integrity. 5 µg of purified probe 
was added to approximately 10 ml of hybridisation buffer depending on probe 
quality (determined on a 2% (w/v) agarose gel) and stored at -20°C. 
5.2. WISH 
Embryos were rehydrated from 100% methanol by using 100%, 75%, 50% 25% 
(v/v) methanol intermediates (in PBST) for 5 mins each followed by two PBST 
washes for the same time, all with rocking at RT. Embryos were then treated with 
10 µg/ml proteinase K (no rocking) for varying times depending on the embryo 
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stages (e.g Xenopus stage 38 – 10 mins; stage 25 – 4 mins; stage 10.5 – 1 min). 
Xenopus embryos were then subsequently washed twice in PBST for 5 mins and 
incubated in 3.7% (v/v) formaldehyde/PBST for 45 mins with rocking. The 
embryos were washed with 50% hybridisation buffer (in PBST) followed by 100% 
hybridisation buffer both for 10 mins. Following this, embryos were prehybridised 
in 100% hybridisation buffer for 2-3 h at hybridisation temperature (48°C for LNA 
probes, 65°C RNA probes) 
Probes were removed and stored at -20°C and embryos were washed with fresh 
hybridisation buffer for 10 mins followed by two 15 min washes with wash solution 
and one 10 min wash in 50% MABT/ 50% wash buffer. All steps were completed 
at hybridisation temperature. Embryos then underwent two 30 min washes in 
maleic acid buffer with 0.1% Tween-20 (1XMABT), a 1 h wash in 2% (w/v) 
Boerhinger Mannhein blocking reagent (BBR) (in MABT) and a 2-3 h wash in 
20% (v/v) Goat serum in 2% (w/v) BBR, all at RT. BBR solution was replaced with 
antibody solution containing anti-Dig antibody (Roche; 150 U) (1:3000) made in 
20% (v/v) goat serum and 2% (v/v) BBR at 4°C overnight. All steps with rocking. 
Antibody solution was removed and embryos were washed in 1X MABT five times 
for 60 min each at RT and incubated in a sixth MABT wash overnight at 4°C with 
rocking. The colour reaction was then carried out by washing the embryos in fresh 
alkaline phosphate buffer twice for 10 min at RT with rocking. Embryos were then 
put in NBT/BCIP in alkaline phosphate buffer (4.5 µl/ml NBT, 3.5 µl/ml BCIP) 
protected from light, until the desired level of colour was noted. Embryos were 
placed in 5X TBST solution O/N if needed to remove background staining and 
then imaged.  
5.2.1. Double WISH:  
Embryos were hybridised overnight with the RNA probe at 65°C, then washed 
with fresh hybridisation buffer for 10 min followed by two 15 min washes with 
wash solution and one 10 min wash in 50% MABT/ 50% wash solution. All steps 
were completed at 65°C. Embryos then underwent two 30 min washes in 1X 
MABT for 30 min. The embryos were prehybridised for 2-3 h in hybridisation 
buffer at 48°C (LNA probe hybridisation temperature) and hybridised overnight 
with the LNA probe. The LNA probe was then detected as described above. 
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When the colour was developed the embryos were fixed in MEMFA O/N and 
washed in MABT at 65°C for 1 h to inactivate the anti-DIG antibody. The embryos 
were then blocked and incubated in anti-Fluorescein antibody (Promega; 150U), 
1:1000 dilution. The RNA probe was then detected as described above but using 
Fast Red solution (Sigma) instead of NBT/BCIP. When the colour reaction was 
complete, the reaction was stopped with three PBST washes at RT and the 
embryos were fixed in MEMFA for two h at RT. 
Materials for WISH and double WISH: 
• PBS – 10X: 2.5 g NaH2 PO4.H2O, 11.94 g NaHPO4.H2O, 102.2 g NaCl 
• PBST – PBS with 0.1% (v/v) Tween-20  
• Proteinase K (10 µg/ml): 1 µl Proteinase K, 1 ml PBST 
• Hybridisation buffer: 50% (v/v) formamide, 5X SSC, 1 mg/ml Torula RNA, 
100 µg/ml Heparin, 1X Denharts solution, 0.1% (v/v) Tween-20, 0.1% (w/v) 
CHAPS, 10 mM EDTA. 
• Washing buffer: 50% (v/v) formamide, 1X SSC, 0.1% (v/v) Tween-20 
• MABT (1X): 100 mM Maleic acid, 150 mM NaCl, 0.1% (v/v) Tween-20, (pH 
7.5) 
• BMB (10%): 10% (w/v) in BMB preheated (50°C), 1X MAB, stirred until 
dissolved and then autoclaved, aliquoted and stored at -20°C. 
• Alkaline phosphatase buffer: 100 mM Tris (pH 9.5), 50 mM MgCl2, 100 
mM NaCl, 0.1% (v/v) Tween-20. 
• BCIP: 50 mg/ml in 100% DMF 
• NBT (Nitro Blue tetrazolium): 75 mg/ml in 70% dimethylformamide (DMF) 
• TBST: 125 ml 1M Tris pH 7.5 40 g NaCl, 1 g KCl and 450ml with dH2O. 
Autoclaved then add 50 ml of Tween-20. 
• MEMFA: 10% (v/v) MEM salts, 10% (v/v) formaldehyde 
• MEM salts: 0.1 M MOPS, 2 mM EGTA, 1 mM MgSO4, pH7.4 
• Fast Red Solution: SIGMAFASTTM Fast Red TR/Naphthol AS-MX Tablets 
dissolved in 10 ml alkaline phosphatase buffer 
5.2.2. Cryosectioning of WISH embryos 
Embryos were fixed in MEMFA for 2 h, washed twice for 5 min with PBST and 
placed in 30% (w/v) sucrose overnight at 4°C. Embryos were transferred to cryo-
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moulds filled with optimal cutting temperature (OCT) compound and left for 4 h at 
RT. Embryos were positioned appropriately for sectioning, frozen on dry ice for 
30 min and then left overnight at -20°C. Embryos were sectioned using the LEICA 
CM 1950 Cryostat and sections were placed on 5% TESPA slides. Slides 
underwent three 5 min washes in PBS and coverslips were mounted using 
hydromount. Images were taken using a Zeiss CCD upright microscope with 
colour camera. 
6. Alcian blue staining 
Embryos were fixed for 1.5 hat RT, dehydrated with five washes of 100% ethanol 
for 5 min each at RT and then left in Alcian blue staining solution for three nights. 
Embryos were then washed three times for 15 min in 95% ethanol at RT and 
gradually rehydrated to 2% KOH using 10 min washes of 75% EtOH in 2% KOH, 
50% EtOH in 2% KOH, 25% EtOH in 2% KOH twice and finally 3 x 2% KOH 
washes. Embryos were then transferred into glycerol using 1 h washes of 20% 
glycerol in 2% KOH, 40% glycerol in 2% KOH, 60% glycerol in 2% KOH and 80% 
glycerol in 2% KOH. Craniofacial cartilage was then dissected out prior to 
imaging. 
Solutions: 
• Alcian blue solution: 20mg Alcian blue, 15 ml acetic acid, 35ml 100% EtoH 
• 2% (w/v) KOH: 1g KOH tablets in 500ml dH2O 
7. Microinjection 
Embryos undergoing microinjection were placed in 3% Ficoll PM400 (Sigma, UK) 
and injected at either the two-cell stage into the animal pole of both blastomeres 
using a 10 nl calibrated needle or at the four-cell stage in one dorsal blastomere 
using a 5 nl calibrated needle Morpgolino sequences are listed in Table 2. 
Following a 2 h incubation in Ficol the embryos were transferred into 0.1X MMR 
and left to develop to the appropriate stage. The injections were completed using 
a Harvard apparatus injector (Medical Systems Research products) and the 
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injector was set up at Pout = 90, Pbalance = 0.6 and Pinject = 16.  
Table 2: Morpholino sequences  
Morpholino Sequence 
miR-219 MO 5’-AGAATTGCGTTTGGACAATCAAGGG-3’ 
miR-219 mismatch 5’ ACAATTGCCTTTCGAGAATCAACGG-3’ 
miR-196a 5’- CAATCCCAACAACATGAAACTACCT-3’ 
miR-196a mismatch  5’-CATTGCCAAGAACATCAAAGTACCT-3’ 
 
Solutions: 
3% (w/v) Ficoll: 6 g Ficoll PM400, 60 ml 1X MMR, 140 ml dH2O 
8. Animal cap assay for sRNA sequencing 
8.1.1. Capped RNA synthesis 
10 µg of plasmid DNA was digested using 5 µl buffer, 2 µl restriction enzyme in 
at total volume of 50 µl with RNAse free water. This was left at 37°C for 2 h and 
purified using a Qiagon PCR purification kit according to manufacturer’s 
instructions. The linearized DNA was analysed using a nanodrop to determine 
the concentration. For capped RNA synthesis 1 µg linearized DNA, 10 µl 
NTP/CAP, 2 µl buffer, 2 µl SP6/T7 RNA polymerase(20U/ul; Promega) were 
mixed and made up to 20 µl with RNAse free water. This was left for 2 h at 37C. 
1µl of DNAse-1 (2 U/ul; Roche) was added for 15 min at 37C. 1 µl was analysed 
by gel electrophoresis. The capped RNA then underwent lithium chloride 
purification and was split into 1 ng/ 10 nl stocks used to make 5 µl aliquots and 
stored at -80°C. The plasmids used are displayed in Table 3. 
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Table 3: Plasmids used for capped RNA synthesis 
Clone name Sense RE Sense polymerase Source 
Noggin Not1 Sp6 Dr Dave Hsu 
Wnt1 Xba1 Sp6 Dr Oliver Destree 
Lac-Z Not1 Sp6 Dr Maggie Walmesly 
GFP Not1 Sp6 Dr Maggie Walmesly 
 
At the two-cell stage cRNA was injected into the animal pole of both blastomeres 
with either Noggin cRNA alone to induce neuroectoderm or Noggin and Wnt 
cRNA to induce neural crest. Non-injected embryos gave caps with ectoderm cell 
fate. 2 h following injection Ficoll solution was replaced with 0.1x 
MMR/gentamycin (1:1000) and the embryos were left to develop until stage 9 
when animal caps were cut (Figure 4).  
Caps were cut in filter-sterilised 1XMMR and the vitelline membrane was 
removed using sharp forceps and the cap was cut from the centre of the animal 
hemisphere. Caps were transferred to a 12-well dish containing 0.7MMR, 1mg/ml 
Bovine serum albumin, 100 µg/ml gentamycin. Caps were kept at a constant 
temperature until they reached stage 15, when they were harvested for RNA 
extraction. 
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Figure 4: A schematic drawing of an animal cap assay.  
Embryos are injected at stage 2 with cappedRNA and left to develop until stage 9 when the animal cap was 
removed. Animal caps were left to develop until stage 15 where they underwent RNA extraction. 
8.2. RNA extraction for sRNA sequencing 
RNA extraction was completed using the miRCURYTM RNA Isolation (for tissue) 
kit according to manufacturer’s instructions. In summary, animal cap tissue was 
placed in a 2 ml Eppendorf tube and flash frozen in liquid nitrogen. To 
homogenise the tissue, 300 µl of lysis solution was added to the sample and put 
through bead homogenization for 1.5 min at 50 shakes per second using 
TissueLyser (Qiagen). 600 µl of RNAse free water and 20 µl of  proteinase K was 
added to the lysate and incubated at 55°C for 15 min and spun for 1 min at 14,000 
x g. 450 µl of 95% ethanol was added and the lysate was passed through a 
column by centrifuging for 1 min at 14,000 x g. 400 µl of wash solution was 
subsequently passed through the column at 14,000 x g for 1 min to wash the 
resin. This was repeated a further two times. The resin was then dried by a 2 min 
spin at 14,000 x g. The RNA was eluted by adding 50 µl of elution buffer to the 
column and spun for 2 min at 200 x g followed by 1 min at 14,000 x g. The 50 µl 
was then split into two 25 µl samples (one for sRNA library construction and one 
for validation of tissue induction). RNA integrity was confirmed by gel-
electrophoresis 
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8.2.1. RNA Quantification 
RNA was quantified using a standard spectrophotometer; 260/280 ratios of 1.8-2.0 
indicated good quality RNA. 
8.3. Semi-quantitative mRNA PCR to validate animal 
cap tissue induction 
8.3.1. Reverse Transcription  
First strand cDNA Synthesis with SuperScript II Reverse Transcriptase:  
For reverse transcription, 500 ng RNA and 1 µl Oligo(dT) 12-18 primer were 
mixed and brought up to 11 µl using nuclease-free water. The mixture was heated 
to 70°C using a PTC- 100 Peltier Thermal Cycler (Bio-Rad) for 10 min before 
being put back on ice where 4 μl 5X First-Strand Buffer (Sigma, UK), 1 μl 10mM 
dNTPs (Roche UK), 1 μl RNasin (40U/ul; Roche, UK), 1 μl of SuperScript II 
Reverse Transcriptase (200U/ul; Invitrogen, UK) and 2 µl 100mM DTT (Sigma, 
UK) were added to each tube. The samples were incubated at 42°C for 1 h.  
TaqMan RT-PCR:  
The reaction mixture was as follows: 12.5 µl of Bioline Taq mix (Bioline, UK), 1 µl 
cDNA as a template, 2 µl of forward primer, 2 µl of reverse primer made up to 25 
µl with nuclease-free water. The reaction conditions were 95°C for 3 min, 25-35 
cycles (specific for each primer set) of 95°C for 30 sec, 50-60°C temp gradient 
for 1 min (specific for each primer set), 72°C for 2 min and one final 72°C for 10 
min. 5 µl samples were then analysed by agarose gel electrophoresis. 
9. sRNA library construction for Next 
Generation Sequencing 
9.1.1. HD adapter synthesis 
To phosphorylate the adapters, 6 µl of 100 µM 3’ adapter (Sigma), 10 µl of 10X 
T4 polynucleotides kinase buffer, 10 µl of 10 mM ATP, 72 µl of nuclease free 
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water and 2 µl of T4 polynucleotide kinase (10 U/µl) was mixed and incubated at 
37°C on the DNA Englie Dyad Peltier Thermal Cycler (Genetic Technologies) for 
30 min. The phosphorylation product was then mixed with 2 µl of 5 mg/ml 
glycogen, 10 µl of 3 M sodium acetate and 250 µl of ethanol and stored O/N at -
20°C. The sample was centrifuged at 20,000 x g for 10 min at 4°C and the 
supernatant was removed. The pellet was washed in 250 µl of 80% ethanol and 
centrifuged at 20,000 x g for 5 min at 4°C. The pellet was then air dried and 
resuspended in 12 µl of water. To adenylate the adapters 2 reaction mixtures 
(table 8) were incubated at 65°C for 1 h on the thermal cycler and then at 85°C 
for 5 min to inactivate RNA ligase. 
Table 4: Master mix for adapter adenylation 
Reagent 1 Reaction 
Phosphorylated DNA oligonucleotide 4.5 µl 
10X 5’ DNA Adenylation reaction 
buffer 
4 µl 
1 mM ATP 4 µl 
Mth RNA ligase (NEB) 4 µl 
Water 23.5 µl 
Total volume 40 µl 
 
Both samples were then combined, added to 200 µl of 
phenol:choloroform:isoamyl (1:1:1), 120 µl of water and centrifuged at 20,000 x 
g for 10 min at 4°C. The supernatant was transferred and added to 50 µl of water, 
2 µl of 5 mg/ml glycogen, 16 µl of 3M sodium acetate, 400 µl of ethanol and left 
to precipitate overnight at -20°C. The sample was then centrifuged at 20,000 x g 
for 15 min at 4°C and the supernatant was removed. The pellet was washed in 
500 µl of 80% ethanol, centrifuged at 20,000 x g for 5 min at 4°C and left to air 
dry. Finally, the pellet was resuspended in 20 µl of water and run on a 16% (w/v) 
PAGE urea gel (Table 5).  
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Table 5: Materials required for 16% (w/v) PAGE urea gel synthesis 
Reagent Amount 
Water 2.5 ml 
5X TBE 1 ml 
Urea (microwave for 20 secs after adding) 4.2 g 
 40% (w/v) (19:1) acrylamide/bis solution 4 ml 
TEMED 5 µl 
10% (w/v) ammonium persulphate (APS) 100 µl 
Total volume 10 ml 
 
In order to assess the quality and concentration of the adapter synthesis the 
samples were run alongside (Figure 5): 
1) 5 µl water + 1 µl ScriptMiner adapter + 2 µl Stop solution loading dye 
2) 5 µl water + 1 µl 3’ HD adapter + 2 µl Stop solution loading dye 
3) 4 µl water + 1 µl 3’ HD adapter + 1 µl non-adenylated adapter + 2 µl Stop 
solution loading 
4) 5 µl water + 1 µl non-adenylated adapter + 2 µl Stop solution loading dye 
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Figure 5: HD adapter synthesis  
Concentration of adenylated 3’ adapter is 40uM. To assess the concentration of the adenylated adapter 
(lane2) it was run next to a 20uM ScriptMiner adapter (lane1) a non adenylated adapter (lane4) and a 
combination of both adenylated and non-adenylated adapters (lane3). From this it appears that the 
adenylated adapter is approximately twice the concentration of the ScriptMiner therefore making it 40 µM/µL 
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9.2. Illumina SRNA preparation 
9.2.1. 3’ adapter ligation 
To ligate adapters to RNA, 3 µg of RNA was made up to 11.25 µl with nuclease 
free water, mixed with 1 µl of 3’ HD adapter and incubated at 70°C for 2 min to 
denature the RNA. Next, a master mix was made (Table 6). Following a pulse 
spin, 4 µl of 50% (w/v) PEG solution (NEB) was added and incubated at 26°C for 
2.5h.  
Table 6: Master mix for 3’ adapter ligation 
Reagent 1 reaction 
T4 RNA ligase 2 (NEB) 10X Buffer 2 µl 
RNaseOUT (Invitrogen) 40 U/µL 0.75 µl 
T4 RNA Ligase 2 (200U/µL) (NEB) 1 µl 
Total volume 20 µl 
 
9.2.2. RNA clean up 
The RNA was then cleaned using RNA Clean and ConcentratorTM -25 (Zymo 
Research) according to manufacturer’s instructions. In summary, 40ml of RNA 
Binding Buffer and 60ml of ethanol was mixed to each sample and centrifuged 
through a Zymo-Spin Column at 12,000 x g for 1 min. 800 µl of RNA Wash Buffer 
was then centrifuged through the column at 12,000 x g for 30 secs. This was 
repeated using 400 µl RNA Wash Buffer. The column was then centrifuged dry 
for 2 mins at 12,000 x g. Finally, RNA was eluted using 13.5 µl of RNase-Free 
water by centrifugation at 12,000 x g for 1 min. 
9.2.3. Deadenylation and removal of 3’ adapters 
To deadenylate the adapter, 3.9 µl of a master mix (Table 7) was added to each 
sample, mixed and incubated at 30°C for 30 mins. To stop the reaction, 4 µl of 
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25mM EDTA was added. 
Table 7: Master mix for deadenylation of adapter 
Reagent 1 reaction 
10X deadenylase buffer (Epicentre) 1.6 µl 
100 mM DTT (Epicentre) 0.8 µl 
RNaseOUT 40U/µL (Invitrogen) 0.5 µl 
5’ deadenylase (10U/µL (Epigenetics) 1 µl 
Total volume 3.9 µl 
 
To degrade the adapters, a 10 µl master mix (Table 8) was added to each sample 
and incubated at 37°C for 30 mins. 
Table 8: Master mix for degradation of adapter of adapter 
Reagent 1 reaction 
500 mM Tris-HCl pH 9 (Sigma) 2 µl 
50 mM MgCl2 to be determined 7 µl 
RecJ Exonuclease (10U/µl) (epicentre) 1 µl 
Total volume 10 µl 
9.2.4. 5’ HD adapter ligation 
For ligation, 5 µl of a master mix (Table 9) was added to each sample. 7 µl of 
50% (w/v) PEG was then added to each sample and incubated at 26°C for 2 h. 
Following incubation, 10 µl of nuclease free water was added to each sample. 
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Table 9: Master mix for 5’ adapter ligation 
Reagent 1 reaction 
T4 RNA ligase 1 buffer (epicenter) 1 µl 
10 mM ATP (NEB) 1 µl 
5’ HD adapter (20 µM) 2 µl 
T4 RNA ligase (epicentre) (do 2 mins before end) 1 µl 
Total volume 5 µl 
 
9.2.5. Di-Tagged RNA purification 
The RNA was then cleaned using RNA Clean and ConcentratorTM -25 (Zymo 
Research) according to manufacturer’s instructions. In summary, 100 ml of RNA 
Binding Buffer and 150 ml of ethanol was mixed to each sample, and centrifuged 
through a Zymo-Spin Column at 12,000 x g for 1 min. 400 µl of RNA Prep Buffer 
was then centrifuged at 12,000 x g for 1 min followed by 800 µl of RNA Wash 
Buffer at 12,000 x g for 30 secs. This was repeated using 400 µl RNA Wash 
Buffer. The column is then centrifuged dry for 2 min at 12,000 x g. Finally, RNA 
was eluted twice using 13.5 µl of RNase-Free water by centrifuging at 12,000 x 
g for 1 min each time. The final eluate was then made up to 30 µl using nuclease 
free water. 
9.2.6. Reverse transcription 
In order to synthesise cDNA 10 µl of master mix (Table 10) was added to each 
30 µl sample of purified di-tagged RNA. The samples underwent a pulse spin and 
were incubated at 37°C for 20 mins followed by 85°C for 15 mins to terminate the 
reaction. 
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Table 10: Master mix for reverse transcription 
Reagent 1 reaction 
1X MMLV reverse transcription buffer (epicenter) 4 µl 
10 mM dNTP premix 2 µl 
100 mM DTT (epicenter) 2 µl 
RTP (20 µM) 1 µl 
High performance MMLV reverse transcriptase 1 µl 
Total volume 10 µl 
9.2.7. Polymerase chain reaction 
For PCR amplification 15 µl of master mix (Table 11) was added to each PCR 
tube along with 1 µl of secondary index primer (alternative primers for alternative 
samples) and 4 ul of cDNA.  
Table 11: Master mix for PCR amplification 
Reagent 1 reaction 
Nuclease free water 9.3 µl 
10 mM dNTPs 0.5 µl 
5X high fidelity phusion buffer 4 µl 
Illumina RP-1 primer (10 µM) 1 µl 
Phusion DNA polymerase (2 U/µL) 0.2 µl 
Total volume 15 µl 
 
cDNA was amplified using the following amplification programme: pre-incubation 
for Phusion DNA polymerase activation at 98°C for 30 s, followed by either 13, 
15 or 17 amplification cycles of denaturation at 98°C for 10 secs, annealing at 
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60°C for 30 secs and extending at 72°C for 15 secs. The programme finished 
with a final extension at 72°C for 10 mins. 
9.2.8. 8% PAGE Gel and library band recovery 
20 µl of each sample was run on an 8% (w/v) PAGE gel (Table 12) at 120V for 
approximately 2 h and then stained with SYBR gold (in 0.5X TBE). Gels were 
imaged using a Bio-Rad Molecular Imager FX. 
Table 12: Materials required for 8% PAGE gel synthesis 
Reagent Amount 
Water 20 ml 
5X TBE 3 ml 
40% (w/v) (19:1) Acrylamide/bis solution 6 ml 
TEMED 15 µl 
10% (w/v) ammonium persulphate (APS) 300 µl 
Total volume 30 ml 
10. Bioinformatic analysis 
Most of the bioinformatic analyses were performed in collaboration with Dr. Janet 
Higgins and Dr. Leighton Folkes who will be acknowledged where appropriate. 
10.1.1. Raw sequence mapping and filtering 
FASTQ files were converted to FASTA format and adapter sequences were 
trimmed with custom pearl scripts. Only reads ranging from 16 to 35 nucleotides 
in length that mapped perfectly by PatMaN v1.2.2 (Prufer et al., 2008) to the latest 
version of the Xenopus laevis genome assembly (8.0). 
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10.1.2. Profiling of mapped reads to miRBase 
Mapped reads were profiled to miRBase release 20 with the UEA SRNA 
Workbench tool, miRProf. A whole genome annotation of miRNAs was carried 
out, using all the hairpins in miRBase for BLASTN searches (E-value <1e-06) 
against the Xenopus laevis genome assembly 8.0 (removing any hits which have 
>= 30 blast hits or hairpin length <= 55). MiRNAs with a low abundance (<100 
sequences mapping to the hairpin across all the samples) and miRNAs which did 
not have a typical hairpin structure, were removed from subsequent analyses (all 
hairpins were retained for a family if at least one member of the family had 
alignments). 
10.1.3. Differential Expression Analysis  
Counts were obtained for all the reads aligning to each hairpin for each sample. 
These counts were used as input for DESeq2_1.8.2. A Padj value of <0.001 was 
used to call differential expression. Lists of miRNA which were either up or down 
regulated between tissues were obtained. Overlap between these lists was used 
to find miRNAs with a tissue specific expression. A heatmap and PCA plot were 
generated using the rlog (regularized-logarithm transformation) transformed 
values. Principal components analysis (PCA) was used to visualize sample-to-
sample distances. Heat maps were used to show how much each gene deviates 
in a specific sample from the gene’s average across all samples. 
10.1.4. Novel miRNA predictions 
Novel microRNAs were predicted using the three UEA SRNA workbench tools – 
miRCat, miRCat 2 and miRDeep v.2-0.07 (Stocks et al., 2012, Paicu et al., 2017, 
An et al., 2013, Friedlander et al., 2008). An intersect bed was used to find 
hairpins that were predicted by all 3 tools. Those miRNAs predicted by all three 
tools and those with a good hairpin structure (confirmed manually) were then 
used for subsequent analyses. These hairpins were clustered using cd-hit-est, 
hairpins with a sequence similarity > 80% were clustered together. The principle 
behind the novel miRNA predictions was based on their sequence, their genomic 
location, their abundance and their predicted folded structure of the surrounding 
genomic sequence.  
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11. Validation of sRNA sequencing  
11.1.1. Quantitative miRNA qRT-PCR 
Total RNA was quantified and 10 ng of RNA was reverse transcribed to cDNA 
using universal cDNA synthesis kit (Exiqon, Vedbæk, Danemark). cDNA was 
diluted 1:40 and used in the reaction. PCR reactions were set up in triplicates 
with three biological replicates in ABI one step detection system using SYBR 
green master mix (Exiqon) following the manufacturer’s instructions. The mature 
miRNA sequence was used to synthesize custom miRNA LNA PCR primer sets 
(Exiqon) (Appendix 2) snU6 was used as a control. 
12. Experimental evaluation of putative 
miRNA targets  
12.1. Generation of miRNA sensing luciferase construct  
A Luciferase sensor construct for the EYA1-3’UTR was generated by Dr. Camille 
Viaut from the Münsterberg lab and generously provided for this experiment. 
Used sequence originated from chicken tissues, however EYA1 is homologues 
to the Xenopus laveis variant (Figure 6A).  
12.2. Generating a mutant pGL3-EYA1 construct  
pGL3 mutant constructs were generated using the FastCloning strategy 
developed by Li et al. (2011).  
12.2.1. Mutagenesis PCR of pGL3-EYA1 construct 
A pair of primers placed in the ampicillin resistance gene were used as universal 
primers in the mutagenesis cloning. Primers were designed over the miRNA 
target site which contained mismatched nucleotides chosen to create an enzyme 
restriction site out of the miRNA target site (Figure 6A-B). 
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The two halves of each pGL3 construct were amplified using phusion High-
Fidelity DNA polymerase (Finnzymes, NEB). 
Phusion PCR: 
2.5 µl Forward primer (10 uM), 2.5 µl Reverse primer (10um) and 20ng pDNA 
were combined in a PCR tube with the mastermix displayed in Table 13: 
Table 13: Master mix for phusion PCR 
Reagent 1 reaction 
Nuclease free water 31.5 µl 
10 mM dNTPs 1 µl 
5X high fidelity phusion buffer 10 µl 
Phusion DNA polymerase (2 U/µL) 0.5 µl 
Total volume 43 µl 
 
The reaction conditions were 98°C for 30 sec, 22 cycles of 98°C for 10 sec, 59°C 
temp gradient for 30 sec, 72°C for 2 min (Eya F)/ 4 min (Eya R) and one final 
72°C for 10 mins. 
Once finished, 5 U Dpn1 restriction enzyme (Promega) was added to the PCR 
mixture and incubated on a thermocycler at 37°C for 2 h to digest any remaining 
pDNA. PCR products were verified on an agarose gel. 
1 µl of each the products were transformed into 200 µl of DH5α competent cells 
for recombination.  
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Figure 6: Luciferase assay protocol used to assess EYA1 as a target of miR-219  
Modified pGL3 plasmid with the region of the 3’ UTR of EYA1 incorporated which includes the miR-219 
binding site. Forward and Reverse EYA1 primers designed for mutagenesis are labelled in purple (A). A 
zoomed in version of the primers designed for mutagenesis of EYA1 3’UTR. By mutating three nucleotides 
the miR-219 target sequence was changed to a SalI restriction site (B). An alignment of the Eya1 3’UTR 
sequence of various organisms. The region highlighted in white in the target sequence for miR-219 (C). A 
schematic drawing of the luciferase assay protocol (D). 
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12.3. Luciferase assays of PGl3-EYA1 construct 
12.3.1. Cell culture  
Chicken DF1 fibroblast cells were cultured in Dulbecco’s modified Eagle medium 
(DMEM) containing GutaMAX, 1g/L D-glucose and pyruvate (Life Technologies), 
with 10% fetal bovine serum (FBS) (Gibco, Life Technologies) and 1% penicillin-
streptomycin (Gibco, Life Technologies) added on first use. Cells were passaged 
every other day by treatment with 1ml 0.25% Trypsin-EDTA (Gibco, Life 
Technologies) for 30 secs at RT followed by removal of trypsin and further 
incubation at 37°C for approximately 2 mins. Cells were then transferred to a new 
flask containing media at a 1:4 dilution. Cells were maintained in a humidified cell 
culture incubator at 37°C with 5% CO2. 
12.3.2. Cell transfection 
Cells were detached from the flask surfaces as described in 9.3.1 and counted 
using a hemocytometer. Approximately 7,000 cells were added to each well of a 
96-well plate and media added to make a volume of 100 µl. Cells were incubated 
for 24 h to allow re-attachment to the plate surface. The medium was removed 
and replaced with 50 µl serum-free medium. A transfection mix was prepared as 
described below.  
Transfection mix 1: 
100 ng pGL3 pDNA  
50 nM miRNA mimic  
25 ng Renilla pDNA 
x µl Serum free media to a total volume of 25 µl 
 
Transfection mix 2: 
25 µl Serum-free media  
0.2 µl Lipofectamine 2000 Transfection reagent (Life Technologies) 
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Tubes were left at RT for 5 mins. Transfection mixes 1 and 2 were combined and 
left at RT for 20 mins. 50 µl of the combined transfection mix was added to the 
wells followed by 50µl of serum-free media and cells were left to incubate at 37C 
for 24 h in a humidified incubator. Custom siRNA oligos (Sigma) were used as 
miRNA mimics. Each construct was evaluated in the presence of the putative 
target miRNA mimic, a control miRNA (MISSION siRNA Universal negative 
control (#1) from Sigma) and without a miRNA mimic.  
12.3.3. Luciferase assay 
A Dual-Luciferase Reporter Assay System kit was used to assess luciferase 
activity (Promega). This kit allows Renilla Luciferase to serve as an internal 
control of transfection efficiency. 
Cells were washed twice with cold PBS and 60 µl 1x Passive Lysis buffer was 
added to each well and the plate was rocked gently for at least 15 mins. 10 µl 
lysis solution and 50 µl luciferase assay reagent II were combined and photo 
emission was measured at 562 nm using a multi-label counter (Perkin Elmer). 50 
µl Stop and Glo reagent was added and the Renilla Luciferase photo emission 
measured at 562nm.  
12.3.4. Normalisation of luciferase assay data 
Three biological replicates, each with four technical replicates, were performed. 
Each firefly luciferase assay reading was normalized to its Renilla luciferase 
reading. The average activity of the plasmid transfected with control mimic was 
set to 100%. The activity of the constructs transfected with the putative target 
miRNA mimic was normalized to the average activity of the plasmid transfected 
with the control mimic. A Mann-Whitney test was performed using GraphPad 
Prism version 6 for Mac (GraphPad Software, San Diego California, USA, 
www.graphpad.com). 
 49 
13. Microsurgical removal of cranial neural 
crest tissue for RNA sequencing 
All dissections of neural crest tissue were carried out in collaboration with Prof. 
Anne-Helene Monsoro-Burq at the institut Curie (Orsay).  
Morpholinos were injected into one dorsal blastomere of a four-cell embryo with 
the morpholinos at a concentration of 60ng. GFP was co-injected as a tracer. 
Stage 14 or stage 17 embryos were placed in an 60 mm Petri dish coated with 
10ml of 2% agarose in 1/3 MMR. The vitelline envelope was removed manually 
using forceps. For dissection, depressions were made in the agarose using the 
forceps and the embryos were placed in the holes dorsal side up. Once secured 
the first incision was made in the lateral part of the anterior neural fold using an 
eyebrow knife and an insect pin. The second incision was then made parallel to 
the first in the more dorsal part of the neural fold using the same instruments. The 
third incision in then made perpendicular to the first two incisions at the posterior 
side. Using the side of the eyebrow knife, the NC were then detached from the 
embryo starting from the third incision. The NC tissue was easy to distinguish as 
it is rather greyish, while the underlying cephalic mesoderm is white. The two 
tissues were carefully separated and then the NC was detached anteriorly from 
the optic vesicle the explant was cut free. Explants were then transferred from 
the dissection dish into an Eppendorf tube containing 50 µl of TRIzol® using a 
P20 pipet, immediately vortexed for 30 secs, left for 5 mins at RT and then stored 
at -20°C prior to extraction. 
13.1.1. Total RNA purification for RNA seq  
TRIzol® was completed to 400 µl and then all samples were sheared by pipetting 
up and down with a 25 G needle and a 1 ml syringe. Chloroform was added in a 
1/5 volume ration and vortexed for 15 seconds. Samples were left for 4 min at RT 
and then inverted multiple times to form a homogenous suspension. Pellet Phase 
Lock Gels were then prepared by centrifuging at 12,000-16,000 x g at 4°C for 20 
seconds. Samples were transferred onto the gels and spun at 12,000-16,000 x g 
at 4°C for 5 min to separate the phases. The nucleic acid phase was then 
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transferred to a new 1.5 ml Eppendorf tube containing 1 µl linear polyacrylamide 
(LPA, Ambion) and vortexed. Isopropanol was added at a ½ volume ratio, 
vortexed, left for 10 min and the samples were left for precipitation O/N at -20°C. 
Samples were centrifuged for 45 min at 4°C and the supernatant was removed. 
Freshly prepared 75% EtOH was used to wash the pellet by vortexing before 
spinning at max RPM for 10 min at 4°C. The supernatant was removed and the 
pellet air-dried for 10 mins. The pellet was resuspended in 30µl of nuclease free 
H2O (sigma). Of this 30 µl, 10 µl was transferred to a new tube for analysis via 
nanodrop, bioanylsyer and q-PCR. The remaining 20 µl were stored at -80°C for 
RNA seq analysis. 
13.1.2. Bioanalyser 
RNA quality was examined using the Agilent 2100 Bioanalyser instrument along 
with the Agilent RNA 6000 Pico Kit (reorder-no 5067-1513). The Agilent 2100 
Bioanalyser is a microfluidics based platform that separates RNA molecules 
depending on their sizes and is able to determine quantities of each molecule. 
Results can be analyzed with 2100 Expert software (Syngene, Cambridge, UK). 
Only samples with RNA integrity number (RIN) values of >7 were used for 
sequencing. 
13.1.3. Reverse transcription 
Following RNA purification, cDNA was synthesized using 4µl of RNA as a 
template. Samples were normalised using housekeeping genes during PCR.  
For cDNA synthesis 4 µl total RNA + 1 µl Random Hexamers (0.05 µg/µl) were 
incubated at 65°C for 5 mins and then cooled on ice for 15-30 mins. 5 µl of RT 
mix was added (Table 14) and left at 42°C for 30 mins. Two tubes were prepared 
for each sample; one with Reverse Transcriptase added (RT+) and one without 
it (RT-) to check whether the RNA was contaminated with DNA.  
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Table 14: Master mix for PCR amplification 
Reagent Amount 
5X Buffer  2 µl 
20 mM DTT 0.5 µl 
10 mM dNTPs 0.5 µl 
RNAsin 0.25 µl 
H2O 1.625 µl 
High performance MMLV reverse transcriptase 
(Promega) 
0.125 µl 
Total volume 5 µl 
 
13.1.4. PCR Amplification 
Aliquots from both RT+ and RT- (water control) tubes were amplified for each 
sample. cDNA was diluted 1/10 and 2 µl of the diluted cDNA was added to 5µl of 
SyberGreen mix (Applied Biosystems, UK), 1 µl of 10uM Primer (0.5 µl of forward 
and 0.5 µl of reverse) and 2 uLof RNAse free H2O. 
13.1.5. RNA sequencing 
RNA sequencing was carried out on nine samples all of which contained three 
replicates each (except miR-219 MO which contained four). The various 
treatment types can be seen in Table 15. All samples were tested prior to 
sequences using PCR (see sections 13.1.3 and 13.1.4) to detect expected gene 
expression. RNA samples were sent to Institut Curie (Paris) for library preparation 
and 50bp paired end sequencing on the HiSeq High Output run mode PE100 for 
sequencing.  
Reads were aligned to the Xenopus laevis 9.1 genome reference (James-Zorn et 
al., 2015, Karpinka et al., 2015) using a topHat2 version 2.0.6 (Kim et al., 2013)
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(Appendix 4). To carry out exploratory and differential expression analysis, the 
aligned reads were fed into the Bioconductor (Huber et al., 2015) RNA-seq 
workflow: gene-level exploratory analysis and differential expression (DE) (Love 
et al., 2015) which makes use of the DE tool called DEseq2 (Love et al., 2014). 
Genes with an adjusted p-value of 0.05 or below were considered significant and 
were reported by the workflow. The gene model used in the DE bioinformatic 
analysis was X. laevis 9.1, annotation version 1.8.3.2 primary gene model (gff3) 
(James-Zorn et al., 2015, Karpinka et al., 2015). Unannotated genes identified 
within the DE results were searched against the NCBI nucleotide collection (nr/nt) 
(Coordinators, 2013) using the local alignment search tool Blastn version 2.6.08 
(Camacho et al., 2009) with default search parameters.  
 Table 15: Samples collected for RNA sequencing (green boxes). All samples had 
three replicates except 219MO (stage 14) which had four. 219MO (stage 17) was 
not sequenced. 
 196a 
Control 
196a 
MM 
196a 
MO 
219 
control 
219 
MM 
219 MO 
Stage 14 Ö Ö Ö Ö Ö Ö  
(4 
replicates) 
Stage 17 Ö Ö Ö    
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Chapter 3: Identification of miRNAs in 
neural crest cells  
Throughout the literature, it has been shown that miRNAs are key regulators 
during the differentiation stages of NC, however, the role of miRNAs in NC 
specification is yet to be investigated. To explore the role of miRNAs during NC 
specification we first set out to identify candidate miRNAs located within the NC 
region. To achieve this, two approaches were chosen. The first was a candidate 
approach which involved looking through a WISH database (XenmiR) and 
characterising candidate miRNAs expression further. The second was an 
unbiased sRNA (sRNA) sequencing approach comparing the miRNA profile of 
induced NC tissue with neural tissue.  
The XenmiR database; a candidate approach 
13.2. Introduction 
The first approach taken to identify candidate miRNAs in the NC was the 
‘XenmiR’ approach’. The main working aim of this, was to identify miRNAs that 
are in the developing NC tissue. To achieve this, WISH was completed for 180 
mature miRNAs using Locked Nucleic Acid (LNA) probes from Exiqon to detect 
NC localisation. Here, a summary of the WISHs completed in this project is 
provided along with the subsequent selection of miRNAs for further investigation. 
13.2.1. The XenmiR database  
In recent years, miRNAs have been shown to play a major role in many 
developmental processes such as early patterning and muscle development 
(Ebert and Sharp, 2012, Goljanek-Whysall et al., 2014). Although hundreds of 
miRNAs have been identified and deposited into the miRNA registry miRBase 
(Kozomara and Griffiths-Jones, 2014), limited data are available on their 
expression patterns during key developmental stages, including NC 
development. Such information is important to consider when investigating a 
 54 
miRNAs potential function in development. To begin to understand the function 
of miRNAs during embryogenesis, WISH was carried out for 180 miRNAs to 
characterise their spatiotemporal expression patterns. These expression profiles 
were then used to locate miRNAs specific to NC regions.  
13.2.2. Expression analysis using WISH 
The technique used for profiling during this approach was WISH. WISH is a 
powerful method used to determine expression profiles and has been used 
extensively over the last 25 years (Hemmati-Brivanlou et al., 1990). Due to the 
small size of a miRNA, WISH has proved to be a difficult technique for looking at 
miRNA expression. Initially, probes against the longer, but short-lived, primary 
transcripts were used (Hubbard et al., 2005). An alternative technique, Northern 
blot analysis, only provides limited spatial and temporal resolution and is 
therefore not an ideal alternative. A more recent technology developed by Exiqon, 
using modified oligos containing miRCURY™ LNA (locked nucleic acid) 
nucleotides as probes (http://www.exiqon.com/), has enabled the clear 
identification of specific expression patterns of mature miRNAs. LNA probes bind 
more strongly to complementary sequences and provide the required specificity 
for detection of mature miRNAs by WISH (Wienholds et al., 2005, Darnell et al., 
2006, Sweetman et al., 2006).  
13.3. Results 
13.3.1. Expression profiling of 180 miRNAs reveals diverse 
expression patterns throughout various developing 
organs and tissues 
The expression patterns of 180 miRNAs in Xenopus laevis were characterised 
(Ahmed et al., 2015). These have now been made freely available and can be 
accessed using the XenMARK and Xenbase websites (Karpinka et al., 2015, 
Gilchrist et al., 2009, Ahmed et al., 2015). At the time of starting this project there 
were 180 miRNAs identified in Xenopus laevis and tropicalis as shown in 
miRBase (Kozomara and Griffiths-Jones, 2014). In collaboration with Exiqon, 174 
LNA probes were generated against these miRNAs. The probes were designed 
to work at the same hybridisation temperature of 50°C. This enabled us to carry 
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out WISH in a high throughput manner.  
Of the 174 miRNAs tested, 140 showed expression at some stages in the 
developing embryo. Analysis of the expression patterns showed that many of the 
miRNAs were expressed during development and many of them were also 
restricted in their expression. Figure 7 shows examples of some of these miRNAs 
with very specific expression patterns. Please refer to Ahmed et al. (2015) for 
more in-depth information about the expression profiles of other miRNAs as this 
will not be discussed further in this thesis. 
13.3.2. LNA WISH on potential neural crest miRNAs 
From this dataset, several miRNAs became interesting candidates because their 
expression was detected in the NP and/or NPB  at neurula stages as well as 
having expression in the branchial arches at tailbud stages. Using these WISH, 
eight preliminary candidates were selected for further analysis.  
For these candidates, a more vigorous investigation of their precise expression 
profile over the neurula stages was conducted and is summarised in Figure 8. 
WISH was completed at NC specification (stage 15) and later just prior to NC 
delamination (stage 17-18) for each of the candidates. LNA WISHs were 
compared to the expression pattern of the neural marker Sox2 and the NC marker 
Sox10 to judge localisation of expression. The results demonstrate that eight of 
the candidate miRNAs had expression patterns that overlapped with both Sox2 
and Sox10 therefore indicating that the miRNAs are expressed in the NP tissue 
and the developing NC tissue. At stage 15/16 the region that is labelled by Sox10 
that gives rise to the NC is named the NPB. Expression in this region was 
particularly apparent for miR-196a (Figure 8 E and Ei). 
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Figure 7:  Xenopus miRNA expression in a diverse number of developing organs 
and cell types. 
Expression patterns of Xenopus laevis miRNAs are shown at varying stages. Arrowheads point to relevant 
expression. Views are lateral with anterior to left except (C, D and K) which is a ventral view with anterior to 
the left and (E) and (F) which are dorsal views with anterior to the bottom. MiR-34b, pancreas; miR-128, 
brain; miR-107, gut; miR-122, liver; miR-126, blood vessels; miR-200a, olfactory placodes; miR-455, liver; 
miR-30d, brain; miR-100, brain; miR-96, brain and olfactory placodes, miR-125, brain and gut, miR-200b, 
olfactory placode (Ahmed et al., 2015). 
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Figure 8: LNA WISHs on neurula staged embryos show expression in the neural 
plate and neural plate border for all candidate miRNAs 
Expression patterns of eight Xenopus laevis miRNAs are shown at neurula stages. Sox10 WISH labels the 
NPB region (I) and Sox2 staining labels the NP region (J). For all eight miRNAs the expression is noted in 
the neural plate (NP) and in the neural plate border (NPB), this is indicated with white arrows (A). Views are 
dorsal with anterior to the top. The most apparent expression of a miRNA in the NPB region is miR-196a 
(E). 
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13.3.3. Co-expression analysis of candidate miRNAs with the 
NC marker Sox10  
13.3.3.1. miR-196a and miR-302 expression overlaps with the NC 
marker Sox10 
To see if the expression of these miRNAs truly overlap with that of the NC, double 
WISH using the NC marker Sox10 were completed. For this experiment, NBT 
was used as the substrate for the LNA WISH resulting in a blue precipitate at the 
location of miRNA expression. Immediately after this, a second WISH, using fast 
red as a substrate, was carried out for the known NC marker Sox10 resulting in 
a red precipitate labelling the NC. These WISH were completed on late neurula 
stages (stage 17-18). 
Of the eight miRNAs that underwent this experiment, two miRNAs came back as 
being expressed in the same region as the NC marker Sox10. This was seen to 
be true for miR-196a and miR-302 (Figure 9 A and F). Another four of the 
miRNAs (miR-17-5p, miR-30a-3p, miR-429 and GNW8) also appeared to have 
some overlap with Sox10 but the overlap was not as evident as with miR-196a 
and miR-302 (Figure 10). Successful double WISH for miR-20a, miR-20b and 
miR-GNW9 were not produced as the background from the LNA WISH was too 
high (data not shown).   
13.3.3.2. Sectioned double WISH clearly demonstrate the overlap 
between miR-196a and miR-302 with the NC marker Sox10 
Often, with double WISH, the dark NBT staining masks the fast-red staining. To 
overcome this problem, the embryos were subjected to sectioning following 
WISH and the fast red was visualised with fluorescence to confirm expression 
localisation. 
Sectioning of the embryos revealed that both miR-196a and miR-302 are 
expressed in both the NP and the NPB. This expression pattern clearly 
overlapped with the NC marker Sox10 providing evidence that both miRNAs are 
co-expressed at the NPB within the developing NC (Figure 9B-J). 
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Figure 9: MiR-302 and miR-196a have clear a overlap in expression with the NC 
marker Sox10  
Double WISH of miR-196a (A) and miR-302 (F) with the NC marker Sox10. Embryos are at stage 17/18 
(late neurula) and are shown with a dorsal view with anterior at the top. Transverse sections show that both 
miR-196a (B-E) and miR-302 (G-J) are expressed in both the NP and the NPB (indicated with a white dotted 
line) and have a significant overlap with the expression of Sox10. 
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Figure 10: GNW8, miR-30a-3p, miR-429 and miR-17-5p all show partial overlap in 
expression with the NC marker Sox10  
Double WISH of GNW8 (A) miR-30a-3p (B) miR-429 (C) and miR-17-5p with the NC marker Sox10 (E). 
Embryos are at stage 17/18 (late neurula) and are shown with a dorsal view with anterior at the top. 
Sectioning shows that all four of the miRNAs appear to have some overlap with the NC marker Sox10 but 
this overlap is not as pronounced as for miR-196a or miR-302 (Figure 9). 
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Next generation sequencing of sRNAs in 
induced neural crest and neural tissue 
13.4. Introduction 
In addition to utilising the XenmiR database, a second, approach was also 
employed to identify miRNAs within the NC. Whilst designing this experiment, the 
main working aim was to try and identify both known and novel miRNAs which 
are specific to the NC tissue when compared to neural tissue. To achieve this, 
Xenopus tissue was induced to become either NC or neural using the animal cap 
method (see section 13.5.1.1). This tissue was then sequenced for sRNAs along 
with control ectoderm tissue and blastula tissue. Bioinformatic analysis was 
performed to identify differentially expressed miRNAs. Here, a summary is 
provided of the sequence strategy employed in this project along with the 
bioinformatic analysis of all known and novel miRNAs identified in the samples. 
13.4.1. Techniques for assessing miRNA expression 
Currently, there are several methods for miRNA expression analysis including 
hybridisation-based miRNA microarrays, quantitative reverse transcription-PCR 
(qRT-PCR), and sRNA library sequencing. Microarrays involve the hybridisation 
of labelled sRNAs to oligonucleotide probes on a platform (Yin et al., 2008). In 
regard to microarray analysis, the design of miRNA probes is often constrained 
by the short length of the miRNAs, such that often the entire miRNA sequence 
must be used as a probe. Consequently, the melting temperatures (Tm) of miRNA 
probes may vary by >20°C. Such a large variation in TM then results in cross-
hybridisation and loss of specificity (Git et al., 2010). In recent years, LNA 
nucleotides in the probe have overcome this problem by enabling an increase in 
hybridisation temperature. This increase in hybridisation temperature has also 
overcome the problem of distinguishing between different members of a miRNA 
family (which can vary by a little as a single nucleotide) (Tolstrup et al., 2003). 
Although analysis of microarray data is simple and well established one major 
flaw is that novel miRNAs are not detected – a key aim of this experiment. 
One of the most popular techniques for validating and accurately quantifying 
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miRNAs is quantitative real time PCR. Once a miRNA has been converted to 
cDNA, amplification proceeds using a miRNA-specific forward primer and a 
universal stem-loop/poly-A primer. The Tm of the forward primer can be adjusted 
by adding a tail (the length of which will depend on the Tm of the mature miRNA), 
(Chen et al., 2005) or by adding LNA nucleotides (Balcells et al., 2011). Following 
amplification, the PCR product can be assayed using the same methods as a 
conventional qPCR experiment using either SYBR® Green, TaqMan® or other 
qPCR variants. However, qPCR has limitations: the design of the miRNA-specific 
qPCR primers can be costly and identification of good normalisers for each 
experiment can prove to labour intensive (Git et al., 2010). Unlike conventional 
qPCR, only one flanking primer can be specific, so care must be taken to ensure 
only one product is being amplified, especially when using SYBR® Green (Vester 
and Wengel, 2004). Moreover, as with microarrays, qPCR cannot be used to 
discover novel miRNAs. 
In contrast to both the latter techniques next generation sequencing (NGS) of 
sRNA libraries does not require prior knowledge of specific miRNAs and therefore 
provides the opportunity to explore new sRNAs and their corresponding 
sequence frequencies. Consequently, NGS was selected as the preferred 
method for this project. The HiSeq 2500 Ultra-High-Throughput Sequencing 
System (Illumina) was chosen for its sequencing yield and accuracy.  
13.4.2. NGS library preparation and sequencing 	
There are several commercially available NGS platforms, the most widely used 
being Illumina, Applied Biosystems (ABI). The general workflow from biological 
sample to sequencing result is similar for all platforms: nucleic acid isolation, 
library preparation, template preparation, sequencing and bioinformatic analysis. 
Library preparation involves the generation of a pool of cDNA from pure, high 
quality input RNA. The length of this cDNA will vary depending on the platform 
and the application, with sequence primers ligated to each end of every strand. 
A sample of this library is then immobilised on a sequencing slide (in the case of 
Illumina platforms), amplified and then sequenced by extending primers by 
synthesis (Metzker, 2010) (Ansorge, 2009). 
A fundamental element of the sRNA library preparation for the HiSeq platform 
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comprises the ligation of alternative sequencing adapters to the 3’ and 5’ end of 
a sRNA enriched sample. The Illumina sequencing platform is available as a kit 
to be used for commercial use. However, the reliability of these kits began to be 
questioned when large variation was noted between replicate samples when 
analysed using alternative NGS platforms (Git et al., 2010). It was suggested that 
one major source of the problem is the RNA ligases used in sRNA library 
construction (Hafner et al., 2011, Jayaprakash et al., 2011). Within the library 
construction protocol both T4 RNA ligases (1 and 2) are used in ligating sRNAs 
to customised adapters. The limiting factor in this ligation reaction is the ability of 
the sRNA to anneal to the adapter. sRNAs with different sequences have different 
ligation efficiencies to certain adapters, which consequently lead to variation in 
representation of different sRNAs. Those sRNAs that can anneal will be ligated 
to an adapter and therefore sequenced; any sRNAs that cannot be ligated will 
therefore not be sequenced resulting in bias (Zhuang et al., 2012a). To overcome 
this problem, we decided to use a new and improved version of these adapters 
which are modified by adding four degenerate nucleotides at each ligating end of 
the Illumina adapters. These adapters, named High Definition (HD) adaptors 
have been shown to dramatically reduce the ligation bias previously seen during 
sRNA sequencing (Sorefan et al., 2012). 
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13.4.3. Are miRNAs the key regulators in the maintenance of 
NC pluripotency? 
Until recently, the model of NC development 
had been a controversial one. Unlike the 
typical differentiation pathway of embryonic 
cell populations (Figure 11, top panel) , NC 
were thought of as unique as they could 
selectively regain pluripotency to increase their 
differentiation ability (unlike their cellular 
neighbours) (Waddington, 1959). In 2015, 
Buitrago-Delgado and colleagues published a 
fundamental paper that changed this working 
model of NC so it no longer defied the 
paradigm of progressive restriction in potential 
(Buitrago-Delgado et al., 2015). They 
demonstrated that the previous model 
whereby the NC could be described as an 
endogenous population of induced pluripotent 
stem cells (Figure 11, middle panel) was 
incorrect. This work provided insight into how 
NC cells retain pluripotency rather than gain it 
and this is selectively inherited from the 
embryonic stem cells from which they are 
derived (Figure 11, bottom panel) (Buitrago-
Delgado et al., 2015). Although extremely 
insightful, one question that arose from the 
results of this paper was; if NC cells can inherit 
their pluripotent ability from the cells they are 
derived from, what is the factor that enables them to do so? miRNAs have been 
shown in many cell populations to be fundamental in the maintenance of 
pluripotency, so could miRNAs be the key factor in the development of NC?  
In light of these results we decided to also complete sRNA sequencing on the 
tissue that NC derive from, that being the animal pole tissue from blastula cells. 
From this we aim to identify miRNAs that are present in both blastula and NC 
Figure 11: Models of NC 
development 
(Top)  A pluripotent blastula cell “rolls” down 
one of four differentiation pathways: 
endoderm (Endo), mesoderm (Meso), 
neural ectoderm (Neuro), and epidermis 
(Epid). Once the cell crosses the dashed 
line, pluripotency is lost. (Middle) Previous 
models implied that the differentiation ability 
of NCC (orange arrow) was induced from an 
ectoderm germ layer by “pushing” the NCC 
back over the dashed line therefore 
increasing it’s differentiation potential. 
(Bottom) The new model by Buitrago-
Delgado et al. shows that NCCs, unlike their 
cellular neighbours, remain pluripotent 
before they differentiate, even potentially 
into endodermal derivatives (Hoppler and 
Wheeler, 2015). 
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samples and explore the possibility of these miRNAs playing a role in maintaining 
the pluripotency of the NC cells.  
13.5. Results: 
13.5.1. Induction of both NC and neural animal cap tissue 
13.5.1.1. Collection of tissue types using the Xenopus animal cap 
assay  
To collect the specific tissue types required for the sRNA sequencing, the 
Xenopus animal cap assay was employed. This assay makes Xenopus an 
excellent model for studying NC development. Through the injection of specific 
cappedRNA (cRNA) into the animal pole of a one or a two-cell stage embryo we 
were able to induce various tissue types. To induce neural tissue, the BMP 
antagonist Noggin cRNA (500pg) was injected, for NC tissue, Noggin (500pg) 
and Wnt (100pg) were injected and our un-injected control resulted in ectoderm. 
At stage 8 the induced region of the embryo (animal cap) was removed and left 
to develop until stage 15 (as judged by sister embryos) at which point RNA was 
extracted. To ensure correct tissue induction, both WISH and PCR were 
employed to assess the presence of various tissue markers. 
13.5.1.2. PCR expression profile of neural and NC markers  
To check for NC induction, the NC transcription factor Snail2 was used as a 
marker. The results show that only animal caps induced to become NC and the 
whole embryo control show Snail2 expression. As expected Snail2 was not 
present in neural and ectodermal tissue. Sox2, a neural marker was 
predominantly expressed in the animal caps induced to become neural tissue as 
well as, to a lesser extent the NC. Epidermal keratin was enriched in the 
ectodermal sample with a small amount of expression in the neural tissue. Two 
control genes were used in this experiment, Histone H4 as a positive control and 
Bracyury for a control of mesoderm contamination. All samples had expression 
of Histone H4 and no expression of Bracyury indicating that there was no 
mesoderm contamination in the animal cap tissue and therefore any gene 
expression was a consequence of prior injections as opposed to mesoderm 
induction (Figure 12A).  
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13.5.1.3. WISH of induced animal cap tissue 
In addition to PCR, WISH for the NC marker Sox10 was used to further validate 
the induction of NC tissue. Results from WISH demonstrate that only those 
animal caps induced to become NC display any expression of Sox10 (Figure 
12B). The expression of Sox10 in the NC animal caps confirms that the NC cell 
fate has been successfully induced. 
13.5.1.4. Quality control of sRNA sequencing 
To make libraries, a minimum of 1.5ug of RNA was required. On average, 40 
animal caps yielded approximately 4ug of RNA, 0.5ug of this was used for PCR 
experiments to validate gene expression, 1.5ug was used to synthesis the 
libraries and any excess was stored for further validation experiments following 
the sequencing. Following RNA extraction, the quality and quantity of the RNA 
was tested using a spectrophotometer. The samples selected for library 
construction and their corresponding spectrophotometer readings are 
demonstrated in Figure 12C. 
13.5.2. SRNA libraries gave two closely sized bands and 
minimal adapter-adapter binding  
SRNA libraries were successfully constructed using the Illumina kit and ran on a 
native 8% polyacrylamide gel. From this gel, the band located at approximately 
144bp (miRNA size with adapters) was cut and libraries were extracted ready for 
sequencing (Figure 13). Surprisingly, all samples appeared to have two bands 
very close to each other in size. This had not been seen previously in the lab on 
non-Xenopus tissue types. For these libraries, both bands were cut out as they 
were too close to separate with enough accuracy and consistency. As 
demonstrated with a black arrow (Figure 13) all samples had a very minimal 
degree of adapter-adapter binding meaning that a large proportion of the sample 
reads will be taken up by sRNAs.  
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Figure 13: sRNA libraries gave two closey sized bands and minimal adapter-
adapter binding 
 
SRNA libraries for ectoderm (A), NC (B), neural (C) and blastula (D) tissue were successfully constructed 
and bands at 144bp in length were cut and extracted. For all samples, two bands very close in size were 
seen, this is indicated with a red box. All samples had minimal adapter-adapter binding, indicated with a 
black arrow. 
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13.5.3. Libraries were enriched for both 23 nt and 29 nt 
sequences  
After being sequenced, the raw sequencing FASTQ files were converted to 
FASTA format and adapter sequences removed with custom Perl scripts. Only 
reads that mapped perfectly by PatMaN (Prufer et al., 2008) to the Xenopus 
laevis (V6.1) genome (Meyer et al., 2013) were retained. Between 21-50 million 
raw reads were obtained per library, of which 49%–70% aligned perfectly to the 
genome depending on the sample. We sequenced up to 4 million unique aligned 
sequences per sample (Table 16). 
Peaks in the length distribution suggest the presence of different classes of 
sRNAs in the libraries (Armisen et al., 2009). For neural (16.1%), NC (15%) and 
ectoderm (18%), the majority of reads had a length of 23 nucleotides (nt) 
indicating that the prepared libraries contained a fraction of RNA corresponding 
to miRNAs in size (Figure 14B). A further peak, approximately 28-29 nt in length 
(which is indicative of Piwi-interacting RNas (piRNAs)) also takes up a large 
proportion of reads for these three tissue types (Armisen et al., 2009). In contrast, 
the blastula sample has a complete shift in distribution with only 5.6% of the reads 
being at 23 nt in length and the majority of reads (17.5%) being at 29 nt. This 
profile is similar to that seen in the literature and therefore confirms that libraries 
containing mostly miRNA-sized sequences were successfully generated as well 
as indicating piRNAs in processes occurring between blastula and more 
specialised tissue in X.laevis (Harding et al., 2014). In addition, as demonstrated 
by the principal component analysis (PCA) plot, replicates cluster well indicating 
the reproducibility of the experiment. It is clear from the PCA plot that the blastula 
sample is the most distinct of the four (Figure 14A).  
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Table 16: A summary of the number of reads obtained from each library and the 
percentage of these reads that aligned to the genome. 
Sample Reads Number of 
sequences 
after 
adaptor 
removal 
Number of 
unique (non-
redundant) 
sequences 
total seqs 
aligned 
% seqs 
aligned 
number of 
unique 
seqs 
aligned 
% unique 
sequences 
aligned 
Neural  40,559,597 27,331,131 3,342,801 13,522,046 49.47 1,777,039 53.16 
Neural   46,613,153 41,902,196 4,517,337 28,487,367 67.99 2,623,461 58.08 
Neural 21,637,139 20,220,692 1,709,192 13,585,683 67.19 916,889 53.64 
NC  50,283,818 24,561,987 3,446,951 13,128,489 53.45 1,902,931 55.21 
NC  50,781,624 42,592,632 5,087,921 29,485,739 69.23 2,925,297 57.49 
NC 27,794,800 25,358,113 4,780,571 17,920,514 70.67 2,959,732 61.91 
Ectoderm  30,983,116 23,443,345 1,762,535 10,938,365 46.66 920,113 52.20 
Ectoderm  29,309,332 23,363,917 3,363,699 16,083,931 68.84 1,937,345 57.60 
Ectoderm  39,291,438 34,598,996 5,491,787 23,802,575 68.80 3,139,468 57.17 
Blastula  29,834,148 24,870,014 5,434,179 15,077,230 60.62 3,052,628 56.17 
Blastula  37,848,041 31,246,471 7,063,141 21,636,112 69.24 4,390,081 62.15 
Blastula  34,762,275 29,884,479 5,771,754 16,190,680 54.18 2,968,797 51.44 
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Figure 14: Size distribution and clustering of sequenced small-RNA enriched total 
RNA 
 
The PCA plot of all libraries sent for sequencing demonstrate that samples cluster well and the blastula 
sample is distinct from the others (A). Bar plots of nucleotide length show that the peak seen at 23 nt 
corresponds to mature miRNA length. For neural, NC and ectoderm tissue the majority of reads are at 23 nt 
with a smaller peak at 29 nucleotides. The counter is seen for the blastula sample with the majority of reads 
being at 29 nt in length. Blue red and green bars represent each of the three replicates for each tissue type 
(B). 
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13.5.4. Blastula peak shift is not caused by piRNAs  
Literature suggests that the peak seen at 29 nt long is indicative of piRNAs 
(Armisen et al., 2009) but in order to validate this we ran a software which detects 
and analyses piRNA clusters (proTRAC, probabilistic TRacking and Analysis of 
Clusters) (Rosenkranz and Zischler, 2012). Surprisingly, we found that, of the 
four tissue types, blastula had the least percentage of reads that can be assigned 
to clusters (3.38%) therefore suggesting that the peak seen at 29 nt is not piRNAs 
and in fact an alternative sRNA (Table 17).  
During blastula stage the embryo undergoes Mid Blastula Transition (MBT), 
during this time the maternal RNA products are broken down in preparation for 
the initiation of zygotic transcription (Mathavan et al., 2005). We therefore 
decided to run transcriptome analysis to investigate whether this peak was a 
consequence of degraded maternal transcripts. The results from the 
transcriptome analysis concluded that there is no increase in the level of sRNAs 
aligning to genes in the blastula sample when compared to the ectoderm, neural 
and NC tissues. In fact, as with the proTRAC results there is a decrease (Table 
17). 
 
Table 17: piRNA clustering and transcriptome analysis of sequenced animal cap 
tissue 
ProTRAC analysis on the smallRNA sequences reveals that the large 28/29 nt peak seen in blastula tissue 
(and not the other tissue types) is not piRNAs. In addition, transcriptome analysis demonstrates that it is not 
consequence of degraded transcripts during mid blastula transition (MBT). 
 
	 	 Ectoderm	 Neural	 Blastula		 NC	
Pr
oT
RA
C	
Predicted	piRNA	clusters	 59	 74	 56	 59	
Total	size	 0.02%	 0.03%	 0.02%	 0.02%	
Sequence	reads	that	can	
be	assigned	to	clusters:		
5.09%	 6.00%	 3.38%	 4.22%	
Tr
an
sc
rip
to
m
e	
an
al
ys
is	
Total	sequences	aligned	
to	transcriptome	
1091358	
	
	
	
1457080	 978399	 2074442	
%	aligning	to	genes	 6.36%	 7.91%	 5.54%	 10.21%	
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13.5.5. miRNA annotation across the four samples 
13.5.5.1. Annotated miRNAs 
In total, over the four tissue types, 106 miRNA families were annotated in X.laevis 
coming from 388 hairpins. Of these, we discovered 15 known animal miRNAs not 
yet formally identified in Xenopus. These will now be added to MiRbase.   
13.5.5.2. Novel miRNAs 
Sequencing of the libraries resulted in the discovery of 102 novel miRNAs from 
137 hairpins. These miRNAs were detected using the programs mircat (Stocks 
et al., 2012) and mirdeep2 (Friedlander et al., 2008) and were evaluated for the 
likelihood of hairpin secondary structure using RNAFold (Gruber et al., 2015). 
Sequences that met this criterion were designated as new Xenopus miRs 
(Appendix 5).  
13.5.6. Global miRNA populations within each tissue type are 
dominated by miR-427 
Of the miRNAs annotated, one known miRNA makes up almost 67% of all miRNA 
reads, this being miR-427. This is the case in all tissue types and is seen most 
strongly in blastula tissue (74%) (Figure 15A). From the sRNA sequencing, five 
isotypes (homologous miRNAs encoded on different gene loci) of miR-427 
hairpins were annotated, all of which had strong conservation in the 5’ sequence 
but poor conservation in the 3’ sequence (data not shown). A breakdown of these 
isotypes by their read number demonstrates that a similar expression profile is 
seen across all the tissue types with isotype C being the most abundant (Figure 
15B).  
Abundance plots of the mature miRNAs (both sequences) for each isotype clearly 
demonstrate that although the hairpins may have a similar expression across the 
tissue types, the profiles of the mature sequences vary greatly (Figure 15C). 
Most of the isotypes have a more abundant 3’ sequence which is present in all 
tissue types at varying degrees. Isotype A proves to have an interesting 
expression profile with a clear switch occurring between the 3’ and 5’ sequences. 
The 3’ sequence is abundant in the more specified tissue types (NC, neural and 
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ectoderm) but absent in the blastula whilst its 5’ sequence has the opposing 
profile being only abundant in the blastula tissue. In isotype C, it is also apparent 
that the 5’ sequence is only apparent in the blastula sample possibly indicating a 
role for these 5’ sequences during the blastula stage of development. 
13.5.7. miRNA expression profile over the samples  
Heatmap analysis of abundant miRNAs across the samples revealed relatively 
low-level miRNA expression in the blastula tissue when compared to the other 
tissue types. A small number of miRNAs were found to be abundant in only one 
tissue type including miR-449c in the ectoderm tissue (Figure 16E).  
A comparison of the ten most highly detected miRNA hairpins in all four tissue 
types revealed that NC, neural and ectoderm all have a similar profile of abundant 
miRNAs with miR-428, miR-200a, miR-141, miR-7, miR-92a and miR-19b being 
present in all three tissues. In this study, the contributions of the top 10 miRNAs 
(including miR-427) were found to total 77% in NC, 81.3% in neural 82.6% in 
ectoderm of the total miRNA hairpin reads sequenced. Following miR-427, the 
second most abundant miRNA in all three samples is miR-428 taking up 6.4% of 
the reads in NC, 5.1% in neural and 2.7% in ectoderm (Figure 16B-D). In 
ectoderm, two abundant miRNAs that are not present in the other samples are 
miR-203 and miR-449. This result was not surprising as these miRNAs have been 
implicated throughout the literature to be key players in both epithelial 
development (McKenna et al., 2010) and cilliogenesis (Song et al., 2014) 
respectively. MiR-26, miR-302 and miR-93 were found to all be uniquely 
abundant in the neural tissue and the four miRNAs miR-219, miR-17, miR-130b 
and miR-20b in the NC sample. Although none of these miRNAs have a direct 
link to NC development, some do have interesting roles in processes during NC 
development and some interesting potential targets which are discussed further 
in section 13.6.4. 
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Figure 15: MiR-427 dominates the miRNA reads in all tissue types. 
MiR-427 makes up over 67% of all miRNA reads and this saturation is seen in all tissue types (A). In total, 
five isotypes of miR-427 were sequenced, all of which had a similar hairpin distribution over the tissue types 
with isotype C being the most abundant (B). Although the hairpins had similar distribution the mature 
miRNAs had unique profiles across the tissue types. The 3’ sequence in all cases is the most abundant. 
Isotype A has an interesting profile with the 5’ sequence being abundant in blastula stage and absent in the 
other tissues and the counter is seen with the 3’ sequence (C). 
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The blastula sample is very distinct from the other three samples and has a 
completely unique profile. miR-428 fails to make it into the top 10 most abundant 
miRNAs, the most abundant miRNA after miR-427 is miR-148a (Figure 16A). 
Interestingly, a novel miRNA (miR-nov-38a-1) is present in the blastula profile. 
As this miRNA is specific to the blastula sample and is in the top 10 most 
abundant miRNAs it proves to be a good candidate for a miRNA with an important 
role in blastula development.  
13.5.8. Several miRNA hairpins are differentially expressed 
between neural tissue and NC tissue 
To identify some candidate miRNAs located in the NC, differential expression 
analysis on neural vs NC tissue was completed using deSEQ2 (Figure 17B) 
(Love et al., 2014). In total, 11 miRNA hairpins were upregulated in NC, all of 
which are listed in Figure 17A. The top miRNA is miR-219 which is abundant in 
all three replicates of NC and almost absent in all other samples. A similar profile 
of expression is seen for miR-130C (Figure 17B,C). Interestingly, one of the 
miRNAs upregulated in NC compared to neural tissue was miR-196a - the main 
candidate that came out of the XenmiR approach. MiR-10b is also in the top 10 
differentially expressed miRNAs, as with miR-196a, miR-10b is also located 
within a HOX cluster (Figure 20) (Yekta et al., 2004). One novel miRNA made it 
into the differentially expressed miRNAs, that being miR-nov-12a (Figure 17D). 
Two miRNAs that were upregulated in the neural tissue when compared to NC 
were miR-302 and miR-9 (Figure 17B), both of which are implicated to have roles 
in neural development throughout the literature (Yang et al., 2015, Li et al., 2016). 
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Figure 16: miRNA expression profiles and heatmap analysis of miRNAs in early 
Xenopus development.  
Pie chart analysis show the distribution of the top 10 most abundant miRNAs across the different tissue 
types (A, B, C, D). miRNAs were clustered by expression similarity for heatmap analysis. miRNA expression 
is displayed using a colour key where blue corresponds to low and red to high numbers of miRNA normalized 
reads. The miRNAs labelled are most abundant in the four libraries (E). 
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Figure 17: Several miRNAs are upregulated in neural crest when compared to 
neural tissue. 
Differential analysis of miRNA hairpins was completed on neural vs NC samples. In green are miRNAs 
upregulated in NC. Blue gives two examples of neural specific miRNAs (A). Scatter plot output from DeSEQ2 
analysis demonstrates that several miRNAs were upregulated in NC (red dots) and in neural (green dots) 
(B). miR-219, miR-nov-12a-1 and miR-130C are three examples of miRNAs upregulated in the NC samples 
when compared to all other tissue types (C, D, E). 
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13.5.9. miR-338 and miR-301a are expressed in both neural 
crest and blastula samples  
To identify potential candidate miRNAs that are key in maintaining a pluripotent 
NC population throughout development, miRNAs that were not differentially 
expressed between blastula tissue and NC as well as being absent in both neural 
tissue and ectoderm tissue were determined. From this, two miRNAs were 
identified, these being miR-338 and miR-301a (Figure 18A). Both miR-338 and 
miR-301a were enriched in both the NC and blastula samples (Figure 18BC) and 
have also been linked throughout the literature to being involved with the 
maintenance of pluripotency (Lin et al., 2009, Li and Belmonte, 2017). This 
therefore makes them interesting candidates for further investigations. 
13.5.10. Validation via qRT-PCR 
To experimentally validate the sRNA sequencing results qRT-PCR was 
employed. We used the remaining RNA from the initial library preps to construct 
cDNA and run qRT-PCR to assess various miRNA expression levels across the 
tissue types. All miRNA expression levels were normalised to U6 snRNA. As 
demonstrated in Figure 19 the miRNAs in question displayed the same 
expression profile using qRT-PCR as they did in the sRNA sequencing. This 
includes the novel miRNA, miR-nov-12a that was only expressed in the NC tissue 
type, two known miRNAs (miR-219 and miR-196a) that were also enriched in the 
NC sample and a miRNA enriched in the neural tissue (miR-302). From the sRNA 
sequencing, miR-302 was found to be most abundant in the neural sample, 
moderately expressed in the NC sample and then low in ectoderm. This profile is 
replicated in the qRT-PCR with the level of miR-302 in both neural (**) and NC 
(*) being statistically different from the ectoderm (Figure 19). To strengthen these 
results, validation on dissected NC tissue could be completed. However, due to 
time constraints these experiments were not completed. 
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Figure 18: MiR-338 and miR-301a are expressed in both neural crest and blastula 
samples. 
Differential analysis was completed on NC and blastula samples. miR-338 and miR-301 were found to be 
not differentially expressed between NC and blastula (A). miR-338-3 and miR-301a were found to be 
enriched in both NC and blastula and are therefore candidates for miRNAs which could have a role of 
maintaining NC pluripotency (B, C). 
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13.6. Discussion 
13.6.1. miR-196a and miR-302 are co-expressed with Sox10 in 
the developing NCC 
Using the XenmiR approach we found multiple miRNAs to be located in NC 
tissue. Through WISH and double WISH it can be concluded that miR-196a and 
miR-302 are expressed in the developing NC as well as in the NP (Figure 9). It 
is also likely that miR-17-5p, miR-30a-3p, miR-429 and GNW8 are expressed in 
the NC although the staining wasn’t quite as strong as for the above miRNAs 
(Figure 10). Potential reasons for the weak staining can be inferior quality of the 
in-situ reaction or a low copy number transcript.  
Taking these results, along with literature searches for potential targets the 
following five miRNAs were chosen for functional analysis: 
miR-196a: 
MiR-196a is a vertebrate specific miRNA that is part of the miR-196 precursor 
family. MiR-196 is present in three HOX clusters: miR-196b on HOXA, miR-196a-
1 on HOXB and miR-196a-2 on HOXC (Figure 20). MiR-196a-1 and miR-196a-
2 have an identical mature sequence, whereas miR-196b differs by a single 
nucleotide (Liu et al., 2013). Gessert et al. (2010) showed that KD of miR-196a 
using MO resulted in abnormal expression of various neural and NC related 
genes including a reduction in the expression of the NC marker Snail2. However, 
this phenotype was not investigated any further by the authors. MiR-196a has 
been shown to target several HOX genes, 
including HOXA5, HOXB7, HOXB8 and HOXC8 (Asli and Kessel, 2010, Li et al., 
2010, Liu et al., 2012, Braig et al., 2010) and is predicted using computational 
algorithms to target many more. HOX genes are expressed at the time of NC 
induction and play a central role in NC patterning (Lumsden and Krumlauf, 1996). 
There are multiple papers which demonstrate the link between NC development 
and anterior HOX genes. It was demonstrated using mice that a rhombomere 4 
(r4) specific triple HOX loss-of-function mutation resulted in loss of the expression 
of all r4 NC derived markers and all the structures normally derived from them 
(Gavalas et al., 2001). Using gain of function experiments, Gouti and colleagues 
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showed that the NC markers, Msx1/2 and Snail1 were upregulated in response 
to HOXB1 expression and that when expressed in the neural tube of the trunk 
region of the developing chick embryo, anterior HOX genes can induce a switch 
in cell fate from neural to NC  (Gouti and Gavalas, 2008, Gouti et al., 2011).  In 
addition, miR-196a has been shown to regulate sonic hedgehog (shh) signalling 
via the direct targeting of HOXB8 during limb development (Hornstein et al., 
2005). Shh is also involved in NC development (Jeong et al., 2004). These 
findings clearly indicate that anterior HOX genes are directly involved in NC 
specification and as a master regulator of HOX gene expression, is miR-196a 
part of this network? 
 
Figure 20: Schematic representation of the structure of the four mammalian HOX 
gene clusters with the location of the hosted miRNAs. 
miR-302: 
The miR-302/367 cluster is highly conserved and is vertebrate-specific. The 
cluster was initially identified in undifferentiated human embryonic stem cells and 
was shown to play a role in the maintenance of the pluripotency (Suh et al., 2004). 
Previous studies in chick have shown using WISH that miR-302 is highly 
expressed in neural folds, the region where NC arise from (Jeong et al., 2014). 
The miR-302/367 cluster has been demonstrated to be involved in regulation of 
various cellular signalling pathways linked with NC development, such as the 
BMP and TGF-β signalling pathway. During development, for the NC lineage to 
be specified, an intermediate level of BMP signalling is necessary, with a high 
level required for ectoderm and a low level for neural specification (LaBonne and 
Bronner-Fraser, 1998). MiR-302 members have been shown to be capable of 
fine-tuning BMP signalling via regulation of three BMP inhibitors, TOB2, DAZAP2 
and SLAIN1 (Lipchina et al., 2011). It is therefore possible that miR-302 is 
regulating this confined intermediate level of BMP expression required for NC 
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development. Another key process in NC development is the epithelial to 
mesenchymal transition (EMT), EMT is the switch to a mesenchymal cell type 
that enables the NC to delaminate away from the dorsal neural tube and migrate 
along various axes of the embryo (Theveneau and Mayor, 2012). Using in vitro 
assays, miR-302 has been shown to facilitate the induction of EMT through 
directly repressing the translation of transforming growth factor beta receptor 2 
(TGFBR2), and Ras homologue gene family, member C (RHOC) genes 
(O'Connor and Gomez, 2014, Subramanyam et al., 2011). Finally, through 
targeting of Lefty1 and Lefty2 (Nodal inhibitors), and thus modulation of the TGF-
β/Nodal signalling pathway, miR-302 members have been shown to regulate the 
balance between a pluripotent state and a differentiated state of a cell - a key 
aspect of NC development (Barroso-delJesus et al., 2011). 
Mir-17-5p:  
miR-17 is part of the miRNA precursor miR-17 family, which includes miR-17, 
miR-20a/b, miR-93, and miR-106a/b, all of which have the an identical seed 
sequence (Concepcion et al., 2012). Using computational target algorithms, two 
interesting predicted targets of miR-17 were identified, these being the BMP 
inhibitor BAMBI and the hypoxia factor Hif-1α. As mentioned previously whilst 
discussing miR-302, an intermediate level of BMP is required for NC 
specification. It is therefore possible that, as with miR-302, miR-17 is regulating 
this confined intermediate level of BMP expression required for NC development 
through regulation of BMP inhibitors. The second interesting predicted target of 
miR-17 - Hif-1α, has previously been demonstrated to be essential for successful 
EMT and chemotaxis of NCC therefore potentially linking this miRNA into the 
regulation of NC motility (Barriga et al., 2013). As well as interesting predicted 
targets, functional analysis has also shown links between miR-17 and NC 
development. Gokey et al. (2012) demonstrated using microarray analysis on 
tissue depleted of the NC transcription factor Sox10 that miR-17 was a Sox10 
dependent miRNA. In addition, data has shown that miR-17 is regulated by the 
transcription factor c-Myc, an essential regulator of NC formation (Bellmeyer et 
al., 2003, Hatch et al., 2016). 
miR-429: 
miR-429 is a member of the mir-200 family along with miR-200c, miR-200b, miR-
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200a, and miR-141. In recent years, the miR-200 family has been extensively 
studied in the literature in the context of inhibition of EMT and metastasis in 
various cancer types (Pieraccioli et al., 2013). One gene that multiple members 
of this family have been shown to target within various biological contexts is Ets1 
(Chan et al., 2011). Ets1 is a NC regulator, specific to cranial NC population. It is 
suggested to have a unique function of establishing a regulatory state that 
activates cranial crest–specific effector genes responsible for the transition from 
the pre-migratory to migratory state (Gao et al., 2010). This therefore raises the 
possibility that miR-429 may play a role in inhibiting premature migration through 
regulation of Ets1. To support this potential role of miR-429 in NCC, it is known 
that members of the miR-200 family inhibit the translation of ZEB1 and ZEB2. 
These ZEB proteins are transcription factors that promote NC EMT, thus by 
inhibiting their translation this results in a stabilised epithelial phenotype and E-
cadherin expression until the cells are ready to delaminate (Van de Putte et al., 
2007) (Christoffersen et al., 2007). Further, in an endothelial cells context, it was 
shown that the transcription factor Snail (key in NC development) can repress 
members of the miR-200 family resulting in the promotion of EMT (Gill et al., 
2012). Together, this provides a strong potential link between miR-429 and the 
governance of NC migration. 
miR-30a-3p: 
miR-30a is a member of the well characterized miR-30 family. This family 
includes five members (a–e) that are broadly conserved (Rodriguez et al., 2004). 
Throughout the literature, miR-30a-3p has had links with migration in various cell 
populations. In endothelial cells, miR-30a-3p targets the methyl CpG binding 
protein MeCP2 resulting in migratory defects (Volkmann et al., 2013). This is 
interesting in the context of NC development as decreased levels of MeCP2 are 
associated with Hirschsprung disease, a disease characterised by the absence 
of the intramural ganglion which itself is associated with impaired proliferation 
and migration of NCC (Zhou et al., 2013). In addition to this, miR-30a-3p has 
been demonstrated to upregulate HIf2a in renal cell carcinomas (Mathew et al., 
2014). Hif2a has been shown in various cell types, including NC like tumour cells, 
to be key in ensuring the maintenance of an undifferentiated/ proliferative state 
(Pietras et al., 2009). Finally, miR-30a-3p has been demonstrated to target the 
NC transcription factor Snail1 and as a result of this regulate EMT in hepatocytes 
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(Zhang et al., 2012a). Together, this indicates the miR-30a-3p could have a role 
in the maintenance of a multipotent state and/or inhibition of NC migratory 
capabilities. 
13.6.2. Libraries were enriched for both 23 nt and 29 nt 
sequences  
SRNA sequencing libraries were successfully prepared from samples enriched 
for sequences of 23 nt, containing mature miRNA transcripts (Figure 14B). In the 
ectoderm, neural and NC samples this peak was the largest with another smaller 
peak seen at 29 nt. In the blastula sample, the counter was seen with the largest 
enrichment of sequences being at 29 nt and a smaller one seen at 23 nt. These 
results are consistent with sequencing results from other experiments, many of 
which have concluded that this peak is piRNAs (Faunes et al., 2012). PiRNAs 
are not processed by Dicer during their biogenesis and are largely known for their 
roles in epigenetic changes and maintenance of the gonads and germ cells of 
vertebrates (Aravin et al., 2006). PiRNAs are said to be between 26-31 nt long 
so fit the profile of this large peak in the blastula sample perfectly (Weick and 
Miska, 2014). However, using proTRAC to analyse this sRNA dataset for piRNA 
clusters we show that there is not an enrichment of piRNAs in the blastula tissue 
(3.38%) compared to neural (6%) NC (4.22%) and ectoderm (5.09%) (Table 16).  
Following this, we used transcriptome analysis to investigate whether the sRNAs 
in this 29 nt peak are degraded protein coding genes. During blastula stage, the 
embryo undergoes Mid Blastula Transition (MBT), at this time the maternal RNA 
products are broken down as zygotic transcription is initiated (Mathavan et al., 
2005). Therefore, it would make sense that the blastula embryo had this large 
peak compared to the more specialised tissue samples. Surprisingly, as with 
proTRAC we found there was no increase in the number of sRNAs aligning to 
genes in the blastula sample (5.54%) when compared to the others (6.36%-
10.21%) (Table 16). 
The number of reads at 28/29 nt account for 35% of the total reads in blastula 
compared to approximately 20% in the other tissue types. This implies that 
whatever this subset of sRNAs are, it is likely they are playing a key role in the 
processes during or after MBT. One strong possibility is that this peak is result of 
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a newly discovered class of sRNAs named site RNAs. Site RNAs are 
approximately 28 nt in length and are derived from remnants of transposable 
elements which align in clusters to the introns in protein coding genes (Harding 
et al., 2014). The focus of this work is the miRNA expression profile of the 
sequenced tissue so no further analysis was completed, however, this data set 
could be probed for more information on the origination of this peak and its role 
in early development. 
13.6.3. Global miRNA populations within each tissue type are 
dominated by miR-427 
Our sRNA sequencing reveals a striking dominance of miR-427 in all four of the 
samples making up over 67% of all the miRNA reads (Figure 15). This robust 
accumulation of one miRNA across the tissue types is likely to be a result of the 
presence of hundreds of copies of a -1.2kb DNA repeat sequence in the X. laevis 
genome encoding the various isotypes of miR-427 (Lund et al., 2009). 
Throughout the literature, miR-427 has been implicated in early embryo 
development, specifically during MBT. As discussed previously in section 13.6.2, 
just after stage 8 is when MBT occurs and maternal transcripts are broken down 
as zygotic transcription is initiated. miR-427 has been shown previously to reach 
maximum levels just after MBT (Watanabe et al., 2005) (Newport and Kirschner, 
1982) and to play a key role in the deadenylation and destabilisation of these 
maternal transcripts. MiR-427 has orthologues in both Zebrafish (miR-430) and 
humans (miR-302) (Chen et al., 2005) (Rosa et al., 2009), both of which share 
the same seed sequence and have the same conserved function (Giraldez et al., 
2005) (Mishima et al., 2006, Rosa et al., 2009).  
In total, five isotypes of miR-427 hairpins were identified across the four tissues 
(Figure 15C). Previous work studying the function of miR-427 in Xenopus has 
reported only four isotypes (A, C, D and E) but this work was completed on the 
blastula staged embryos and our results demonstrate that the fifth sequence is 
not expressed in blastula (Lund et al., 2009). Although a similar expression profile 
is seen for all hairpin isotypes across the samples (Figure 15B), abundance plots 
of the mature miRNA sequences (3’ sequence and 5’ sequence) clearly 
demonstrate stage specific expression (Figure 15C). It has been shown that for 
deadenylation of maternal mRNAs the functioning mature sequence of miR-427 
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is the conserved 3’ sequence (Lund et al., 2009). However, which individual 
isotypes are responsible has yet to be investigated. Although miRNAs primarily 
bind using their seed sequence (which is identical across the isotypes), often 
other regions of the miRNA influence binding to its target and ability to complete 
its function. From this sequencing, two isotypes had abundant expression of the 
3’ mature miRNA in the blastula sample, that being isotype C and D. It is therefore 
likely that it is these isotypes that are responsible for deadenylation of maternal 
transcripts although further investigations need to be carried out.  
Whilst analysing the distribution of the mature sequences, isoform A proved to 
have an interesting expression profile with a clear switch occurring between the 
3’ and 5’ sequences depending on the tissue type. The 3’ sequence is abundant 
in the more specified tissue types (NC, neural and ectoderm) but absent in the 
blastula whilst its 5’ sequence has the opposing profile being only abundant in 
the blastula tissue (Figure 15). This result was surprising as it was expected that 
the sequence shown to be involved in maternal deadenylation would be abundant 
in the blastula sample. This point opens two questions; firstly, what is the function 
of the 5’ sequence in the blastula tissue? As there is such an enrichment of this 
mature sequence at blastula stages it would be interesting to investigate potential 
targets. Secondly, with such a clear switch in tissue specific expression of the 
two mature sequences does the 3’ sequence in the more specialised tissues play 
any kind of biological role? Is it the case that the same hairpin plays a different 
role at different stages of development and if so what controls the processing to 
permit this? These are all interesting questions which should be investigated but 
as it is not the aim of the project they will not be discussed any further. 
13.6.4. miRNA expression profile over the samples  
Comparisons of miRNAs sequenced in neural, NC and ectodermal tissues 
revealed several points. First, miRNA diversity over the three tissues is 
remarkably limited. Just a few miRNAs were found to dominate the sequencing 
space in all three of these samples (Figure 16B-D). In total, the contributions of 
the top 10 miRNAs were found to total approximately 80% of the total miRNA 
hairpin reads sequenced across the samples. Following miR-427, the second 
most abundant miRNA in all three samples is miR-428 taking up between 2.4% 
and 6.4% of all reads. MiR-428 is a Xenopus specific miRNA and although its 5′ 
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region has some similarity to previously identified mammalian miR-302 and miR-
20, the function of this miRNA has yet to be investigated (Watanabe et al., 2005).  
Despite this limited complexity, we did identify several differentially expressed or 
tissue-specific miRNAs, some of which are present at high abundance. Examples 
of these include miR-203 and miR-449, which are expressed in the ectoderm 
(Figure 16B). Both miR-203 and miR-449 have been implicated in epidermal 
development. MiR-203 is known to target the transcription factor p63 (Nissan et 
al., 2011), a p53 family member which is known to be critical in the development 
of stratifying epithelia in both human (Rinne et al., 2007) and mouse (Mills et al., 
1999). miR-449 has been shown to play a vital role in cilliogenesis of epithelial 
tissue in both Xenopus and mice (Song et al., 2014). In neural tissue, miR-302 
and miR-93 are both highly expressed (Figure 16C). MiR-302 has been 
previously documented to play a role in neural development. Previous studies 
have shown using WISH that miR-302 is highly expressed in early 
neuroepithelium (Jeong et al., 2014). In addition, knockout mouse models of miR-
302 results in early embryonic lethality characterised by an open neural tube 
defect (Parchem et al., 2015). Finally, and most interestingly, the four miRNAs 
miR-219, miR-17, miR-130b and miR-20b are all abundant in the NC sample 
(Figure 16D). None of these miRNAs have previously been linked to NC 
development but most have indirect links. For example, microarray analysis on 
tissue depleted of the NC transcription factor Sox10 demonstrated that both miR-
17 and miR-20b were Sox10 dependent miRNAs (Gokey et al., 2012). In addition, 
data has shown that miR-17 is regulated by the transcription factor c-Myc, an 
essential regulator of NC formation (Bellmeyer et al., 2003, Hatch et al., 2016). 
MiR-219 and its link to NC will be discussed more extensively in section 13.6.5. 
In contrast to the neural, NC and ectodermal tissue, blastula is more distinct 
(Figure 16A). Unlike the other tissue types, miR-428 is not in the top 10 most 
abundant miRNAs, the most abundant miRNA after miR-427 is miR-148a which 
makes up almost 4% of the total reads. Also highly expressed in the blastula 
sample were miR-30a, miR-16 and miR-101-2. Previous data demonstrates that 
both miR-148a and miR-101 are abundant in Xenopus eggs so it is possible that 
the expression of these two seen in the blastula is a carry-over from the egg 
(Armisen et al., 2009).  Through targeting of Nodal receptors, miR-16 has been 
shown to be key in the development of the dorsal signalling centre - Spemann’s 
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organiser (Martello et al., 2007). It is therefore not surprising that this miRNA was 
relatively highly expressed in the blastula tissue. Interestingly, a novel miRNA 
(miR-nov-38a-1) is present in blastula profile taking up 2.5% total miRNA reads. 
With such relatively large read numbers it is possible that this miRNA is playing 
a role in early development and although it is not the focus of this work it should 
be followed up further.  
13.6.5. Several miRNA hairpins are differentially expressed 
between the neural and NC samples 
In total, 11 miRNA hairpins were differentially upregulated in the NC sample when 
compared to neural. Of these, the top miRNA which is abundant in all three NC 
replicates is miR-219 (Figure 17C). Although there is no direct link between NC 
and miR-219 in the literature, miR-219 has some interesting NC related targets 
(both validated throughout the literature and predicted using target algorithms). 
One of these is PDGFRα (Dugas et al., 2010). PDGFRα is a receptor for the 
ligand PDGF. Once bound, the PDGF ligands exert their function by causing 
dimerisation and activation of the PDGF receptors. This, in turn, results in 
activation of a multitude of intracellular signalling cascades. The outcomes of 
these signalling events are diverse and include proliferation, migration, matrix 
deposition, survival and EMT (Betsholtz et al., 2001). PDGFRα has been 
demonstrated to be vital for initiation of NC migration through multiple 
mechanisms such as up-regulation of MMP2 for matrix degradation prior to 
migration (Robbins et al., 1999) and inhibition of apoptosis (Soriano, 1997). Loss 
of function experiments for PDGFRα result in cleft palatal defects in zebrafish, 
mice and humans (Roessler et al., 1996) (Tallquist and Soriano, 2003) (Li et al., 
2009b). The ligand, PDGF is often used as a marker for migrating NCC. It is 
therefore possible that miR-219 plays a function in repressing activity in the early 
pre-migratory NCC to prevent premature migration. In addition, using 
computational target algorithms multiple interesting targets were recorded for 
miR-219 including multiple members of the Pax, Six, Eya, Dach (PSED) network. 
Multiple members of this network have been demonstrated to play roles in all 
derivatives of the NPB (Schlosser, 2007). For an extensive review of these PSED 
network targets see section 13.12.2. 
Interestingly, one of the miRNAs upregulated in NC - miR-196a, was the 
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strongest candidate that came out of the XenmiR approach (see section 13.6.1). 
MiR-10b is also in the top 10 differentially expressed miRNAs and as with miR-
196a, miR-10b is also located within a HOX cluster (Figure 20) (Yekta et al., 
2004). As with miR-196a (see section 13.6.1) miR-10b is known to target multiple 
HOX genes, some of which are implicated in NC development (Woltering and 
Durston, 2008). In addition, miR-10b has been shown previously in vitro to target 
the histone deacetylase - HDAC4 (Ahmad et al., 2015). HDAC4 has been shown 
to be required for the generation of anterior facial structures in zebrafish by 
modulating the migration of CNC cells (DeLaurier et al., 2012). Finally, miR-10b 
has been shown to modulate the TGFb pathway by directly targeting TGFb (Han 
et al., 2014). TGF-beta ligands and their signalling intermediates have significant 
roles in patterning and specification of cranial NC cells (Chai et al., 2003). 
Notably, the miR-130 family had multiple members differentially expressed 
between neural and NC. This family of miRNAs is vertebrate specific and has 
recently been shown to be upregulated by the protein YAP (Shen et al., 2015). 
YAP is an activator of the Hippo pathway, a pathway that has been shown to be 
key in the establishment of a NC fate (Hindley et al., 2016). 
miR-nov-12a was the only novel miRNA to make the top 10 differentially 
expressed miRNAs (Figure 17D). Although the read numbers were not high it is 
still possible that this miRNA is playing a role in NC development. Due to time 
restraints, this miRNA was not followed up further but computational target 
analysis should be performed for this miRNA to investigate potential interesting 
targets.  
13.6.6. miR-338 and miR-301a are expressed in both NC and 
blastula samples  
Two miRNAs were found to have an enriched expression in both NC and blastula 
tissues when compared to ectoderm and neural (Figure 18A). This makes them 
both candidates for miRNAs that are involved in maintaining this ‘pluripotent cell 
population’ of NC cells recently described by Buitrago-Delgado et al that originate 
in the blastula (Buitrago-Delgado et al., 2015). The first of these miRNAs is miR-
338 (Figure 18B). miR-338 is an intronic miRNA, transcribed together with a host 
gene encoding an apoptosis-associated tyrosine kinase (Aak) (Barik, 2008). It 
has been shown that miR-338 is regulated by Sox10 via the direct regulation of 
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its host gene, therefore providing a link between this miRNA and NC (Gokey et 
al., 2012). In addition, miR-338 has been shown in multiple biological contexts to 
be a negative regulator of differentiation. For example, miR-338 can inhibit the 
expression of osteoblast differentiation markers such as Osterix (Osx), thus 
reducing osteoblast differentiation (Liu et al., 2014). Finally, and most 
interestingly, miR-338, is known to be upregulated specifically by c-Myc in 
embryonic stem cells (Lin et al., 2009). This proves very interesting as Myc 
proteins are known to have an important function in stem cell maintenance and 
c-Myc has been demonstrated to be key in NC development (Cartwright et al., 
2005, Bellmeyer et al., 2003, Hatch et al., 2016).   
The second miRNA found to be enriched in both blastula and NC samples is miR-
301a (Figure 18C). miR-301a has a strong link to the maintenance of 
pluripotency as it has been shown to partake in a positive feedback loop essential 
for human pluripotent stem cell (hPSC) self-renewal and reprogramming (Lu et 
al., 2014). Lu et al demonstrated that miR-301a inhibits the translation of both 
SFRS2 and MBD2. SFRS2 is a splicing factor, targeted by OCT4 and required 
for pluripotency. SFRS2 regulates alternative splicing of the methyl-CpG-binding 
protein MBD2, whose isoforms play opposing roles in maintenance of, and 
reprogramming to, pluripotency (Lu et al., 2014). They concluded that the miR-
301 family independently regulate SFRS2 and MBD2 to “fine-tune” the 
expression of MBD2 isoforms in the favour of self-renewal (Lu et al., 2014). In 
addition, miR-301 has also been shown to regulate the induction of induced 
pluripotent stem cells (iPSCs). It was first identified using a miRNA library screen 
whereby miR-301 was shown to enhance the efficiency of iPSC generation by 
repressing the homeobox transcription factor Meox2 (Pfaff et al., 2011).  
Clearly, from the results of this sRNA sequencing and through literature 
searches, both miR-338 and miR-301a are strong candidates for miRNAs that 
are responsible for maintaining this novel pluripotent cell population which gives 
rise to NC (Buitrago-Delgado et al., 2015). Unfortunately, it is not the aim of this 
project so functional analysis will not be performed but the data should be 
followed up by a future student. 
From both the XenmiR approach and the sRNA sequencing presented in this 
chapter a number of candidate miRNAs that are located in the NC region became 
 93 
apparent. To explore the possibility of these miRNAs playing a role in NC 
development, functional analysis using morpholinos (MOs) to knock down the 
miRNAs of interest was implemented. 
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Chapter 4: Functional analysis of 
candidate miRNAs  
13.7. Introduction 
The results obtained from the candidate identification in chapter three suggested 
that there are six potential miRNAs that could be involved in NC development, 
those being miR-196a, miR-219, miR-302, miR-429, miR-30a-3p and miR-17-5p. 
To further investigate this, functional analysis was completed using MOs 
designed against the miRNAs in question (refer to materials and methods for MO 
sequences). The working aim of this experiment was to knockdown (KD) the six 
miRNAs individually and assess the phenotype at both whole embryo and a 
transcriptome level. 
13.8. miRNA knockdown  
To determine the importance of these candidate miRNAs on NC development the 
level of expression of each miRNA was depleted individually and the impact of 
the KD on NC derived structures (i.e. craniofacial cartilage) was assessed along 
with any changes in the expression of various NC markers. Since it is difficult to 
obtain a genetic mutant for a miRNA in Xenopus laevis we looked for alternative 
strategies. Antisense molecules such as 2′-O-methyl and locked nucleic acid 
(LNA) oligonucleotides (oligos) have been used to inhibit miRNAs in cell lines 
(Hutvagner et al., 2004), Drosophila embryos (Leaman et al., 2005), and adult 
mice (Krutzfeldt et al., 2005). However, they have been reported in multiple model 
organisms to cause severe toxic effects at the level required for sufficient KDs in 
vivo.  
One alternative to the LNA modified oligos are MOs, a different type of oligos. 
MOs are synthetic molecules usually 25 bases in length, that bind to 
complementary sequences of RNA by base-pairing. Structurally, the difference 
between MOs and DNA is that, while DNA bases are bound to deoxyribose rings 
which are linked through phosphates, whereas the MO structure is based on 
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nucleic acids that are bound to morphine rings which are linked through 
phosphorodiamidate groups (Summerton and Weller, 1997). Consequently, the 
backbone of MOs is no longer charged making it unrecognisable to enzymes or 
signalling proteins and is therefore more resilient to nucleases and does not 
trigger an innate immune response. This significantly reduces loss due to oligo 
degradation, interferon induction and inflammation which are problems 
commonly encountered with LNA oligonucleotides (Summerton, 1999). MOs do 
not degrade their target miRNA molecules, instead they act by "steric blocking", 
binding to a target sequence within an miRNA and simply getting in the way of 
molecules that might otherwise interact with it (Eisen and Smith, 2008). MOs are 
commonly used in species such as Xenopus and Zebrafish, to study the role of 
mRNAs and miRNAs in development. For example, in Zebrafish, MOs 
complementary to miR-214 have revealed that this miRNA regulates expression 
of su(fu), which encodes a modulator of Hedgehog signalling (Flynt et al., 2007), 
and MOs complementary to miR-140 have revealed that this miRNA regulates 
Pdgf signalling during palate formation (Eberhart et al., 2008). In Xenopus, the 
activities of miR-15 and miR-16 have been inhibited by MOs to reveal that these 
miRNAs target the type II Nodal receptor Acvr2a (Martello et al., 2007).  
13.9. Results 
13.9.1. Preliminary MO injections 
To screen which of the candidate miRNAs may have a functional role in NC 
development, MOs for all miRNAs were injected at both 40 ng and 60 ng to 
assess the general phenotype of the developing embryo and the effect on the 
expression of the NC marker Sox10 by WISH. MO’s were injected into one dorsal 
blastomere of an eight-cell embryo so only the prospective neural and NC tissue 
on one half of the embryo would be affected (Figure 21A). 
Of the six MO’s injected, four gave phenotypes in varying degrees. The two MO’s 
that gave no phenotype were those that targeted miR-17-5p and miR-30A-3p. 
The embryos appeared to develop normally and the expression of Sox10 was 
unaltered on the injected side (Figure 21B). Although no phenotype was 
observed, these embryos were treated as useful controls for toxicity.The 
phenotype of the MO KD of MiR-429 was delayed. Changes were not seen before 
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embryos reached tadpole stages; they were unable to swim indicating either a 
neuronal or muscular defect (Appendix 6). The KD of the remaining three 
miRNAs (miR-219, miR-196a and miR-302) gave a phenotype related to NC 
and/or neural tissue development. 
All three MO injections resulted in a reduction and/or loss of the NC marker Sox10 
on the injected side (indicated by red arrow head) (Figure 21B). This was most 
prominent with the miR-219 MO (60ng) with 26% of the injected embryos having 
a complete loss of Sox10 expression and 49% with a partial loss. A similar level 
was seen with miR-196a MO (9% complete loss and 48% reduction) and miR-
302 MO (13% loss and 45% reduction) (Figure 21C). 
In addition to the loss of Sox10, multiple alternative phenotypes were observed 
during the development of the injected embryos. For miR-219 MO, a clear 
craniofacial deformation was noted in the later embryos (see section 13.9.3.1 for 
further discussion). As craniofacial cartilage is derived from cranial NC cells, this 
phenotype is indicative of NC defects. This phenotype was also noted for the 
miR-196a injected embryos along with an enlarged NP during the neurula stages 
of development (Figure 21B, black bar). During neurulation, the neural tube 
appeared to close properly on the injected side, however it was substantially 
wider. Nearly 90% of the embryos injected with 60ng of MO displayed this 
phenotype (Figure 21D). For miR-302 MO injected embryos, a more pronounced 
phenotype in the neural tissue was observed. As with miR-196a KD there was an 
enlarged NP in 77% of the embryos. Unlike miR-219 MO and miR-196a MO there 
was no craniofacial malformations, but instead a clear eye phenotype (see 
section 13.10.1 for further discussion). 
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Figure 21: Preliminary MO screens show miR-219, miR-196a and miR-302 KDs to 
give a NC phenotype.   
Mos were injected into one dorsal blastomere of an eight cell embryo with 60ng of MO therefore targeting 
only one half of the embryos prospective neural and neural crest tissue. Injection side is always the right 
side (A). Embryos with a KD of miR-17-5p and miR-30A-3p gave no altered NC or neural tissue phenotype 
and the expression of the NC marker Sox10 was equal on both the injected and unijected side. miR-429 KD 
had no change in the levels of Sox10 but older embryos were unable to swim. KD of miR-302, miR-196a 
and miR-219 resulted in a reduction and / or loss of the NC marker Sox10 on the injected side (indicated by 
red arrow head). MiR-219 and miR-196a KD gave a clear craniofacial deformation in the later embryo and 
miR-302 KD resulted an abnormal eye. Both miR-196a and miR-302 KD resulted in an enlarged NP 
(indicated by black bars) (B).  Quantification of embryo phenotypes of each treatment, that had either 
reduced or lost expression of Sox10 (C). Quantification of embryo phenotypes of each treatment, that had 
an expanded NP (D). Embryos depicted in dorsal view with anterior at the top.  
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qRT-PCR validation of MO knock down 
Once it was apparent that miR-196a, miR-219 and miR-302 were likely playing a 
role in early neural/NC development qRT-PCR was employed to validate that the 
MO was efficiently knocking down the miRNA in question. As a control for off-
target effects, a 5-base pair mismatch (MM) control was designed for each 
miRNA. MiR-196a, miR-219 and miR-302 were all shown to be knocked down in 
a dose dependent manner by the appropriate MOs (Figure 22). 
 
Figure 22: qRT-PCR confirms that MOs targetting miR-302, miR-219 and miR-196a 
cause dose dependent knockdown.  
Embryos were injected into both cells of a two cell embryo  with either 40ng or 60ng of MO and left to develop 
until satge 15. RNA was extracted and qRT-PCR was ran. One way ANOVA with Tukey post test statistical 
analyses were performed on the results of each qRT-PCR. For significance: 0.05³P>0.01: *; 0.01³P>0.001: 
**; 0.001³P> 0.0001: ***; P£0.0001: ****. 
13.9.2. MiR-302 KD results in defective neural development  
As described in section 13.9.1, although miR-302 MO does reduce the 
expression of the NC marker Sox10, the strongest phenotype seems to be neural 
based. This is not surprising as from the sRNA sequencing results in chapter 
three we found miR-302 to be expressed in both neural and NC tissue with a 
higher abundance in the former (Figure 19). The phenotype observed following 
miR-302 MO injection is characterised with an expanded NP and a deformed eye 
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in the later embryo (Figure 21). Although phenotypes in neural tissue are not the 
main aim of this work, this phenotype was characterised further to generate 
preliminary data for upcoming projects in the lab. 
13.9.2.1. miR-302 KD results in an abnormal eye development 
MiR-302 MO (60ng) was injected into one dorsal blastomere of an eight-cell 
embryo to target neural and NC tissue specifically. Embryos were left to develop 
until stage 37 and then fixed for analysis. The injection of miR-302 MO lead to a 
smaller, deformed eye (Figure 23Ai, black arrow head) which lacked pigment in 
certain regions. Closer inspection revealed the retinal pigmented epithelium 
(RPE) had failed to develop fully. Sections showed that although primitive 
structures were present, retinal lamination was severely disorganised upon miR-
302 deficiency (Figure 23Aii, black arrow head). 
13.9.2.2. Sox2 is miss-expressed in miR-302KD embryos  
To characterise the eye phenotype further, WISH were completed on miR-302 
MO injected embryos (stage 24) for a gene that is key in neural and eye 
development – Sox2. Interestingly, when miR-302 was knocked down we 
obtained two separate observations. In the NP tissue, there was an expansion 
(Figure 23Bi, white arrow head), this was confirmed on cryo-sections (Figure 
23Bii). The second observation made was the loss of expression of Sox2 in the 
prospective eye region (Figure 23Bi, black arrow head). This was seen in 95% 
of the injected embryos at a whole mount level (Figure 23Ci). Surprisingly, 
following sectioning of these embryos it became clear that the optic vesicle 
(Figure 23Cii) had failed to form and the tissue was poorly organised (Figure 
23Ci). This was a surprising result as miR-302 KD embryos do go on to develop 
an eye (albeit primitive). 
As this was not the focus of this project, miR-302 was not investigated any further. 
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13.9.3. Full characterisation of miR-219 and miR-196a knock 
down 
13.9.3.1. Effect of miRNA KD on craniofacial cartilage development  
As noted previously (Figure 21B), embryos with a KD of miR-196a or miR-219 
had a craniofacial phenotype indicative of abnormalities in cranial NC 
development. To fully characterise this phenotype, embryos were injected with 
60ng of MO into one dorsal blastomere of an eight-cell embryo and were left to 
develop until stage 28 for initial observations or stage 45 for alcian blue staining. 
By stage 28, both un-injected and MM injected control embryos showed normal 
craniofacial development characterised by the cement gland being located 
approximately the same distance away from both eyes of the embryo. In addition 
to this, clear facial primordiua are apparent (Figure 24A, white dotted line). This 
is compared to miR-196a and miR-219 KD embryos where malformations in 
craniofacial cartilage development was already very clear by this stage. With 
these embryos, the cement gland is positioned closer to the eye of the injected 
side of the embryo due to the clear lack of facial primordium (Figure 24A, black 
arrow).  
To fully investigate the extent of this malformation, alcian blue staining was 
conducted on stage 45 embryos. Alcian blue is a stain that will label the 
glycosaminoglycans whilst leaving the rest of the embryo unstained. The staining 
worked well for miR-196a KD embryos but unfortunately for miR-219 KD embryos 
it failed to work. Following staining, cartilage was carefully dissected from the 
embryos. Analysis of dissected tissue demonstrates that the MM injected 
embryos showed normal organisation in the injected side when compared to the 
control side. This was not the case for miR-196a MO injected embryos which 
displayed much smaller and disorganised cartilage on the injected side despite 
some primitive structure being present (Figure 24B). 
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Figure 24: miR-196a and miR-219 KD results in abnormal craniofacial cartilage 
development. 
 Embryos were injected in one dorsal blastomere of an eight-cell embryo with 60ng of MO and then fixed at 
stage 28 for initial observations (A) and stage 45 for alcian blue staining (B). GFP was used as a tracer. 
Embryos are positioned in lateral view (A) and dorsal view (B). Downregulation of both miRNAs resulted in 
reduced facial primordium on the injected side (highlighted in non-injected side with a white dotted line) 
(n=15/18 embryos for miR-196a and 21/22 embryos for miR-219). As a result of the reduced primordium the 
cement gland (CG) is positioned closer to the eye on the injected side (indicated with black arrow) (A). Alcian 
blue staining reveals that for miR-196a KD the cartiladge was smaller and disorganised although a primitive 
structure is present (n=7/8). Control MO (196a MM) did not interfere with cartilage development (n=8/8). * 
indicates injected side (B). 
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13.9.3.2. Analysis of key NC and NPB genes effected by miRNA 
knockdowns using WISH 
The results thus far delivered clear evidence that implicate miR-196a and miR-
219 in NC development. This is primarily through the loss of the NC marker Sox10 
and abnormalities in the NC derived craniofacial cartilage following MO KD. To 
further elucidate what is happening at a molecular level, embryos were injected 
in one dorsal blastomere of an eight-cell embryo with 60ng of MO and then fixed 
at two neurula stages (stage 14 and stage 17). These embryos then underwent 
WISH for key NC and NPB markers.  
miR-196a 
At stage 14, WISH was completed on whole embryos for Snail2, an early 
transcription factor specific to NC. At stage 14, there a clear loss of the NC marker 
Snail2 in the miR-196a MO injected embryos was observed. This loss was not 
seen in the miR-196a MM or control embryos. Sections of these embryos 
demonstrated that Snail2 is completely lost throughout the tissue layers (Figure 
25).  
At stage 17, WISH was carried out for the NC transcription factor Sox10 and the 
NPB marker Pax3. As with Snail2, Sox10 is decreased in the miR-196a MO 
injected side of the embryo. Surprisingly, we found the NPB marker Pax3 to be 
expanded on the injected side of the embryo. Through closer inspection it 
became clear that there are two regions of Pax3 expression, both of which were 
affected following miR-196a depletion. The dark intense staining on the 
superficial ectodermal layer of the embryo (indicated on the control side with the 
black arrow head) is the prospective hatching gland (a gland that releases 
proteolytic enzymes to enable the tadpole to degrade the vitelline membrane), 
this staining is lost in the injected side. On the contrary, the Pax3 positive cells in 
the NPB zone that go on to become NC cells (indicated with the red arrow head) 
are expanded (Figure 25). As this expansion of the Pax3 positive NC progenitor 
field was concomitant with a decrease in genes expressed by specified, pre-
migratory NC (snail2 and sox10), this suggests that miR-196a depletion holds 
these cells in a progenitor, undifferentiated state and prevents them from 
becoming NC cells. 
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Figure 25: MiR-196a kd alters expression of neural crest and neural plate border 
markers.  
Embryos were injected into one dorsal blastomere of an eight-cell embryo with 60ng of MO and then fixed 
at stage 14 (A) or stage 17 (B). GFP was used as a tracer. Injection side is always the left side. Embryos 
are positioned in dorsal view with anterior at the top. At both stage 14 (A) and stage 17 (B) the NC markers 
Snail2 (n= 9/11) and Sox10 (n=10/11) are lost/reduced in the injected side, this is not seen in the MM injected 
embryos (11/12). Sectioning of the embryos revealed in both cases that the expression is lost throughout all 
of the tissue layers. At stage 17 the NPB marker Pax3 is expanded (n=11/13). The expansion seen is by the 
underlying NPB zone Pax3 positive cells (indicated with a red arrow in the control side) whilst the Pax3 
positive hatching gland cells (see black arrow on control side) are lost. 
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Following the clear effect miR-196a KD is having on both NC and prospective NC 
cells, WISH was completed for several other markers to further decipher the 
signalling events at a transcriptional level when miR-196a is depleted.  
The first group of genes that were investigated were various NPB markers. These 
included Zic1, Zic3 and Msx2. As indicated with black arrows in Figure 26A-C, 
both Zic1 and Zic3 were expanded on the injected side of the embryo which 
reemphasises that the NPB region of NC progenitor cells is expanded. 
Interestingly, the NPB marker Msx2 showed a loss of expression in the most 
anterior region which is clearly illustrated through sectioning of the embryo 
(Figure 26C).  
Expression of the NP marker Sox2 was broadened in a lateral direction following 
depletion of miR-196a. This indicates an expansion of the NP. This is true for 
both the anterior and posterior regions of the NP. In addition, where there is 
usually a dark concentrated patch of expression towards the more anterior part 
of the embryo (see control side) this is lost in the injected side (Figure 26D, see 
black arrow). Interestingly, despite an expansion of the sox2 positive progenitor 
population being apparent, the neural differentiation markers; N-tubulin and elrC 
had reduced expression (Figure 26H,I). However, this did seem to be restricted 
to the more anterior region of the labelled primary neurons. Sectioning of the 
embryos exemplifies this phenotype. In addition to labelling primary neurons, 
both N-tubulin and elrC are also expressed in the trigeminal placodes. Following 
depletion of miR-196a it became apparent that the expression in this region of 
the embryo had extended both anteriorly and posteriorly, likely because of the 
lateral expansion of the NP (Figure 26H,I, see white arrow). 
It is well documented that increased Notch expression and/or signalling 
correlates with increased numbers of neural progenitors and decreased 
differentiated neurons (Imayoshi et al., 2010). Therefore, WISH was completed 
for Hairy1 – a downstream target of Notch signalling. Surprisingly, miR-196a KD 
resulted in a reduction in the mRNA levels of Hairy1 although the region of 
expression appears to be expanded laterally along the axis of the NP (Figure 
26F).  
Another neural gene, Pax6 gave two phenotypes, the first of which was an 
enlarged expression domain in the anterior neural fold (lens primordia) and the 
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second was a loss of the forebrain stripe (Li et al., 1997) (Figure 26E). 
As miR-196a is positioned within a HOX gene the next task was to check 
expression of Engrailed2 (Eng2), a neuronal regionalisation marker, which is 
important for patterning. Although Eng2 had a broader expression pattern and 
was fainter (as with Hairy1) it did not seem to shift in position implying that 
patterning was not affected (Figure 26I).  
miR-219 
As with miR-196a KD, both the NC markers Snail2 (stage 14) and Sox10 (stage 
17) were dramatically reduced following depletion of miR-219. Sectioning of 
these embryos demonstrated that the markers are lost throughout all tissue 
layers (Figure 27).  
Interestingly, the NPB marker Pax3 was vastly expanded on the injected side at 
both stage 14 and stage 17 (Figure 27). Unlike miR-196a MO injected embryos 
that had an apparent loss of pax3 positive hatching gland cells and an expansion 
of Pax3 positive NPB zone cells, the inverse was seen in miR-219 depleted 
embryos. Sectioning revealed that the intense dark staining seen covering the 
injected side of the embryo is localised to the superficial ectoderm and is 
therefore likely an expansion of the Pax3 positive hatching gland cells (see 
control side, red arrow). Conversely, Pax3 expression in the deeper layer of 
tissue where the NC arise from is completely lost (see green arrows, Figure 27). 
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Figure 26: The effect of miR-196a knock down on various markers.  
Embryos were injected into one dorsal blastomere of an eight-cell embryo with 60ng of miR-196aMO and 
then fixed at stage 14 (A-E), stage 15 (F-G) or stage 17 (H-I). GFP was used as a tracer. Injection side is 
always the left side. Embryos are positioned in dorsal view with anterior at the top. Injection of the MO 
caused an expansion in the NPB markers Zic1 (n= 28/30) and Zic3  (n=34/37) but a loss in the anterior 
region of the NPB marker MSX2 (n=18/19) (A-C). The neural marker Sox2 was expanded in a lateral 
direction and appeared to lose the intense dark region of expression seen in the control side (see black 
arrow) (n=37/37) (D). Expression of the neural marker Pax6 was slightly enlarged across the anterior neural 
fold (lens primordia) (see white arrow) but reduced in the position of the forebrain stripe (see black arrow) 
(n=18/24) (E). The donstream target of Notch – Hairy1 had a reduced but broadened expression (n=22/25) 
(F) and the same phenotype was seen for the neuronal regionalisation marker – Eng2 (n=19/25) (G). Both 
neuronal differentiation markers N-tub (n=24-30) and ELRC (n=23/24) were reduced following miR-196aMO 
injection although this was restricted to the anterior most part of the NP (see black arrows). The expression 
of these two markers in the trigeminal placodes had extended in both an anterior and posterior direction (see 
white arrows) (H,I). 
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Figure 27: The effect of miR-219 knock down on both neural plate border and 
neural crest markers. 
 Embryos were injected into one dorsal blastomere of an eight-cell embryo with 60ng of MO and then fixed 
at stage 14 (A) or stage 17 (B). GFP was used as a tracer. Injection side is always the left side. Embryos 
are positioned dorsal view with anterior at the top. Embryos fixed at stage 14 underwent WISH for Snail2 
(n=26/29) and Pax3 (n=21/21) and embryos fixed at stage 17 underwent WISH for Sox10 (n=32/37) and 
Pax3 (n=24/24). At both stage 14 and stage 17 the NC markers (Snail2 and Sox10) are lost in the injected 
side (indicated with a black arrow) (AII and BII), this is not seen in either the MM injected or control embryos. 
Sectioning of the embryos revealed that in both cases the expression is lost throughout all of the tissue 
layers (AII’ and BII’). At both stage 14 and 17 the NPB marker Pax3 is expanded vastly across the injected 
side of the embryo (indicated with a black arrow) (AV and BV). Sectioning revealed that in the uninjected 
side of the embryo there are two regions of Pax3 expression; the hatching gland (see red arrow) and the 
NPB zone cells (see green arrow) (AV’). When compared to the injected side it is apparent that the 
expansion seen at a wholemount level is from the hatching gland region and that infact those Pax3 positive 
NPB zone cells have been lost (AV’ and BV’).   
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13.10. Discussion 
Throughout this chapter, the function of six candidate miRNAs in NC 
development has been assessed using KD experiments. From this approach, one 
miRNA (miR-302) was found to result in neural defects when depleted and two 
miRNAs (miR-219 and miR-196a) gave phenotypes indicative of NC defects 
when depleted. This was evident at both the whole embryo level (abnormal 
craniofacial cartilage development) and at a transcriptome level (abnormal 
expression of NC genes using WISH). 
13.10.1. MiR-302 KD impairs development of neural tissue  
Following miR-302 KD a clear phenotype in neural tissue was observed 
characterised initially by a smaller, deformed eye that lacked a fully developed 
RPE (Figure 23Ai, Aii). To characterise this phenotype further, WISH for the 
neural marker Sox2 on miR-302 KD embryos was completed. These ISHs 
revealed an expansion of Sox2 in the NP and a loss of expression in the 
prospective eye region of a whole mount embryo (Figure 23Bi). Surprisingly, 
sectioning of the embryo revealed that the optic vesicle had failed to form by this 
stage on the injected side despite the embryos eventually forming an eye, albeit 
primitive (Figure 23Ci). One possible reason for this observed eye phenotype 
could be a pertubance of early neural or eye field induction and differentiation. 
Although there appears to be no optic vesicle in the earlier embryo, the embryos 
do go on to form an eye so a vesicle must form at some point. For a more 
thorough analysis of the time in which this occurs embryos would need to be 
sectioned at various stages of neural development. 
Throughout the literature, miR-302 has been linked to the regulation of a 
proliferative state in many models (Card et al., 2008, Subramanyam et al., 2011, 
Parchem et al., 2015). It is possible that the removal of miR-302 encourages a 
more proliferative state, which causes a delay in development of the optic vesicle. 
A similar phenotype was observed with the removal of Sox4 in Xenopus (Cizelsky 
et al., 2013). If the KD of miR-302 does perturb the balance between proliferation 
and differentiation this also gives a reason as to why we observed an expansion 
of Sox2 positive NP tissue in the injected side of the embryo. 
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As development of neural tissue is not the focus of this project no further work 
was carried out on miR-302, however, to investigate whether the phenotype seen 
is due to a lag in development or whether it is in fact a morphological defect, 
several experiments could be done to test this. To explore the possibility of 
increased proliferation Bromodeoxyuridine (BRDU) staining could be used. To 
complement this, a tunel assay could be used to assay the level of apoptosis. 
Finally, to assess the development of the optic vesicle, embryos could be fixed at 
various stages and WISH for optic vesicle markers could be used to see if and 
when one does form. 
13.10.2. miR-196a and miR-219 KD result in an inhibition of NC 
development 
Using KD experiments, we show, using WISH on key NC markers, along with 
analysis of NC derivative structures (craniofacial cartilage) that both miR-196a 
and miR-219 are playing a role in NC development. Using further WISH on 
various neural and NC markers we set out to characterise where in the NC 
network these miRNAs are functioning. 
13.10.2.1. miR-196a 
miR-196a may be involved in the fine tuning of BMP and/or Wnt signalling 
to enable NC progenitor specification: 
Using WISH for various markers it was observed that at neurula stages, two 
progenitor populations were expanded (sox2 positive NP; pax3 positive NPB), 
whereas differentiation markers of these tissues (N-tubulin positive primary 
neurons and Sox10 positive NC) were reduced following depletion of miR-196a 
(Figure 24 Figure 25). This suggests that these cells are being held in a 
progenitor, undifferentiated state which prevents them from undergoing 
specification. This is supported by work by Kim et al. (2009) who showed using 
mesenchymal stem cells that inhibition of miR-196a enhanced proliferation and 
decreased osteogenic differentiation 
Throughout the literature there are strong links between the maintenance of 
progenitor populations and increased Notch signalling (Imayoshi et al., 2010). To 
explore whether miR-196a functions in a Notch dependent manner WISH was 
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carried out for Hairy1, a direct Notch signalling target gene (Jouve et al., 2000). 
Surprisingly, miR-196a KD reduced the mRNA levels of Hairy1 (Figure 26F). 
These results indicate that the ability of miR-196a to repress differentiation is 
likely independent of Notch signalling. However, it is possible that there could be 
a feedback mechanism that is resulting in this phenotype. In addition, Notch 
signalling has many independent downstream targets (including multiple Hairy 
genes) so more WISH need to be completed on various downstream targets 
before conclusions can be made.  
Along with Pax3, multiple other NPB markers were expanded in miR-196a 
depleted embryos including Zic1 (Figure 26A). Zic1 expression is induced by low 
levels of BMP. It is expressed at the same time as Pax3 and they work 
synergistically to induce NC fate through the activation of Snail2 and Foxd3 in a 
Wnt dependent manner (Plouhinec et al., 2014). This reiterates the importance 
of an appropriate balance of BMP and Wnt signalling for induction of NC. The 
observed changes therefore indicate that the depletion of miR-196a alters this 
balance enough to prevent induction of NC (Steventon et al., 2009).  
One way in which an alteration in this balance may have prevented NC induction 
is through changes in expression of MSX genes. In contrary to the other NPB 
genes, the expression of Msx2 was lost in the anterior most region of the NPB 
following depletion of miR-196a (Figure 26C). Previous studies have shown that 
MSX genes play a key role in specifying ectodermal cells as NC cells during NC 
specification. When inhibited, the prospective NC are transformed into NP and 
epidermis (Khadka et al., 2006). This may account for why a depletion of miR-
196a results in an enlarged NP in the injected embryos (Figure 21A). Msx2 has 
been shown previously to be induced by an intermediate level of BMP and WNT 
(Tribulo et al., 2003). This therefore further reiterates that miR-196a could play a 
role in fine tuning the balance of BMP and/or Wnt signalling. Further experiments 
could be used to test this hypothesis including BMP and Wnt reporters (Faure et 
al., 2000) to assess the changes in the level of BMP/Wnt following miR-196a KD. 
Depletion of miR-196a does not alter neural patterning: 
Despite miR-196a being positioned within a HOX gene there was no shift in 
position of the neuronal regionalisation marker – Eng2 suggesting that the 
depletion of miR-196a does not alter neural patterning (Figure 26G). This 
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expression of Eng2 however was broader and fainter again reiterating that there 
appears to be more neural tissue. 
13.10.2.2. miR-219 
Depletion of miR-219 upregulates Pax3 positive hatching gland cells whilst 
Pax3 positive NC cells are lost 
As with miR-196a KD, depletion of miR-219 resulted in a loss of NC markers and 
deformations in craniofacial cartilage clearly demonstrating that this miRNA plays 
a role in NC development (Figure 21). Surprisingly, in contrary to the NC 
markers, the NPB marker Pax3 was expanded vastly following miR-219 KD. 
Through sectioning of the embryo, it became clear that this expansion is isolated 
to the Pax3 positive hatching gland cells. The Pax3 positive cells that give rise to 
NC cells (Pax3 positive NPB zone cells) had been lost (Figure 27). This suggests 
that miR-219 is playing a role early in NC development, before even the NC 
precursor cells (NPB cells) are formed. 
The expansion of the Pax3 positive hatching gland cells in conjunction with the 
loss of NC is a phenotype seen previously in the literature. Hong and Saint-
Jeannet (2007) show that the specification of cells into hatching gland and NC is 
a consequence of distinct thresholds of Pax3. They show that for both cell 
populations, Pax3 expression is required, however, both NC and hatching gland 
fate can only coexist in the embryo up to a certain amount of Pax3. At high levels 
of Pax3 activity the entire ectoderm is converted into hatching gland precursor 
cells and NC are lost. This appears to be the phenotype seen here following miR-
219 KD but to validate this, a WISH for hatching gland markers such as Xhe2 
needs to be completed. Evidently the loss of NC through the KD of miR-219 is 
Pax3 dependent. Pax3 is however not a target of miR-219 as there are no 
potential binding sites in the 3’ UTR, therefore the effect we see on Pax3 is 
indirect. To investigate this further, direct targets of miR-219 which feed into the 
Pax3 gene network should be explored. 
To conclude this chapter, KD of both miR-196a and miR-219 result in aberrant 
NC development. Thus far we can speculate that KD of miR-196a triggers this 
phenotype because of an extension of the time the progenitor pools stay in an 
undifferentiated state resulting in a failure of differentiation. This contrasts with 
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miR-219 where we speculate that the NC fail to form in these embryos because 
of a loss of the NC progenitor pool. To investigate how these phenotypes are 
achieved at a transcriptional level target analysis was employed.  
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Chapter 5: Downstream target analysis of 
miR-196a and miR-219  
Results obtained from the miR-219 and miR-196a KD experiments demonstrate 
that both miRNAs a have key roles in NC development. However, the specific 
roles for miR-219 and miR196a in NC development remains unknown. To 
elucidate this, potential targets of both miRNAs were analysed using two 
approaches. The first approach was using computational miRNA target prediction 
followed by validation using luciferase assays (for direct targets) and the second 
approach was a transcriptome analysis of NC tissue following KD of the miRNAs 
in question (for both direct and indirect targets).  
Approach one – Computational miRNA target 
prediction  
13.11. Introduction 
The first approach used to decipher the targets of both miR-219 and miR-196a 
was computational miRNA target prediction. Luciferase assays were used to 
validate predicted targets in vitro.  
13.11.1. miRNA-mRNA interactions 
In order for miRNAs to downregulate gene expression, they use imperfect binding 
to complementary sites within transcript sequences (usually in the 3’UTR) and 
result in either suppression of translation, deadenylation and degradation or 
induced cleavage of their target transcript (Chekulaeva and Filipowicz, 2009). 
The sites that the miRNAs bind to are named target sites, in animals, these target 
sites are usually found clustered at both ends of the 3’UTR as opposed to being 
evenly distributed (Hon and Zhang, 2007). Many mRNAs have multiple predicted 
binding sites for the same miRNA, which can enhance the degree of 
downregulation (Grimson et al., 2007, Doench et al., 2003). Located at the 5’ end 
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of the miRNA is a region called the “seed”, (positions 2-7) which is characterised 
by complementary base pairing between miRNA and its target site (Lim et al., 
2003). The classification of miRNA target sites is based on the complementarity 
within the seed region and its target site. To date, the effect of different types of 
seed matches has been assessed by means of signal-to-noise ratio, the degree 
of mRNA or protein repression (Lewis et al., 2005) (Grimson et al., 2007) (Baek 
et al., 2008). Based on these experiments, a set of  seed matches that differ in 
abundance and intensity of the regulatory effect have been defined including: (1) 
canonical, (2) 3’-supplementary and (3) 3’-compensatory sites (Bartel, 2009) 
(Figure 28).  
The majority of miRNAs target confirmed mRNA sites via canonical sites 
(summarised in Figure 28). Canonical sites have alternative pairing within the 
seed region which determines the certainty of the interaction. There are three 
types of canonical sites: the 7mer1A that has an adenine in position 1 at the 5’ 
end of miRNA (the presence of which acts as an anchor for RISC and therefore 
improves the degree of gene silencing (Nielsen et al., 2007), the 8mer having 
matched adenine in position 1 and an additional match in position 8 and the 7mer-
m8 that has a match in position 8 (Lewis et al., 2005). In addition to seed binding, 
many miRNA-mRNA interactions have additional pairing within the 3’ part of a 
miRNA and the 5’ part of the mRNA transcript. It has been reported that 
consecutive pairing in positions 13-16 of at least 3-4 of miRNAs are usually 
required to enhance the efficacy of the interaction (Grimson et al., 2007). 
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Figure 28: A schematic representation of various miRNA interactions  
Seed regions of miRNAs are marked in red and the adenine at binding position one in green. In the case of 
3’-suppelmentary and 3’-compensatory sites two regions of pairing (in blue) result in the formation of a loop 
structure (Witkos et al., 2011). 
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13.11.2. Computational miRNA target prediction  
For any given miRNA, an extremely large number of potential target sites exists 
and the process of validating a potential miRNA target in the laboratory is time 
consuming and costly. To narrow down the list of candidates, a computational 
approach for miRNA target prediction is often used. Computational approaches 
model how miRNAs interact with specific mRNAs for which an increasing 
collection of tools is available. Each of these has a distinct approach to miRNA 
target prediction. To assess the probability of a potential target these various 
algorithms use their own unique set of parameters which will include a measure 
of conservation level (the maintenance of a sequence across species), free 
energy (a measure of the hybridization stability) and site accessibility (a measure 
of the ease with which a miRNA can locate and hybridize with an mRNA target). 
Two of the most commonly used computational algorithms in the scientific 
community are miRanda and TargetScan, both of which take different 
approaches to predicting targets and will briefly be described below: 
13.11.2.1. miRanda 
The main parameters the miRanda algorithm focuses on when predicting targets 
include the binding energy of the duplex structure, evolutionary conservation of 
the whole target site and its position within 3’UTR (John et al., 2004). Together, 
along with the level of seed sequence base pairing these factors are scored. 
miRanda allows for one wobble pairing in the seed region that is compensated 
by matches in the 3’ end of miRNA. This strategy incorporates different natures 
of miRNA-mRNA interactions and is therefore beneficial for predicting sites with 
imperfect binding within the seed region, but it has been criticised for 
underestimating miRNAs with single but perfect base pairing. As a consequence, 
this algorithm often results in a large number of false positives (Witkos et al., 
2011). Even though still widely accepted, updates for this prediction algorithm 
have stopped in 2010. 
13.11.2.2. TargetScan  
In contrast to miRanda, TargetScan uses a more precise search that puts 
emphasis on the sites that have full complementarity in the miRNA seed region 
(Lewis et al., 2005). In addition to a precise seed match, several parameters 
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determined in a previous experimentally validated dataset contribute to 
TargetScan’s outcome score including: (1) pairing contribution outside the seed 
region (2) AU content of the region surrounding the predicted site and (3) the 
distance to the nearest end of the annotated UTR of the target gene (Grimson et 
al., 2007). Importantly, the conservation of target sites among orthologous 
3’UTRs has a fundamental importance for an outcome score in TargetScan 
(Friedman et al., 2009). As a result of the number of stringent parameters used 
by TargetScan, it is seen as more precise than some alternative target prediction 
algorithms, however, as full complementarity is needed in the seed sequence 
those sites with poor seed pairing are omitted.  
13.12. Results and discussion  
To investigate the potential targets of both miR-219 and miR-196a computational 
miRNA target prediction was employed. As a result of poor genome annotation 
in X.laevis, algorithms were run using the H.sapiens genome and strongly 
predicted targets were manually checked for conservation within X.laevis. Due to 
the vast number of predicted targets which are omitted from these various 
algorithms, multiple algorithms were used and potential target output results were 
collated to identify strongly predicted common targets.  
Initially, target prediction was carried out manually using the following algorithms: 
TargetScan (Lewis et al., 2005), DIANA (Paraskevopoulou et al., 2013), PicTar 
(Krek et al., 2005), miRanda (John et al., 2004) and miRDB (Wong and Wang, 
2015). Interesting targets that came up across multiple result outputs were then 
further investigated using literature searches. In addition to manual analysis 
another integrated programme was used alongside, this being miR-system (Lu et 
al., 2012). When running the algorithm sites manually, challenges began to arise 
when predictions were inconsistent due to the different modelling formulas. miR-
system is able to overcome this problem by integrating the results of various 
algorithms ranging from ones that consider seed-matching (TargetScan) to those 
who focus on other parameters such as affinity (DIANA). miR-system uses a 
voting scheme and establishes a statistical threshold based on existing data to 
identify the optimal cutting point. In addition to this, following identification, this 
system provides information on pathway analyses of the target mRNA therefore 
facilitating the understanding of the biological functions regulated by the miRNA 
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(Lu et al., 2012). 
13.12.1. Predicted targets for miR-196a include various HOX 
genes  
Results from both the manual target analysis (Figure 29) and miR-system 
(Appendix 8) show that across various algorithm sites, a number of HOX genes 
are strongly predicted targets for miR-196a (Figure 29). Interestingly, miR-196 is 
located in the intronic regions of three HOX gene clusters: miR-196b on HOXA, 
miR-196a-1 on HOXB and miR-196a-2 on HOXC. miR-196a-1 and miR-196a-2 
have an identical mature sequence, whereas miR-196b differs by a single 
nucleotide (Liu et al., 2013). These miRNAs target HOX genes located 5’ of their 
locus, supporting the theory of posterior prevalence (Yekta et al., 2004, McGlinn 
et al., 2009). miR-196a targets several HOX genes, including HOXA5, HOXB7, 
HOXB8 and HOXC8 (Liu et al., 2012, Braig et al., 2010, Asli and Kessel, 2010, 
Li et al., 2010), and is predicted to target many more (Figure 29). 
HOX genes are expressed at the time of NC induction and play a central role in 
NC patterning (Trainor and Krumlauf, 2001). Studies in mouse have shown an 
important link between NC development and HOX genes. For example, Gouti et 
al. (2011) showed that multiple HOX genes play a central role in NC cell 
specification by inducing the expression of Snail2 and Msx1/2 and that 
simultaneous loss of HOXA1 and HOXB1 function resulted in NC specification 
defects. They reported a neural progenitor to NC cell fate switch characterised 
by cell adhesion changes and an epithelial-to-mesenchymal transition. 
For us, the most interesting HOX gene that was predicted (but not experimentally 
validated) to be a target of miR-196a was HOXB1. This HOX gene is of particular 
interest because it has direct links with NC development. Gouti et al. (2011) 
showed that, in chick, HOXB1 functions to induce NC cells through mediating an 
optimal level of Notch signalling. This was achieved through repression of the 
downstream effector Hes5. In chapter four we showed that the downstream 
Notch target hairy1 had a broader expression but was fainter following miR-196a 
KD (Figure 26). This contradicts the idea that the phenotype we observe is 
mediated through Notch signalling. However, it is possible that the effect could 
be mediated by other Notch downstream effectors (i.e. Hes-5) and therefore 
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further WISH using other markers of Notch signalling and other means of 
experimental confirmation should be employed. 
13.12.2. Predicted targets for miR-219 include the co-factor 
Eya1 
Results from both the manual target analysis (Figure 30) and miR-system 
(Appendix 7) show that across various algorithms, a number of genes from the 
PSED (Pax-Six-Eya-Dach) network were predicted to be targeted by miR-219 
(Figure 30A,B). The PSED network is a group of proteins that are connected by 
protein-protein interactions. They have been shown to be involved in a variety of 
developmental processes including muscle development and sensory placodal 
development (Donner and Maas, 2004, Friedrich, 2006, Kozmik et al., 2007). This 
is interesting for multiple reasons in the context of miR-219 and NC development, 
firstly because as with NC, the cranial sensory placodes are also derived from 
the NPB zone (Saint-Jeannet and Moody, 2014). Classic histological descriptions 
of cranial sensory placode formation identified the origin of all cranial placodes 
from a common precursor region called the pre-placodal ectoderm (PPE) which 
is a U-shaped band of ectoderm that surrounds the anterior margin of the NP 
lateral to the NC (Figure 31) (Moody and LaMantia, 2015). The second reason 
is that some of the genes within this network have been shown to act upstream 
of Pax3 in alternative systems which could account for why we get expanded 
Pax3 expression (Figure 27) following KD of miR-219 (Grifone et al., 2007, 
Lagutin et al., 2003). One of the PSED genes predicted to be targeted by miR-
219 but not yet experimentally validated in any system is the coactivator, Eya1. 
The EYA proteins are components of a conserved regulatory network involved in 
cell-fate determination in organisms ranging from insects to humans. Together, 
along with the other members of the PSED network they play a key regulatory 
role in the development of multiple organs including but not limited to the eye, 
muscle, ears, heart and craniofacial skeleton (Tadjuidje and Hegde, 2013). 
Vertebrates encode four EYA proteins (EYA1-4) that are characterised by a 
conserved C-terminal 271 amino-acid domain commonly referred to as the EYA 
domain (Ohto et al., 1999). Early studies in Drosophila characterised the 
transcriptional role of EYA through genetic and/or biochemical interaction with 
the SIX (Pignoni et al., 1997) and DACH (Chen et al., 1997) classes of 
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transcription factors. In vertebrates, SIX proteins (SIX1 and SIX4) binds to and 
translocate EYA1 to the nucleus, where they act as cofactors to activate SIX 
genes including Pax3. The presence of EYA1 converts SIX which is usually a 
weak activator of transcription into a strong transcriptional activator (Li et al., 
2003, Patrick et al., 2013). In the context of somitogenesis Eya1 has been shown 
to act upstream of Pax3 with Eya1 null embryos losing all expression of Pax3 in 
the dermamyotome (Grifone et al., 2007).  
Eya1 is predicted to be a miR-219 target by all five of the online algorithms and 
through miR-system (Appendix 7) making it a very strong candidate. The seed 
binding is classified as an 8-mer meaning there is an adenine in position 1 and 
an additional match in position 8 (Figure 30C). As a result of being such a strong 
potential target of miR-219, Eya1 was chosen to be validated as a direct target 
using luciferase assays.  
13.12.3. Validation of Eya1 as a target of miR-219 using 
luciferase assays 
Validation of Eya1 as a direct target was done by luciferase assays of modified 
pGL3 reporter constructs containing the 3’UTR of Eya1. This bioluminescence 
assay is a quantitative method based on sequential measurements of Firefly and 
Renilla luciferase activities in a single sample. The 3’UTR of Eya1 contains one 
conserved predicted miR-219 binding site which was mutated to show that 
repression is mediated specifically through the predicted target site. 
In summary, WT or mutant constructs (100ng) were co-transfected, into chicken 
DF1 fibroblast cells, with Renilla vector (25ng) and either with or without the miR-
219 siRNA (si-219). This siRNA is used to mimic the action of miR-219. A 
universal negative control siRNA (siC; Sigma) was used as a negative control.  
 
 122 
 
Figure 29: Multiple HOX genes are predicted to be targeted by miR-196a. 
The top fifteen genes predicted to be targeted by miR-196a using five different computational tools 
(TargetScan, DIANA, PicTar, miRanda and miRDB) (A). Multiple HOX genes were predicted to be targeted 
by miR-196a (B).  
  
 123 
 
Figure 30: Multiple members of the PSED network are predicted to be targeted by 
miR-219.  
The top fifteen genes predicted to be targeted by miR-219 using five different computational tools 
(TargetScan, DIANA, PicTar, miRanda and miRDB) (A). (Multiple members of the PSED network were 
predicted to be targeted by miR-219, one that was predicted by all computational tools is Eya1 (indicated 
with black box) (B). The predicted pairing region of miR-219 seed sequence (bottom row) with Eya1 3’UTR 
(C). 
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Figure 31: Schematic drawing of the various regions induced during early neural 
plate development. 
Top: The embryonic ectoderm of a neurula stage has been flattened into a sheet. The left represents the 
fields apparent at early NP stages: epidermis (Epi), neural border zone (NB) and neural plate (NP). On the 
right the NB has divided into its neural crest (NC) and pre-placodal ectoderm (PPE) derivatives. 
Bottom: Different sets of transcription factors are differentially expressed in these ectodermal domains over 
developmental time (Moody and LaMantia, 2015). 
 
13.12.3.1. miR-219 targets Eya1 3’UTR 
Luciferase reporter assays showed that miR-219 targets the Eya1 3’UTR, leading 
to a decrease in luciferase activity by approximately 50% (Mann Whitney test: 
p<0.0001). This reduction was rescued by mutating the predicted miR-219 
binding site (Figure 32). This validates that Eya1 is a direct target of miR-219 in 
vitro. A future experiment that needs to be completed is to investigate whether 
the NC phenotype observed is a consequence of miR-219 targeting Eya1 and 
not a result of alternative miR-219 interactions. To investigate this, several 
experiments could be employed. One example would be to inject custom MOs 
(also known as target protectors) that bind the miR-219 target site on the Eya1 
3’UTR in vitro  and then assess the embryo for the various NC phenotypes. This 
MO would work by preventing any interactions between the miRNA and Eya1. If 
the same phenotype as miR-219 KD is observed then using the appropriate 
rescues it could be speculated that it is the inhibition of this interaction specifically 
that prohibits NC development. 
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Figure 32: EYA1 is a target of miR-219 in vitro.  
The unmodifed 3’UTR and the 3’UTR with the miR-219 target site mutated were assayed using chicken DF1 
cells with the miRNA mimics indicated below the graph. MiR-219 reduced luciferase activity by over 50% 
and this was rescued when the target site was mutated. For statistical analyses, a Mann-Whitney test was 
performed. For significance: P£0.05: *; P£0.01: **; P£0.001: ***; P£0.0001: **** 
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Approach two: Transcriptomic analysis of 
neural crest tissue following knockdown of 
miR-219 and miR196a  
13.13. Introduction 
The second approach that was used to gain a global overview of what gene 
changes were occurring following miR-219 or miR-196a KD was RNA 
sequencing. The main aim of this experiment was to complete RNA sequencing 
on NC dissections which had been injected with MO for either miR-196a or miR-
219 and compare the gene expression to controls. This would enable us to 
assess any pathways or NC specific genes that have been altered as a result of 
a KD of the two miRNAs. These experiments were carried out at the Institut Curie 
(Orsay) in collaboration with Professor Anne-Helene Monsoro-Burq. She is a 
pioneer in the technique of NC dissection and therefore her expertise was 
valuable for obtaining carefully dissected NC tissue. 
13.13.1. Experimental pipeline 
At 4-cell stage, embryos were injected with 60ng of one of four MO’s (miR-219, 
miR-219MM, miR-196a or miR-196aMM) into one dorsal blastomere to target 
neural and NC tissue in one side of the embryo only. Embryos were left to develop 
until stage 14, 17 and 28. Stage 14 and 17 for dissections and stage 28 for 
craniofacial cartilage deformations. Those embryos left to develop until stage 
14/17 were split into two groups. One group underwent WISH to check NC genes 
were knocked down and the other group underwent NC dissections. During 
dissections, the NC region was dissected, mesoderm was removed and RNA was 
extracted. Three replicates were collected for each condition (MO, MM and non-
injected control) at both stage 14 and 17 for each miRNA KD. RNA samples 
underwent quality control using a Bioanalyser and qRT-PCR was used to further 
validate the KD of NC specific genes in MO injected samples. Samples were then 
processed to illumina sequencing. A summary of the protocol used is shown in  
Figure 33. 
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13.14. Results and discussion 
13.14.1. Validation of knockdowns using qRT-PCR 
Prior to sending the samples for sequencing, multiple techniques were used to to 
confirm successful miRNA KD. These include an analysis of the craniofacial 
cartilage in stage 28 embryos, WISH for various NC markers and qRT-PCR. 
Following injections, both miR-196a and miR-219 KD embryos had the abnormal 
craniofacial cartilage phenotype as described previously in section 13.9.3.1. In 
addition, they also showed loss of key NC genes (Snail2 and Sox10) as shown 
by WISH (as previously described in section 13.9.3.2). These experiments were 
completed on sister embryos of those that had been dissected. To ensure that 
the dissected tissue had the NC KD seen in the sisters embryos, qRT-PCR was 
employed. qRT-PCR was completed on several different genes including NPB 
markers (Pax3 and Six1) NC markers (Snail2 and Sox10) neural markers (Sox2) 
and ectodermal markers (Keratin). 
qRT-PCR results for all dissections are shown in Appendix 9 and Appendix 10. 
For some of the results, interpretation of the data was inconclusive so these 
genes will not be discussed any further (Six1 and Sox10). In addition, miR-219 
(stage 17) showed an inconsistent gene expression profile with some NC genes 
increasing in expression following miR-219 KD (Appendix 9). As a result, it was 
decided that miR-219 (stage 17) samples would not be sequenced.  
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Figure 33: Schematic drawing of the steps taken for the RNA sequencing of 
dissected neural crest (NC) tissue. 
 At 4-cell stage, embryos were injected with 60ng of one of four MO’s (miR-219, miR-219MM, miR-196a or 
miR-196aMM) into one dorsal blastomere to target only neural and NC tissue in one side of the embryo. 
GFP was co-injected and used as a tracer. Embryos were left to develop until stage 14, 17 and 28. Stage 
14 and 17 for dissections and stage 28 for craniofacial cartilage deformations. Those embryos left to develop 
until stage 14/17 were split into two groups. Half underwent WISH to check NC genes were knocked down 
and the other half underwent NC dissections. During dissections, the NC region was dissected, mesoderm 
was removed and RNA was extracted. Three replicates were collected for each condition (MO, MM and non-
injected control) at both stage 14 and 17 for each miRNA. RNA samples underwent quality control using a 
Bioanalyser and qRT-PCR was used to further validate the knockdown of NC genes in MO injected samples. 
Samples then underwent RNA sequencing (A). WISH were completed on dissected embryos to check 
dissection accuracy for Pax3 (stage 14) (B) and Snai2 (stage 14). (C) 
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After miR-196a KD (stage 14) the NC specific gene Snail2 was reduced in the 
three biological replicates indicating a loss of NC. In addition, the epidermal 
marker Keratin was also lost indicating a loss of epidermis. In contrast, the neural 
marker Sox2 had increased expression in two of the three biological replicates. 
The expression of the NPB marker Pax3 varies between the biological replicates 
with two showing a downregulation compared to the controls and one showing 
an up regulation (Figure 34A). A similar expression profile was seen with miR-
196a KD (stage 17) which also showed the loss of both the NC marker Snail2 
and the epidermal marker Keratin (Figure 34B). In contrast to stage 14, the 
expression of the NPB marker Pax3 increased compared to the control in all three 
MO injected samples. 
For miR-219 (stage 14) the results were not quite as clear. Consequently, four 
MO samples were sent for sequencing. Of these four samples, three had a 
downregulation of the NC marker Snail2. The NPB marker Pax3 showed no 
significant changes in expression but the neural marker Sox2 was increased in 
three of the samples (Figure 34C). A possible explanation for no change being 
seen in Pax3 expression is because although using WISH an expansion is seen 
in the surface ectoderm of the embryo there is also a loss in the prospective NC 
region (Figure 27). This therefore may balance the expression levels so that 
although there has been a shift in Pax3 localisation the overall expression levels 
within the whole explant are not significantly altered. 
13.14.2. RNA sequencing results  
13.14.2.1. Quality control of RNA sequencing 
To assess the quality of the RNA sequencing results, clustering of replicates was 
assessed using both PCA plots (Figure 35) and sample distance heat maps 
(Figure 36). MO injected samples were analysed against MM injected samples 
to ensure any gene changes are consequence of the miRNA KD as opposed to 
just the injection. When replicates were clustered the results demonstrate that for 
miR-219 KD (stage 14) (Figure 35A and Figure 36A) miR-196a KD (stage 14) 
(Figure 35B and Figure 36B) and miR-196a KD (stage 17) (Figure 35C and 
Figure 36C) all replicates for each condition cluster consistently therefore 
validating the reproducibility of the replicates. The two conditions are also distinct 
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from one another on the PCA plot confirming that there are gene changes which 
separate the two groups that can be attributed to the miRNA KD. This is 
compared to PCA plots (Appendix 11) and sample distance heat maps 
(Appendix 12) for MM injected embryos vs control (non-injected) embryos where 
the replicates do not show any clustering and thus no clear separation between 
the two groups. For miR-219 MO samples, one of the four replicates deviated 
substantially from the rest and so this replicate was removed from any further 
analysis.  
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Figure 35: PCA plot showing clustering of replicates between MO injected 
embryos and MM control.  
 
PCA plots of MO samples (blue dots) vs MM controls (red dots) demonstrated that for miR219 (stage 14), 
(A) miR-196a (stage 14) (B) and miR-196a (stage 17) (C) the replicates cluster and the two treatment types 
are distinct from one another.  
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Figure 36: Sample distance heat map showing clustering of replicates between 
MO injected embryos and MM control  
Sample distance heat maps of MO samples vs MM controls demonstrated that for miR-219 (stage 14) (A), 
miR-196a (stage 14) (B) and miR-196a (stage 17) (C) the replicates cluster with the MO samples being 
distinct from the MM control. 
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13.14.2.2. miR-219 stage 14  
As mentioned previously, RNA sequencing for miR-219 KD was only completed 
for stage 14 because of poor quality qRT-PCR results for stage 17. Comparative 
expression analysis between miR-219 KD with miR-219 MM reveals multiple 
transcripts that are both upregulated and downregulated in the miR-219 KD 
tissue (Appendix 14). In total, 110 genes were significantly (P<0.05) upregulated 
whilst 104 genes were downregulated (Figure 37). This is compared to MM vs 
non-injected control tissue where only five genes were differentially expressed 
(Appendix 13). 
GO Analysis of miR-219KD transcriptome 
To gain an overview of the molecular processes operational in the miR-219 KD 
transcriptome, gene ontology enrichment analysis (GO analysis) using the 
programme DAVID (v.6.8), along with manual literature searches, were 
completed on differentially expressed gene sets.  
 135 
 
Figure 37: Gene changes following miR-219 KD.  
Scatter plot comparing global gene expression profiles between miR-196a KD and miR-196a MM samples. 
Differentially expressed genes (P<0.05) are represented as red dots (A). Heatmap for selected differentially 
expressed genes (miR-196aMO vs miR-196a MM). Colour depicts gene expression where yellow represents 
overexpression and blue underexpression. The blue line running throughout the boxes is a histogram 
representing the level of either upregulation or downregulation against the dotted midline (no change) (B).  
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13.14.2.3. NC is lost following miR-219 KD  
Unsurprisingly, for the downregulated gene set, GO analysis only identified 
‘neural crest development’ as an output. Manually, the expression of bona fide 
NC transcription factors was assessed and as expected, many were significantly 
downregulated in the miR-219 KD sample (Figure 37). Snail2, Foxd3, Twist1, 
Sox8 and Sox9 are all key NC specifier genes (Rogers et al., 2012) and were 
among the most downregulated genes following miR-219 KD. In addition to NC 
specifiers, genes known to play important roles in various alternative aspects of 
NC development were also found to be significantly downregulated. Capn8, 
Pdgfra, Pcdh8 and Anxa2 are four examples of these, all of which have roles in 
the promotion of NC cell migration (Cousin et al., 2011, Smith and Tallquist, 2010, 
Lumb et al., 2017, Rangarajan et al., 2006). Interestingly, the cell adhesion 
protein - Hapln3, was the fifth most downregulated gene following miR-219 KD 
(Figure 38). Although no functional analysis has been completed on this gene in 
a NC context, it has recently been put forward as a novel potential member of the 
NC gene network following transcriptome analysis of dissected pre-migratory NC 
(Plouhinec et al., 2014). Together this clearly demonstrates that following KD of 
miR-219, NC tissue is either lost or never forms. Interestingly, although the 
expression levels were reduced, NPB specifiers (including Msx1/2, Dlx5/6, Gbx2) 
were not significantly downregulated. This therefore suggests that the NPB does 
form but the NC fail to do so from the NPB.  
The expression of many placodal genes were also not significantly altered 
following miR-219 KD (i.e six1, six4, pax8, gata2/3). This implies that placode 
tissue developed efficiently and supports the hypothesis the NPB does form. 
However, some less well-established placodal genes were found to be 
significantly upregulated following miR-219 KD one of which being the histone-
modifying factor Prdm12 (Figure 37). Prdm12 is expressed in the lateral pre-
placodal ectoderm during neurula development, and has recently been shown to 
be key in separating the placodal tissue from NC (Matsukawa et al., 2015). 
PRDM12 represses the expression of NC specifier genes in the placodal region 
via methylation of histone H3K9. ChIP-qPCR analyses showed that PRDM12 
promoted the occupancy of the trimethylated histone H3K9 (H3K9me3) on the 
Foxd3, Snail2, and Sox8 promoters specifically (Matsukawa et al., 2015). All 
three of the latter genes were shown to be significantly downregulated in this 
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dataset. Another placodal related gene upregulated in miR-219 KD tissue is the 
transmembrane protein, Ta-2. Although the function of this protein is yet to be 
fully elucidated its expression is restricted to the superficial ectoderm which is 
where the expansion of Pax3 is localised to following miR-219 KD (Figure 27) 
(Chalmers et al., 2006).  
13.14.2.4. Pax3 expansion in the superficial ectoderm does not induce 
expression of its downstream hatching gland specific target 
Xhe2 
Whilst analysing the list of enhanced genes following miR-219 KD the expression 
of Pax3, Eya1 and Xhe2 were assessed manually to investigate whether the 
results supported earlier hypotheses formulated in previous chapters (see section 
13.10.2.2). Although Pax3 and Eya1 do increase in expression levels following 
miR-219 KD, this is not significant. For Pax3 this supports the qRT-PCR results 
discussed in section 13.14.1. One explanation could be because both genes are 
already expressed in that region rather than been induced from a region in which 
it is not usually expressed. Alternatively, it could be that because Pax3 
expression was expanded across the surface ectoderm but also lost in 
prospective NC region (Figure 27) the overall number of transcripts may not have 
changed. To make this assumption for Eya1, WISH needs to be completed on 
miR-219 KD embryos to assess if the same changes in expression are seen for 
Eya1 as they are for Pax3. As Pax3 acts upstream of Xhe2 in the superficial layer 
of the ectoderm it was postulated that because of the severe expansion of Pax3 
in this region following miR-219 KD we would predict the same expansion for 
Xhe2. In fact, the opposite was seen with a significant decrease in expression 
being observed (Figure 38). As with Eya1, WISH needs to be completed to 
confirm this result. 
13.14.2.5. Multiple genes involved in neural pluripotency were 
upregulated following miR-219 KD 
Unexpectedly, the top upregulated gene following miR-219 KD corresponded to 
the miR-219 primary miRNA transcript (Figure 38). The reason for this is likely 
because when designing the MO against miR-219, GeneTools designed it so it 
works by binding to the primary transcript and stops it from being processed by 
Drosha. Therefore, in miR-219 KD tissue there is an accumulation of primary 
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transcript which in the control tissue has been processed into the mature 
transcript. This was not the case for miR-196a KD as the MO against miR-196a 
binds to the dicer cleavage site following further processing of the miRNA (not to 
the primary transcript as is the case for miR-219 MO). The results from GO 
analysis along with manual analysis on upregulated genes resulted in three main 
outputs including regulation of neural pluripotency and two signalling pathways 
(Notch and BMP). In total, there were 13 upregulated genes identified as being 
linked with neural pluripotency including the bona fide neural transcription factors 
Pax6, Sox2 and Sox3 (Figure 37). Interestingly, the previously discussed 
placodal gene Eya1 also has links with increased pluripotency. Previous studies 
have shown Eya1 to be involved in placodal neurogenesis. Neurogenic placodes 
express many of the same genes that regulate neurogenesis in the NP including 
Sox2 and Sox3 (Abu-Elmagd et al., 2001, Schlosser and Ahrens, 2004). 
Schlosser et al. (2008) showed that through activation of Sox2 and Sox3, an 
incease in expression of Eya1 results in a promotion of proliferating neural 
progenitors. Therefore, this could explain why following miR-219 KD, an 
expansion of  neural progenitors is seen.  
Another upregulated neural gene included the forkhead transcription factor 
FoxB1. FoxB1 has been shown previously to be upregulated by POU class V 
transcription factors (Pou5f3) and to be a key factor in the patterning of the dorso-
ventral axis of the ectoderm during neurulation (Takebayashi-Suzuki et al., 2007). 
FoxB1 promotes neural induction and inhibits epidermal differentiation by 
suppressing BMP signalling (Takebayashi-Suzuki et al., 2011). As discussed 
previously in section 1.1 it is the level of BMP signalling (along with other 
signalling pathways) that determines the fate of embryonic ectodermal stem cells 
as either epidermal, NC or neural (Liem et al., 1995). Analysis of changes in 
expression levels of BMP signalling molecules and their downstream signalling 
transducers such as SMADS showed no significant difference in this data set. 
However, this was not an unexpected result as Foxb1 mediates BMP signalling 
at a protein level. For future investigations, experiments using BMP reporters 
should identify any changes in the level of BMP signalling at a protein level 
following miR-219 KD (discussed in section 13.18.5). 
Of the 13 upregulated neural genes, many have been shown to have roles in the 
maintenance of an immature neural state whilst inhibiting differentiation. 
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FoxD4L1 is a forkhead transcription factor that expands the neural ectoderm by 
down-regulating genes that promote the onset of neural differentiation and up-
regulating genes that maintain proliferative neural precursors in an immature 
state (Yan et al., 2009). Overexpression of FoxD4L1 results in an expansion of 
the expression domain for Sox2 and Sox3 (both of which are also significantly 
upregulated in this data set) in NP stem cell stages (Yan et al., 2009). Another 
upregulated gene which is linked to maintaining a neural stem cell population and 
has previously been mentioned as an upregulator of FoxB1 is Pou5f3.3. It is a 
member of the Pou5f3 genes (Pou5f3.1 Pou5f3.2 Pou5f3.3), all of which have 
been shown to have a conserved role in the maintenance of pluripotency 
(Morrison and Brickman, 2006, Cao et al., 2007). Recently, Young et al. (2014) 
found that ectopic expression of Pou5f3 resulted in an increase in pluripotency 
and a failure of the neuroectoderm to differentiate in response to transforming 
signals. Together, this upregulation of pluripotent neural factors strongly suggests 
that the region that has been dissected is mainly composed of neural precursors 
following miR-219 KD.  
13.14.2.6. Notch signalling is increased further promoting neural 
pluripotency  
Notch signalling, which is highly conserved from Drosophila to humans, plays 
essential roles in many processes during development including neurogenesis 
(Artavanis-Tsakonas et al., 1999, Lai, 2004, Bray, 2006). When the Notch 
transmembrane receptor on the cell surface is activated by its ligands, 
downstream target genes are activated which mainly include members of the 
HES (Hairy/ Enhancer of Split) family of basic helix-loop-helix (bHLH) 
transcriptional regulators (Mumm and Kopan, 2000, Weinmaster, 2000). During 
early vertebrate development, Notch is expressed broadly throughout the NP, 
and its signalling pathway plays an essential role in maintaining the neural 
progenitor state and regulating the diversification of cell fate (Yoon and Gaiano, 
2005, Louvi and Artavanis-Tsakonas, 2006). The classical view is that increasing 
Notch signalling within a cell up-regulates HES genes that subsequently repress 
neural differentiation bHLH genes (such as ngn and neuroD) (Sullivan et al., 
2001). In addition to neural development, Notch has also been shown to play 
multiple roles during NC development, although its importance and mode of 
action has been controversial. Results obtained in chick and frog indicate that 
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Notch regulates NC through modulation of BMPs. In Xenopus, Notch signalling 
induces NC cell-autonomously by downregulation of BMP4 at the NPB (Glavic et 
al., 2004). In chick, both gain and loss of function of Notch signalling inhibit BMP4 
and Notch induces NC non-cell-autonomously (Endo et al., 2002). From this data 
set, after miR-219 KD, an increase in expression was seen for multiple members 
of the Notch signalling network including the downstream targets of Notch - Hes3 
and Hes5 (Figure 37). Using a triple knock-out of Hes1; Hes3; Hes5 in mice, 
Hatakeyama et al. (2004) showed that in the absence of these genes, 
neuroepithelial cells are not properly maintained and prematurely differentiate 
into neurons at the NP stage. Another upregulated Notch related gene is the 
Hes5-like gene Esr10. This gene is upregulated by the pro-neural protein Xngnr1 
and as with the HES genes has been shown to be key in regulating the 
differentiation of neural precursors. Of these upregulated Notch genes, Hes5 is 
of particular interest as it has been implicated in NC development as discussed 
previously in section 13.12.1. Gouti et al. (2011) showed that for NC to be 
induced, an optimum level of Hes5 is required. Within NC, a repressor of Hes5 
and therefore a regulator of this optimum level is Hoxb1 (Gouti et al., 2011). 
Misexpression of Hoxb1 in the trunk neural tube results in a repression of Hes5 
and a neural to NC cell fate switch which is accompanied by a reduction in 
proliferation (Gouti et al., 2011). Within this dataset, Hoxb1 is in the top 50 most 
downregulated genes (Figure 38) which may explain why we get (1) the loss of 
NC and (2) the upregulation of Hes5 resulting in a clear increase in a neural 
progenitor population. 
13.14.2.7. BMP antagonists are upregulated indicating that BMP 
signalling is decreased  
In addition to members of Notch signalling pathway there was also an 
upregulation of members of BMP signalling, specifically, genes linked to an 
inhibition of BMP signalling (Figure 37). As a downregulation of BMP signalling 
(through BMP antagonists) is required for neural induction this fits with the 
upregulation of neural genes previously discussed. Two key BMP antagonists, 
Chrd and Irx1, were significantly upregulated following KD of miR-219. Chordin 
is a well-established BMP antagonist which has been shown to be key in the 
establishment of the dorsal ventral axis of the embryo during development. Using 
loss of function experiments, it has been shown that KD of Chordin inhibits neural 
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formation (Oelgeschlager et al., 2003, Kuroda et al., 2004). The second BMP 
antagonist, Irx1(Xiro1) is a member of the Iroquois family of Iroquois (iro) genes. 
The iro genes, which encode evolutionary conserved homeoproteins, participate 
in neurogenesis and in many other developmental processes (reviewed in 
(Cavodeassi et al., 2001). So far, five iro genes have been identified in Xenopus 
(Bellefroid et al., 1998, Garriock et al., 2001, Gomez-Skarmeta et al., 1998). 
Among them, Iro1, Iro2 and Iro3 have very similar patterns of expression and 
participate, as their Drosophila counterparts do, in proneural gene activation 
(Bellefroid et al., 1998, Gomez-Skarmeta et al., 1998, Gomez-Skarmeta et al., 
1996, Leyns et al., 1996). Irx1 acts early in NP development to induce expression 
of proneural genes, and specifies a neural precursor state (Bellefroid et al., 1998, 
Gomez-Skarmeta et al., 1998). In addition, it has been shown that Irx1 is a 
repressor that is also required for patterning of the dorso-ventral axis of the 
embryo including specification of the NP, NC and preplacodal field. This is at least 
in part by downregulating BMP-4 (Gomez-Skarmeta et al., 2001). 
To conclude, from these results it is apparent that following miR-219 KD NC 
tissue is either lost or never generated (characterised by a decrease in 
expression of NC specifier genes) and the tissue that has replaced it is an early 
neural progenitor population (characterised by an increase in expression of 
multiple neural genes). As GFP is still seen in the injected embryos prior to 
dissection and as there is no apparent expression of apoptotic or necrotic genes 
it can be deduced that the tissue is not dead. Instead it appears the NC never 
formed and changes in gene expression following miR-219 KD has caused a cell 
fate switch to neural. 
In addition to giving us information regarding the fate of the sequenced tissue, 
this data also gives clues to several potential mechanisms behind this switch in 
tissue types. These potential mechanisms have been discussed previously in this 
section but for clarity they have been summarised in Figure 39. To fully elucidate 
the mechanism behind miR-219, the 3’ UTR of any potential direct targets 
(indicated by a dashed line in Figure 39) need to be assessed for a miR-219 
binding site and then validated using luciferase assays.   
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Figure 38:The top 50 downregulated and upregulated genes following miR-219 KD. 
RNA was sequenced for miR-219MO NC tissue and miR-219MM NC tissue. Differential analysis was 
completed on miR-219KD vs the MM control to find the top 50 significantly (P<0.05) downregulated genes 
(blue) and the top 50 significantly (P<0.05) upregulated genes (yellow) following KD of miR-219.  
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13.14.2.8. miR-196a  
Comparative expression analysis between miR-196a KD with miR-196a MM 
(stage 14 and stage 17) revealed multiple transcripts that are both upregulated 
and downregulated in the miR-196a KD tissue (Appendix 14). For stage 14, 1099 
genes were significantly upregulated whilst 1333 genes were downregulated and 
for stage 17, 591 genes were significantly upregulated whilst 264 genes were 
downregulated (Figure 40).  
13.14.2.9. miR-196a KD results in impaired induction of the NPB and a 
loss of NC specification 
As with the miR-219 KD dataset, the expression of multiple bona fide NC 
transcription factors were significantly reduced following miR-196a KD. Some 
were noted at both stage 14 and stage 17 (Snail2, Tfap2e, Sox8) whilst others 
were specific to either stage 14 (Snail1, Ets1, c-myc, Tfap2a/b/c, Foxd3, Sox9, 
Twist1, Msx1/2) or stage 17 (Foxi1, Foxi2, Sox10). In addition to these TF, 
various other genes which have recently been shown to be part of the NC 
transcriptome signature were also found to be significantly downregulated 
including the metalloproteinase Mmp28 (stage 14 and 17), the ECM component, 
Hapln3 and the membrane component, Greb1 (stage 14) (Plouhinec et al., 2014) 
(Figure 41 Figure 42).  
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Figure 40: Gene changes following miR-196a KD.  
 
Scatter plot comparing global gene expression profiles between miR-196a KD and miR-196a MM samples. 
Differentially expressed genes (P<0.05) are represented as red dots for stages 14 (A) and stage 17 (B). 
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Interestingly, despite the expression of almost all known NC specifiers being 
reduced following miR-196a KD the general changes in expression of NPB 
specifiers were not clear. The TFs Pax3/7, Dlx5/6 and Gbx2 had no significant 
change in expression whilst Zic1 and Hairy2a were both significantly upregulated. 
The only NPB specifier genes to have significantly reduced expression were 
Msx1/2 and Tfap2a.The expansion of Zic1 in combination with a loss of Tfap2a 
has been described previously. de Croze et al. (2011) concluded using loss of 
function experiments that TFAP2A is essential in initiating the induction of the 
NPB. They showed that when Tfap2a is lost, the NPB is impaired (characterised 
by a loss of Msx1, Pax3 and Hairy2a) and instead it is specified as NP 
(characterised by an upregulation of Sox2 and Zic1). Hairy2a has been shown 
using overexpression experiments to lie downstream of Zic1 so this may explain 
the upregulation of Hairy2a (Nichane et al., 2008a). Although the upregulation of 
both Zic1 and Hairy2a may be accounted for, how and why Pax3 expression 
remained unaltered following a loss of tfap2a remains unanswered. One possible 
explanation is that Tfap2a expression may have been induced prior to stage 14 
and then lost. This would give Tfap2a enough time to initiate the transcription of 
Pax3 which subsequently has been shown to auto-regulate its own expression 
(Plouhinec et al., 2014). The second possible explanation is that although the 
expression is significantly reduced (base mean MM: 5363, base mean MO: 2649) 
the gene is still expressed. Therefore, the level of expression in the KD sample 
could still be sufficient to induce expression of downstream targets. Finally, 
Tfap2a is one of five isoforms (a-e) all of which have been shown to have highly 
conserved functions in the development of the NC (Hilger-Eversheim et al., 2000, 
Hoffman et al., 2007). Although four out of five of these isoforms have significantly 
reduced expression following miR-196a KD, it is possible that there is enough 
redundancy between the isoforms to induce the expression of Pax3 and possibly 
Hairy2a.  
13.14.2.10. Induction of all NPB derivatives are lost  
From this dataset, it is clear that following miR-196a KD, NC specifiers are lost 
and the formation of the NPB is impaired. Further support for impaired NPB 
formation comes from the apparent loss of the placodal region following miR-
196a KD which would usually lie lateral to the NC and is also derived from the 
NPB. In this dataset, all bona fide placodal genes are significantly reduced in at 
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least one of the stages following miR-196a KD. These include; Eya1, Six1, Six4, 
Gata2, Gata3 and Pax8 (Figure 41 Figure 42).  
13.14.2.11. Cell fate has been changed to neural and this appears to be 
mediated by an upregulation of the zinc finger protein zic1 
Zic1, is a zinc finger protein which has been shown to play a key role in causing 
the embryonic ectoderm to be more sensitive to neural inductive signals (Kuo et 
al., 1998). As a result of the upregulation of this gene, other neural related genes 
were assessed for changes in expression. As expected, multiple bona fide neural 
related genes were upregulated in the miR-196a KD tissue including Sox2/3 and 
Zic1/2/3 (Figure 41 Figure 42). The expression of these genes reiterated that 
there had been a change in tissue fate from NC / placode to neural tissue. As 
Zic1 is a regulator of ectodermal sensitivity to neural tissue induction and is 
upstream of these other definitive neural markers (ie Sox2) it is possible that this 
gene is key in the cell fate change (Kuo et al., 1998, Marchal et al., 2009). The 
regulation of Zic1 was next to be addressed. Zic1 has been shown previously to 
be an immediate early target of BMP inhibition (Marchal et al., 2009). In fact, 
within the Zic1 promoter is a BMP inhibition responding module, that is sufficient 
for expression in response to BMP inhibition (Tropepe et al., 2006). Therefore, in 
future experiments it needs to be determined whether it is changes in BMP 
signalling that is resulting in the loss of NC/ placodal tissue and an increase in 
neural tissue (possibly via induction of Zic1)?  
13.14.2.12. BMP signalling is attenuated following miR-196a KD which 
potentially regulates Zic1 induction  
Following miR-196a KD two key families of BMP antagonists were significantly 
upregulated, that being three chordin genes; Chrd, Chrd.1 and Chrd.2 and 
multiple members of the iroquois family including; Irx1, Irx2 and Irx3 (Figure 41 
Figure 42). As described previously in section 13.14.2.2 both these families of 
genes are well-established BMP antagonists that are key players in proneural 
gene activation (Bellefroid et al., 1998, Gomez-Skarmeta et al., 1998, Gomez-
Skarmeta et al., 1996, Leyns et al., 1996). Importantly, Irx genes act early in NP 
development to induce expression of proneural genes, and specify a neural 
precursor state (Bellefroid et al., 1998, Gomez-Skarmeta et al., 1998). They have 
been shown to act as repressors that are required for patterning of the dorso-
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ventral axis of the embryo including specification of the NP, NC and pre-placodal 
field. This is at least in part by downregulating BMP-4 (Gomez-Skarmeta et al., 
2001).  Interestingly, following miR-196a KD the mRNA levels of BMP4 (at stage 
14 and 17) was significantly increased which would imply an increase in BMP 
signalling. However, as these BMP antagonists act at a protein level, the increase 
in the level of mRNA could be compensatory and does not show if BMP signalling 
is active or not. To fully assess the changes in BMP signalling a reporter construct 
would need to be used (as described in 13.14.2.2). Another upregulated gene 
linked to BMP signalling is FoxB1. FoxB1 is upregulated by the POU class V 
transcription factors (Pou5f3.1 Pou5f3.2 Pou5f3.3), all of which are also 
upregulated following miR-196a KD. FoxB1 is of particular interest as it is a key 
factor in the patterning of the dorso-ventral axis of the ectoderm during 
neurulation via inhibition of BMP signalling (Takebayashi-Suzuki et al., 2011). 
More specifically this is through reducing the levels of pSmad1/5/8 and it is a 
reduction in pSmad that results in expression of Zic1 (Tropepe et al., 2006). As a 
result of this clear expansion of neural tissue (likely by altering BMP levels), one 
may expect a decrease in epidermal tissue. Levels of the expression of epidermal 
type I cytokeratin shows a significant reduction at both stage 14 and stage 17. 
13.14.2.13. Notch signalling is increased following miR-196a KD 
possibly promoting neural pluripotency  
From this data set, an increase in the expression of many downstream members 
of the Notch signalling pathway was noted. More specifically, there was an 
increase in the expression of the hes genes; hes1, hes3, hes4, hes5 and hes7 in 
at least one of the stages assessed (Figure 41 Figure 42). Interestingly, Zic1 a 
regulator of hes genes has been shown to inhibit neural differentiation through 
mediating the Notch pathway. Aruga et al. (2002) showed that overexpression of 
Zic1 in the spinal cord, expanded the Notch-expressing region and enhanced 
expression of the pro-pluripotent gene, Hes1. This therefore could be yet another 
way in which Zic1 acts to expand a neural population. In addition to Hes1, multiple 
other Hes genes were upregulated following miR-196a KD. As discussed 
previously in section 13.14.2.2 it has been shown that a triple knock-out of Hes1; 
Hes3; Hes5 in mice, results in premature differentiation of neuroepithelial cells 
into neurons at the NP stage. In addition, an optimum level of Hes5 has been 
shown to be required to initiate NC development (Gouti et al., 2011). Together, 
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these studies clearly demonstrate the importance of a tight regulation of Notch 
signalling during early development, specifically in regard to the maintenance of 
pluripotency. Interestingly, the repressor of Hes5, Hoxb1 is downregulated in this 
dataset which may explain the upregulation of Hes5 in our experiments and 
therefore possibly as to why NC is absent. The downregulation of Hoxb1 came 
as a surprise because as discussed in section 13.12.1 it is a predicted target of 
miR-196a. Unexpectedly, following miR-196a KD, many of miR-196a target HOX 
genes were not significantly upregulated. At stage 14, multiple HOX genes 
(mostly from the HOXB cluster) were actually downregulated (Table 18). One 
explanation for this could be that after miR-196a KD, this interferes with an 
indirect positive feedback loop between the miRNA and expression of the Hoxb 
genes. This downregulation was not seen at stage 17 and for Hoxb1 expression 
was significantly upregulated by that stage. This was also the case for three other 
HOX genes not located on the HOXB cluster (Table 18).  
 
Table 18: Changes in the expression of various HOX genes following miR-196a KD 
 STAGE 14 STAGE 17 
UPREGULATED - Hoxa1, Hoxb2, Hoxd1, 
Hoxd4 
DOWNREGULATED Hoxb1/2/3/4/5 
Hoxc3 
- 
 
 
13.14.2.14. The cell population following miR-196a KD is characterised 
by high levels of neural ‘stemness factors’ 
Whilst analysing the list of enhanced genes following miR-196a KD multiple 
genes involved with the maintenance of pluripotency and inhibition of 
differentiation became apparent. For example, the forkhead transcription factor 
FoxD4L1 as well as the Pou5f3 genes are all within the top 50 most upregulated 
genes at both stage 14 and stage 17 (Figure 43 Figure 44). As described 
previously, all of these genes have been shown to be key in maintaining 
proliferative neural precursors in an immature state (Yan et al., 2009). In addition 
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to these, the recently discovered ‘stemness factor’ deptor was also significantly 
upregulated. DEPTOR has been shown to promote pluripotency and self-renewal 
in ESCs by inhibiting mTOR signalling (Agrawal et al., 2014). Another family of 
pluripotent linked TFs upregulated following miR-196a KD is the VENTX family. 
Members of the VENTX family of NKL transcription factors were first identified in 
Xenopus and in total there are 6 ventx paralogs, which can be grouped in 3 
subclasses: ventx1s, ventx2s and ventx3s (Scerbo et al., 2012). Of these, 
Ventx1.1, Ventx1.2, Ventx2.1 and Ventx2.2 are all upregulated in the both stage 
14 and stage 17 miR-196a KD. There is a longstanding agreement that all 
paralogs function in a similar ‘nanog-like’ fashion (Onichtchouk et al., 1998). 
Previous work has given the VENTX proteins two key functions including bmp4-
controlled establishment of dorso-ventral patterning and as guardians of high 
developmental potential during early Xenopus development (Scerbo et al., 2012, 
Onichtchouk et al., 1998). Scerbo et al. (2012) showed that inactivation of 
Ventx1/2 leads to down-regulation of the multipotency marker Pou5f3.1 (Oct91) 
and premature differentiation of blastula cells. Together, this upregulation of 
pluripotent factors strongly suggests that the region that has been dissected is 
mainly composed of neural precursors.  
To conclude, from these results it is apparent that following miR-196a KD the 
NPB formation is impeded and as a result, NPB derivatives (NC and placode) are 
either lost or do not form. It appears as if the tissue that has replaced it is an early 
neural progenitor population. We can hypothesise that under wildtype conditions, 
miR-196a usually controls correct neuroectoderm patterning by modulating two 
pathways. Firstly, through regulating expression levels of BMP signalling and 
consequently changes in the expression of key genes such as the neural TF - 
Zic1. Secondly, through modulation of Notch signalling and therefore changes in 
expression of ‘stemness-like’ genes. 
A summary of the potential roles of miR-196a during normal neuroectoderm 
patterning and NC development is summarised in Figure 45. As if with miR-219, 
any potential direct targets (indicated by a dashed line in Figure 45) need to be 
assessed for a miR-219 binding site and then validated using luciferase assays.  
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Figure 43: The top 50 downregulated and upregulated genes following miR-196a 
(stage 14) KD.  
RNA was sequenced for miR-196a MO NC tissue and miR-196a MM NC tissue. Differential analysis was 
completed on miR-196aKD vs the MM control to find the top 50 significantly (P<0.05) downregulated genes 
(blue) and the top 50 significantly (P<0.05) upregulated genes (yellow) following KD of miR-196a. 
 
 154 
 
Figure 44: The top 50 downregulated and upregulated genes following miR-196a 
(stage 17) KD. 
RNA was sequenced for miR-196a MO NC tissue and miR-196a MM NC tissue. Differential analysis was 
completed on miR-196aKD vs the MM control to find the top 50 significantly (P<0.05) downregulated genes 
(blue) and the top 50 significantly (P<0.05) upregulated genes (yellow) following KD of miR-196a. 
 
 155 
  
Fi
gu
re
 4
5:
 M
od
el
 o
f t
he
 p
ot
en
tia
l m
ol
ec
ul
ar
 m
ec
ha
ni
sm
s 
m
iR
-1
96
a 
us
es
 t
o 
pr
ev
en
t 
ne
ur
al
 in
du
ct
io
n 
an
d 
co
nt
ro
l n
eu
ra
l p
lu
rip
ot
en
cy
 
du
rin
g 
Xe
no
pu
s 
ne
ur
oe
ct
od
er
m
 p
at
te
rn
in
g.
  
R
ed
 re
pr
es
en
ts
 re
pr
es
si
on
, g
re
en
 re
pr
es
en
ts
 e
xp
re
ss
io
n 
an
d 
bl
ue
 re
pr
es
en
ts
 b
al
an
ce
d.
 S
ol
id
 a
nd
 d
as
he
d 
lin
es
 a
re
 th
e 
ve
rif
ie
d 
an
d 
pr
ed
ic
te
d 
re
gu
la
to
ry
 re
la
tio
ns
hi
ps
, r
es
pe
ct
iv
el
y.
 
 156 
Chapter 6: General discussion and 
concluding remarks 
13.15. Study aims 
The aims of this study were: 
5. To identify NC enriched miRNAs 
6. To explore the function of the candidate miRNAs during Xenopus NC 
development  
7. To explore the molecular mechanisms through which these candidate 
miRNAs are working during Xenopus NC development  
8.  To identify miRNAs that are possibly contributing to NC multipotency  
13.16. Candidate miRNAs for NC development  
Candidate NC miRNAs were identified using two methods; sRNA sequencing on 
induced NC and the XenmiR approach.  
13.16.1. Multiple miRNAs are expressed in the developing NC 
To identify candidate miRNAs, a NGS miRNA expression profile was generated 
for induced NC, neural, ectoderm and blastula tissue samples. Bioinformatic 
analyses of this data revealed expression of 388 known hairpins and 102 novel 
miRNAs across the four tissue types. Of these, multiple miRNAs were expressed 
in the NC tissue including miR-219, miR-130C, miR-196a and the novel miRNA 
miR-Nov-12a (Figure 17). In addition to NGS, the XenmiR database was also 
used to identify candidate miRNAs expressed in NC tissue. Using both 
approaches and further literature searches six candidates were chosen to 
undergo functional analysis, those being; miR-219 miR-196a, miR-302, miR-30a-
3p, miR-17-5p and miR-429. 
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13.17. miR-219 and miR-196a KD result in aberrant NC 
development  
To determine the importance of the six candidate NC miRNAs, KD experiments 
using MOs were used. Work from this study has shown that of these six 
candidates, two miRNA KDs resulted in phenotypes indicative of NC 
deformations, those being miR-219 and miR-196a. KD of these miRNAs resulted 
in abnormal craniofacial cartilage development (Figure 24) and a loss/reduction 
of two key NC specification transcription factors - Snail2 and Sox10 (Figure 25 
Figure 27). 
13.17.1. miR-219 and its role in NC development  
13.17.1.1. miR-219 KD causes an expansion of Pax3 in the surface 
ectoderm 
Further characterisation of miR-219 KD phenotype using WISH revealed an 
unexpected result. KD of miR-219 resulted in a complete shift of expression 
pattern of the NPB marker Pax3. This is characterised by a strong expansion 
throughout the surface ectoderm (where the Xenopus hatching gland forms) and 
a loss of expression in the underlying prospective NC tissue (Figure 27).  
13.17.1.2. miR-219 directly targets Eya1, a placodal gene directly 
upstream of Pax3 
Using computational target analysis for miR-219, this study shows that the 
transcription factor Eya1 is a strong predicted target of miR-219 using various 
prediction algorithms (Figure 30). Eya1 is a member of the PSED network which 
is a group of proteins that have been shown to be involved in a variety of 
developmental processes including sensory placodal development (Donner and 
Maas, 2004, Friedrich, 2006). miR-219:Eya1 interaction was chosen to be 
focused on for three main reasons; (1) it acts upstream of Pax3 (Grifone et al., 
2007) (2) it is expressed in the NPB zone (same as NC) (Moody and LaMantia, 
2015) and (3) it is a very strong predicted target of miR-219 (8-mer). Using 
luciferase reporter assays this work demonstrated for the first time that Eya1 is a 
direct target of miR-219 (P<0.0001; control vs miR219 mimic) in vitro (Figure 32). 
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As Eya1 has been shown to act upstream of Pax3 in other biological processes 
such as muscle development it would be interesting to explore the possibility of 
miR-219 playing a similar role in this context (Grifone et al., 2007). As the 
expansion of Pax3 is localised to what appears to be the hatching gland (Figure 
27), one would expect downstream targets of Pax3 in the hatching gland region 
to be upregulated. This however was not the case and the opposite was 
observed. Xhe2 is a hatching gland specific metalloproteinase that has been 
shown previously to have an expanded expression domain following an over 
expression of Pax3 in the hatching gland region (Hong and Saint-Jeannet, 2014). 
Surprisingly, in this dataset, Xhe2 expression was significantly decreased 
following miR-219 KD (Figure 38). To confirm this result, WISH for Xhe2 on 
injected embryos needs to be completed. 
13.17.1.3. RNA sequencing of miR-219 KD tissue reveals multiple 
potential models for its role in NC development 
Results from the RNA sequencing data demonstrate that following miR-219 KD, 
the NC are either lost or never form. This is shown by reduced expression of 
multiple bona fide NC genes (Figure 37). This supports the WISH data discussed 
in chapter 4 where a loss of Snail2 and Sox10 is observed following miR-219 KD 
(Figure 27). As a result of an increase in expression of multiple neural genes it 
appears as if the tissue replacing the NC is a progenitor neural population. 
Through analysis of the RNA seq data, the role and function of miR-219 can be 
proposed in several models (summarised in Figure 39). Two signalling pathways 
implicated in nearly all the models are the BMP and Notch signalling pathway. 
This study indicates that following miR-219 KD there is a decrease in BMP 
signalling and an increase in Notch signalling. This fits with the upregulation of 
neural genes following miR-219 KD as low BMP is required for neural induction. 
These results are supported by several studies in chick whereby an 
overexpression of Notch signalling impeded NC development whilst a KD of 
Notch signalling expanded the NC region. This was shown to be via changes in 
BMP signalling (Endo et al., 2002, Cornell and Eisen, 2005). Conversely, the 
opposite was observed in Xenopus with high Notch signalling (which results in 
increased BMP signalling) being required for NC induction (Glavic et al., 2004). 
The role of Notch signalling in NC development is controversial and not fully 
understood. Conflicting results make it hard to draw final conclusions regarding 
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its specific role. Overall it can be agreed that for specification of the dorsal-ventral 
axis of the ectoderm during development there needs to be a gradient of BMP 
and a fine tuned balanced expression of Notch. miRNAs have been shown in 
many systems to be key in fine tuning biological signalling pathways and from 
this data it can be deduced that miR-219 is playing a role in fine tuning the 
pathways required for NC development. When miR-219 is removed the balance 
of the signalling molecules is altered and the threshold separating different tissue 
types is crossed resulting in a change in tissue fate. An overview of the changes 
induced by miR-219 KD is depicted in Figure 46. 
13.17.2. miR-196a and its role in NC development  
13.17.2.1. WISH on miR-196a KD embryos revealed a loss of NC 
specifiers and a gain of neural markers 
Further characterisation of embryos after miR-196a KD using WISH revealed that 
whilst NC specifiers are reduced and/or lost (snail2 and sox10), the expression 
of NPB specifiers are more varied. Following miR-196a KD, the expression 
domain of Zic1, Zic3 and Pax3 are expanded. Conversely, Msx2 has reduced 
expression. The key neural marker – Sox2 has an expanded domain suggesting 
there is a cell fate switch from NC to neural (Figure 26).  
13.17.2.2. KD of miR-196a results in impeded NPB development, a loss 
of NPB derivatives and an expansion of NP tissue  
RNA sequencing of miR-196a KD tissue supported previous WISH results as 
discussed in section 13.17.2.1. Following miR-196a KD, both the NC and 
placodal tissue are either lost or never developed, whilst the NPB tissue from 
which they derive from has disrupted gene expression. Some NPB specifiers 
have increased expression (Zic1, Hairy2a) whilst others have reduced expression 
(Msx1/2, Tfap2a). Using both the WISH data and the RNA seq data together it 
can be hypothesised that the tissue replacing the absent NC is a neural 
progenitor population. 
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13.17.2.3. miR-196a usually maintains a gradient of BMP signalling 
ensuring correct patterning of the neuroectoderm 
Through analysis of the RNA seq data, the role and function of miR-196a can be 
proposed in several models (summarised in Figure 45). As with miR-219 KD, two 
signalling pathways implicated in nearly all the models are the BMP and Notch 
signalling pathway. From this data, it can be hypothesised that miR-196a plays 
two roles in early Xenopus development, the first of which is maintaining a 
gradient of BMP signalling to ensure correct patterning of the neuroectoderm. 
This study shows that following miR-196a KD there appears to be a decrease in 
BMP signalling characterised by an increase in BMP antagonists (Figure 41 
Figure 42). As discussed previously it is likely that this decrease in BMP 
signalling resulting in changes in expression of key transcription factors towards 
a neural fate, one of which being an increase in Zic1. 
13.17.2.4. Absence of miR-196a alters balances of pluripotency and 
differentiation (via Notch)  
Previous studies have demonstrated strong links between the maintenance of 
progenitor populations and increased Notch signalling (Imayoshi et al., 2010). 
The ‘neural population’ of cells that replace NC following miR-196a KD is 
characterised by an increase in downstream Notch effectors as well as many 
pluripotency related genes including the Pou5f3 factors (Figure 41 Figure 42). 
This therefore suggests that under wildtype conditions miR-196a is involved in 
the maintenance of stem cell like properties of cells, possibly via regulating Notch 
signalling. This is supported by work of Kim and colleagues who showed using 
mesenchymal stem cells that inhibition of miR-196a enhanced proliferation and 
decreased osteogenic differentiation (Kim et al., 2009). Throughout the literature, 
many miRNAs have been described as key players in the regulation of 
pluripotency in many systems including embryonic stem cells (ESC), induced 
pluripotent stem cells (IPSC) and cancer (see section 2.3 for a review). 
Overall, for specification of the dorsal-ventral axis of the ectoderm during 
development there needs to be a gradient of BMP and a fine tuned balanced 
expression of Notch. From these results it is clear that miR-196a plays a role in 
maintaining both of these and when removed, thresholds are broken resulting in 
changes in tissue fate. An overview of the changes induced by miR-196a KD is 
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depicted in Figure 47. 
13.17.3. miR-301 and miR-338 are candidates for the 
maintenance of NC pluripotency  
Recent work in Xenopus has shown that contrary to prior belief, the NC retain 
their pluripotency from the cells in which they derive from (blastula) rather than 
selectively regain it (Buitrago-Delgado et al., 2015). Analysis of miRNAs 
upregulated in both NC and blastula stages in this study revealed two candidates 
that are maybe involved in the mechanism behind the inheritance of pluripotency, 
these being miR-301 and miR-338 (Figure 18). Both miRNAs have links to 
pluripotency throughout the literature (see section 13.5.9) and prove to be strong 
candidates for miRNAs that are responsible for maintaining this pluripotent cell 
population which gives rise to NC (Buitrago-Delgado et al., 2015). These results 
provide a good platform for a future project within the lab. 
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Figure 46 A summary of the changes in gene expression following miR-219 KD. 
Outline of the GRN controlling neural crest development under normal conditions (A) and following miR-219 
KD (B). Black words indicate no significant change in expression, grey words indicate a significant decrease 
in expression and a green box indicates a significant increase in expression. Following miR-219 KD BMP 
signalling is downregulated whilst Notch signalling is upregulated. This results in increased neural tissue 
whilst most key NC specifiers are lost or fails to ever form. The NPB and placodal development appears to 
be unaltered. 
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Figure 47 A summary of the changes in gene expression following miR-196a KD. 
Outline of the GRN controlling neural crest development under normal conditions (A) and following miR-
196a KD (B). Black words indicate no significant change in expression, grey words indicate a significant 
decrease in expression and a green box indicates a significant increase in expression. Following miR-196a 
KD BMP signalling is downregulated whilst Notch signalling is upregulated. This results in increased neural 
tissue whilst both NC and placode tissue is lost or fails to ever form. The NPB development is impaired with 
some genes being downregulated, some upregulated whilst others do not change. 
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13.18. Future work 
Despite achieving the overall aim of this project, there are multiple areas that can 
be developed further in the future in order to consolidate the results presented 
and to try to validate any proposed models. 
13.18.1. WISH  
13.18.1.1. miR-219 expression  
A key experiment that needs to be completed to really begin to understand the 
role miR-219 is playing in NC development is WISH for miR-219. This would 
enable us to gain both spatial and temporal information regarding the expression 
of miR-219. WISH using LNA probes against the mature transcript were 
attempted but only background staining was observed. The reason behind this 
was unknown. As an alternative, probes should be made against the longer 
primary transcripts and WISH completed against that. 
13.18.1.2. RNA sequencing validation 
WISH should be completed on KD embryos for various markers to validate the 
RNA seq results. This has already been completed for some genes including 
Msx1, Zic1, Zic3 (Figure 26) but more markers should be validated. As placodal 
genes were lost following miR-196a KD but not following miR-219 KD WISH for 
these genes would provide strong evidence supporting the sequencing data.   
13.18.1.3. Changes in expression of Eya1 and Xhe2  
These results show that Eya1 is a direct target of miR-219 in vitro (Figure 32) 
and that following miR-219 KD, Pax3 is expanded across the surface ectoderm 
of the embryo (Figure 27). As Eya1 acts upstream of Pax3 and Xhe2 is 
downstream of Pax3 it could be speculated that one and/or both these genes 
display the same changes in expression profile. To investigate this, WISH needs 
to be completed for both genes following miR-219 KD.  
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13.18.2. Can Eya1 KD rescue the expanded Pax3 phenotype? 
From the results in the study, it has been speculated that following miR-219 KD, 
Eya1 is increased and this causes an expansion of Pax3. To provide evidence 
for this, rescue experiments need to be completed. MOs against miR-219 and 
Eya1 should be injected both separately and together. If the upregulation of Eya1 
is responsible for the expansion of Pax3 then the combination of the two MOs 
should recuse the miR-219 KD phenotype. An alternative way to show this is by 
using target protectors. These protectors are single stranded modified RNAs that 
will bind to the miR-219 target site on the 3’UTR of Eya1 and prevent any miR-
219 interactions which would mimic the miR-219 KD phenotype. 
13.18.3. Validating additional NC candidates  
13.18.3.1. NC specific miRNAs identified from sRNA sequencing  
From the sRNA sequencing results, multiple miRNAs were shown to be 
upregulated in the NC when compared to neural (Figure 17). WISH should be 
completed for these miRNAs followed by KD experiments using MOs. One 
miRNA of particular interest is miR-nov-12a. This candidate is a novel miRNA 
that was expressed specifically in the NC. For this miRNA, target analysis would 
further enhance these results. 
13.18.3.2. miR-301 and miR-338 and their role in pluripotency 
As discussed in section 13.5.9, from this data set it is clear that miR-301 and miR-
338 are strong candidates for miRNAs that could play a role in maintaining the 
pluripotency of the developing NC. As discussed previously miRNAs have been 
reported to have roles in regulating pluripotency in many systems making them 
strong candidates (see section 2.3). To investigate this further WISH should be 
carried out to assess the spatial and temporal expression of these miRNAs. In 
addition, functional analysis using MO could be completed followed by WISH for 
bona fide pluripotency markers.  
13.18.4. Validation of direct targets of miR-219 and miR-196a 
From the sequencing results discussed in section 13.14.2, multiple potential 
direct targets have become apparent for both miR-219 and miR-196a and have 
 166 
been incorporated into the theoretical models (Figure 39 Figure 45). To test that 
these genes are direct targets, the 3’ UTR should be assessed for a target binding 
site (complementary to the seed of the miRNA) and then luciferase reporter 
assays can be generated as described previously in section 12.3.3. Alternatively, 
to test for these targets of both miRNAs (along with others) in an unbiased way 
the experimental procedure of ‘cross-linking, ligation and sequencing of hybrids’ 
(CLASH) could be implemented. The concept of the technique is to stabilize 
AGO-RNA complexes in live cells using UV and ligate them to form chimeric 
RNAs. Through sequencing, interacting RNA molecules (bound by AGO) are 
unambiguously identified as chimeric reads and will be sequenced to give the 
miRNA and its interacting mRNA target (Helwak et al., 2013).  
13.18.5. Measuring changes in BMP activity following miR-219 
and miR-196a KD 
From this study, multiple models of how miR-219 and miR-196a regulate correct 
NC development have been proposed. For both the miRNAs, BMP signalling has 
been implicated. This is proposed to be in part, via an upregulation of the BMP 
antagonists; Chordin and Irx1. As these BMP antagonists work by blocking BMP 
signalling at a protein level a decrease of BMP signalling could not be observed 
at a transcriptome level. To assess whether BMP signalling is altered following 
miR-219 KD a reporter construct should be used like that described in Faure et 
al. (2000).  
13.19. Applying these results to regenerative medicine – 
‘the bigger picture’ 
Stroke and many neurodegenerative disorders such as Parkinson's disease, 
Alzheimer's disease, amyotrophic lateral sclerosis need cell replacement 
therapy. Currently, cell-based therapy for treating these diseases is a primary 
goal in regenerative medicine research that attracts great attention. The 
successful use of converted neural cells in transplantations has opened a new 
avenue to treat such diseases (Zhang et al., 2012b). Nevertheless, induced 
neurons, directly converted from fibroblasts are terminally committed and exhibit 
very limited proliferative ability (Yang et al., 2011). From the work presented in 
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this thesis, two miRNAs have been identified which when knocked down result in 
a cell fate switch to an induced neural progenitor state. These results could have 
huge implications when applied to regenerative medicine in terms of both clinical 
applications and disease modelling in vitro. 
In addition, miR-196a and miR-219 KD result in a loss of NC. This can also have 
clinical implications in relation to melanoma cancer. Metastatic melanoma is the 
most aggressive skin cancer and despite tremendous efforts and considerable 
progress in clinical treatment of melanoma patients within recent years, it remains 
a deadly disease (Shakhova, 2014). A growing number of publications highlight 
the existence of phenotypic and functional similarities between embryonic NC 
cells and melanoma cells. These studies provide compelling evidence that the 
propagation of melanoma cells critically depends on genes instrumental in NC 
development (White et al., 2011, Kaufman et al., 2016, Shakhova, 2014). As miR-
196a and miR-219 KD resulted in an aberration of NC development they prove 
to be interesting targets for melanoma treatment. This is particularly true as the 
recent development of miRNA antisense technology (anti-miR) has shown great 
promise in the development of novel therapeutics (Stenvang et al., 2012). 
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Appendices  
As some documents are very large or are videos they have been placed on an 
‘electronic appendix’. To access this please use the following link: 
https://drive.google.com/open?id=0B8k6eLrrbmlGNlg4aHoydW9ZSk0 
Chapter 2 - Materials and methods: 
Appendix 1: plasmids used to make RNA probes 
Clone name Antisense RE Antisense polymerase  Source 
Sox2 EcoR1 T7 Prof Yoshiki Sasai 
Snail2 Bgl2 Sp6 Dr Michael Sargent 
Sox10 EcoR1 T3 Prof Jean-Pierre Saint-
Jeannet 
Pax6 Xbal   
FoxD3 BamH1 T7 Prof Yoshiki Sasai 
Zic1 EcoR1 T3 Dr Jung Aruga 
Zic3 BamH1 T3 Dr Jung Aruga 
Twist BamH1  Michael G. Sargent 
Hairy1 ASP718  Michael G. Sargent 
Snail1 ClaI SP6 Prof Jean-Pierre Saint-
Jeannet 
Hairy2 BamH1 T7 Michael G. Sargent 
MSX1 EcoR1 T7 Jean Illes and Harv 
Isaacs 
MSX2 Sal1 T7 Michael G. Sargent 
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DLX5 Xbal T3 Thomas Sargent  
PAX3 BglII SP6 Prof Anne-Helene-
Monsoro 
ENG2 Xbal T3 Nancy Papalopulus 
N-tubulin Ncol T3 Nancy Papalopulus 
ELRC Hind3 T7 Nancy Papalopulus 
 
Appendix 2: miRNA primers used for smallRNA sequencing validation 
Name Primer 
Xtr-miR-196a UAGGUAGUUUCAUGUUGUUGG 
Ipu-miR-219a AGAAUUGUGCCUGGACAUCUGU 
Xtr-miR-302 UAAGUGCUCCAAUGUUUUAGUGG 
Dps-miR-219 UGAUUGUCCAAACGCAAUUCUUG 
 
Appendix 3: mRNA primers used for qRT-PCR prior to RNA sequencing 
gene Forward primer Reverse primer 
Snail2 CACACGTTACCCTGCGTATG TCTGTCTGCGAATGCTCTGT 
ODC CATGGCATTCTCCCTGAAGT TGGTCCCAAGGCTAAAGTTG 
Pax3 CAAGCTCACAGAGGCGCGAGT AGCTGGCATAGCTGCAGGAGG 
MyoD TACACTGACAGCCCCAATGA TGCAGAGGAGAACAGGGACT 
EF1 ACACTGCTCACATTGCTTGC AGAAGCTCTCCACGCACATT 
SOX10 CTATTACTGACACACGACGGAGC ACCTCTCATCCTCTGAATCCTGC 
XHE CATGTCTAATGGCGGTTGTG TGCTGGATGATCCCCATATT 
Six1 TGGTTCAAGAACAGGAGGCA CGACTTCCCTCCGTCTAGGG 
  
XX 
 
 
Chapter 3 – Identification of miRNAs in 
neural crest cells  
 
Chapter 4 – functional analysis of 
candidate miRNAs 
Document number 2 of electronic appendix: Novel miRNAs were detected using 
the programs mircat (Stocks et al., 2012) and mirdeep2 (Friedlander et al., 2008) 
and were evaluated for the likelihood of hairpin secondary structure using RNAFold 
(Gruber et al., 2015).  
Appendix 5: Structure of novel miRNA hairpins.: 
Document number 3 of the electronic appendix: The first embryo ‘poked’ is a 
control non-injected embryo. This embryo responds immediately and swims off. 
This is compared to miR-429 KD embryo (injected with 60ng of miR-429 MO into 
a one-cell staged embryo) which does not respond at all to being ‘poked’. 
 
Appendix 6: miR-429 KD embryos do not respond during the ‘poke and stroke’ assay. 
Document number 1 on electronic appendix: An excel sheet containing 
information regarding total number of reads, total number of mapped reads 
and percentage of mapped reads for each sample following RNA sequencing 
of miR-219 and miR-196a KD NC tissue 
Appendix 4: Number of reads and percentage of mapped reads following RNA 
sequencing 
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Chapter 5: Downstream target analysis 
of miRNAs miR-196a and miR-219 
 
Appendix 7: Top predicted targets of miR-219 using miR-system 
MiR-system was used to find targets of miR-219. Analysis was completed using human genes and any 
interesting targets were checked for conservation by the author. Only genes predicted to be targets by at 
least 6 of the algorithm sites are displayed in the table (last column). 
  
XXII 
 
 
Appendix 8: Top predicted targets of miR-196a using miR-system. 
MiR-system was used to find targets of miR-196a. Analysis was completed using human genes and any 
interesting targets were checked for conservation by the author. . Only genes predicted to be targets by at 
least 6 of the algorithm sites are displayed in the table (last column). 
 
 
  
XXIII 
 
 
Appendix 9: Expression profile of various genes detected by qRT-PCR in 
dissected samples following KD of miR-219. 
The aim of this experiment was to use qRT-PCR to select the best samples to send to sequencing (those 
with a clear KD of neural crest genes). Embryos were injected into one dorsal blastomere of a four-cell 
embryo with 60ng of one of two MOs (miR-219 MO or miR-219MM). GFP was used as a tracer. Once at the 
appropriate stage (14 or 17) the neural crest region was dissected, RNA extracted and qRT-PCR was ran 
to check gene expression. A non-injected control was used as a reference. ODC was used to normalise 
gene expression. Genes that were investigated include the NPB markers (Six1 and Pax3), the NC markers 
(Snail2 and Sox10), the neural marker (Sox2) and the ectodermal markers (Keratin) (A) Expression of 
various genes at stage 14 dissections. Focusing mainly on the expression levels of Snail2 and Sox2 the 
samples chosen to be sent for sequencing were 2, 3, 5 and 6. Four samples were chosen (instead of three) 
so one could be excluded from analysis if it did not cluster with the other replicates. (B) Expression of various 
genes at stage 17 dissections. As the gene expression looked abnormal (not biologically reproducible) and 
no KD of the NC marker Snail2 was seen no samples were sent for sequencing 
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Appendix 10: Expression profile of various genes detected by qRT-PCR in 
dissected samples following KD of miR-196a. 
The aim of this experiment was to use qRT-PCR to select the best samples to send to sequencing (those 
with a clear KD of neural crest genes). As the first three samples tested all had the appropriate gene 
expression, no further samples were tested (unlike for miR-219).Therefore, all the samples displayed here 
were sent for sequencing. Embryos were injected into one dorsal blastomere of a four-cell embryo with 60ng 
of one of two MOs (miR-196a MO or miR-196aMM). GFP was used as a tracer. Once at the appropriate 
stage (14 or 17) the neural crest region was dissected, RNA extracted and qRT-PCR was ran to check gene 
expression. A non-injected control was used as a reference. ODC was used to normalise gene expression. 
Genes that were investigated include the NPB marker (Pax3), the NC marker (Snail2), the neural marker 
(Sox2) and the ectodermal markers (Keratin) (A) Expression of various genes at stage 14 dissections (B) 
Expression of various genes at stage 17 dissections.  
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Appendix 11: PCA plot showing clustering of replicates between MO injected 
embryos and MM control. 
PCA plots of MM controls (blue dots) vs non-injected controls (red dots) demonstrated that for (A) 
miR219MM (stage 14), (B) miR-196aMM (stage 14) and (C) miR-196aMM (stage 17) there is no clustering 
between the two treatment types and they are not distinct from one another. 
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Appendix 12: Sample distance heat map showing clustering of replicates between 
MM control and control. 
Sample distance heat maps of MM controls vs non-injected controls demonstrated that for (A) miR219MM 
(stage 14), (B) miR-196aMM (stage 14) and (C) miR-196aMM (stage 17) the there is no clustering between 
the two treatment types. 
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Appendix 13: An MA-plot of gene changes between MM control and non-injected 
controls. 
Each gene is represented with a dot. Genes with an adjusted p value below a threshold (here 0.1, the default) 
are shown in red. MA plot of MM controls vs non-injected controls demonstrated that for (A) miR219MM 
(stage 14), (B) miR-196aMM (stage 14) and (C) miR-196aMM (stage 17) there are very few genes which 
deviate from the midline meaning there are not many gene changes between the two treatments. 
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Document number 3 on electronic appendix: The excel document has three 
sheets clearly labelled, one for each of the treatment types. The relevant data 
used by the author for analysis includes column C (log2fold change) column G 
(Padj) and column M (BLAST results). Genes were sorted by Padj and those 
genes with a Padj<0.05 were sorted by log2fold change. 
 
Appendix 14: Differential expression analysis results following RNA sequencing of 
MO vs MM samples   
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